Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.9300820783343303,1.5905563381382375,0.0,0.39354837338863385,0.187,3/38,1.83%,Nfia;Nfib;Nfix
prerank,EPHB-mediated Forward Signaling R-HSA-3928662,0.9031085310272671,1.5299858268557238,0.01715686274509804,1.0,0.705,12/32,5.45%,Kalrn;Tiam1;Grin2b;Itsn1;Ptk2;Actr3;Arpc2;Fyn;Syngap1;Arhgef28;Gprin1;Src
prerank,Budding And Maturation Of HIV Virion R-HSA-162588,0.9133491942122061,1.5289797089376411,0.010230179028132993,0.885796180103306,0.714,3/27,3.48%,Sgip1;Nedd4l;Vps37b
prerank,RNA Polymerase III Transcription Termination R-HSA-73980,0.9674752502831825,1.5230352128771172,0.0,0.7958422661859039,0.775,3/21,1.83%,Nfia;Nfib;Nfix
prerank,Signaling By NOTCH4 R-HSA-9013694,0.8008157938675008,1.517324172082814,0.002288329519450801,0.7533640290582417,0.818,9/80,5.79%,Maml2;Maml3;Notch2;Smad3;Ywhaz;Psen1;Jag1;Crebbp;Cul1
prerank,EPH-Ephrin Signaling R-HSA-2682334,0.787116448529312,1.5104768732824159,0.0044742729306487695,0.7646082682979172,0.869,18/88,3.89%,Kalrn;Epha7;Tiam1;Grin2b;Epha4;Vav3;Epha6;Itsn1;Ptk2;Actr3;Arpc2;Dnm1;Nck2;Sdcbp;Fyn;Arhgef7;Syngap1;Efnb3
prerank,Transmission Across Chemical Synapses R-HSA-112315,0.6850793307817137,1.5092735779338389,0.0044742729306487695,0.6773315541994853,0.872,52/236,2.82%,Gabrb3;Nbea;Grin2a;Cacna1e;Cacnb2;Ppfia2;Gria1;Lrrc7;Grin2b;Kcnj6;Gabra2;Kcnj3;Camk2a;Gabrb1;Nsf;Rims1;Camk2b;Gria2;Adcy1;Cacna2d1;Grik4;Gabrb2;Gabra4;Rasgrf1;Ppm1e;Adcy2;Gria3;Prkag2;Rasgrf2;Gabrg2;Plcb1;Gabbr2;Epb41l1;Arhgef9;Gng7;Syn2;Gnal;Gabra5;Ncald;Tspan7;Mapk1;Nptn;Adcy9;Slc17a7;Nrgn;Gng2;Camkk1;Cacng8;Camk2g;Syn3;Slc1a1;Rps6ka2
prerank,Neuronal System R-HSA-112316,0.6481221305006237,1.4963836509466322,0.0,0.8281694539999703,0.936,82/373,3.10%,Gabrb3;Dlgap2;Nbea;Ntrk3;Dlgap1;Lrrtm4;Grm1;Il1rap;Grin2a;Cacna1e;Cacnb2;Ppfia2;Gria1;Kcnd2;Il1rapl1;Lrrc7;Grin2b;Kcnj6;Gabra2;Kcnj3;Camk2a;Gabrb1;Nsf;Rims1;Camk2b;Gria2;Adcy1;Cacna2d1;Grik4;Kcnh1;Gabrb2;Gabra4;Rasgrf1;Kcnab1;Ppm1e;Adcy2;Gria3;Syt7;Prkag2;Rasgrf2;Gabrg2;Plcb1;Kcnd3;Kcnc3;Grm5;Sipa1l1;Gabbr2;Nlgn1;Epb41l1;Arhgef9;Gng7;Syn2;Gnal;Kcng2;Gabra5;Ncald;Kcnk10;Tspan7;Mapk1;Nptn;Adcy9;Slc17a7;Lrfn2;Syt10;Nrgn;Kcnc4;Gng2;Camkk1;Cacng8;Abcc8;Kcnq3;Kcna4;Kcnk1;Camk2g;Syn3;Slc1a1;Rps6ka2;Slitrk2;Kcng1;Slitrk3;Kcng3;Kcna1
prerank,Late Phase Of HIV Life Cycle R-HSA-162599,0.7424616036558332,1.4962916018558177,0.008948545861297539,0.7378164389984441,0.937,16/125,7.90%,Sgip1;Nedd4l;Gtf2h2;Vps37b;Gtf2f2;Nmt1;Ccnh;Gtf2h5;Ssrp1;Ndc1;Ranbp2;Xpo1;Ncbp1;Mnat1;Ccnt2;Nup93
prerank,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.9043712298676498,-1.4906392613649235,0.02527646129541864,1.0,0.965,4/17,1.12%,Gab2;Stat5b;Cux1;Pik3r1
prerank,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.9244147632956707,1.4904970460718636,0.013888888888888888,0.7602355085935989,0.955,7/20,3.49%,Ntrk3;Il1rap;Ppfia2;Il1rapl1;Slitrk2;Slitrk3;Ptprd
prerank,ER To Golgi Anterograde Transport R-HSA-199977,0.7293597149104017,1.4903902929410884,0.008298755186721992,0.6927132840684784,0.955,12/128,3.13%,Gria1;Ank3;Nsf;Sptb;Cnih3;Tgfa;Sptbn1;Sec24d;Sptbn4;Ank2;Dync1i2;Sptan1
prerank,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.8271398158553191,1.4832860188283046,0.014778325123152709,0.7471172294806445,0.972,8/49,3.84%,Maml2;Maml3;Tnrc6c;Notch2;Jun;Ago1;Tnrc6b;Ago2
prerank,Signaling By SCF-KIT R-HSA-1433557,-0.8410997909763354,-1.4608633225410579,0.019400352733686066,1.0,0.997,13/40,7.35%,Kit;Ptpru;Gab2;Stat5b;Pik3r1;Fer;Grb10;Vav1;Jak2;Tec;Lyn;Prkca;Grb7
prerank,Regulation Of Beta-Cell Development R-HSA-186712,0.865253996292718,1.4599808173622029,0.020100502512562814,1.0,0.997,6/36,3.38%,Maml2;Maml3;Foxo1;Akt3;Onecut1;Neurod1
prerank,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.8563375220686983,1.4577419190135728,0.032407407407407406,1.0,0.997,16/34,6.33%,Wipf3;Wasf1;Baiap2;Nckap1;Abi2;Mapk1;Ptk2;Actr3;Arpc2;Abi1;Cyfip2;Cyfip1;Mapk3;Arpc1a;Nck1;Wasf3
prerank,Signaling By NOTCH2 R-HSA-1980145,0.8781483935961658,1.456181607260973,0.025,1.0,0.998,4/28,1.78%,Maml2;Maml3;Cntn1;Notch2
prerank,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.8877674465569232,1.4557085271341463,0.06944444444444445,0.9713773343163898,0.998,4/19,2.34%,Maml2;Maml3;Notch2;Smad3
prerank,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.6834305091298314,1.4518681139597067,0.017777777777777778,0.9789837314491113,0.999,43/173,2.82%,Gabrb3;Nbea;Grin2a;Gria1;Lrrc7;Grin2b;Kcnj6;Gabra2;Kcnj3;Camk2a;Gabrb1;Nsf;Camk2b;Gria2;Adcy1;Grik4;Gabrb2;Gabra4;Rasgrf1;Ppm1e;Adcy2;Gria3;Prkag2;Rasgrf2;Gabrg2;Plcb1;Gabbr2;Epb41l1;Arhgef9;Gng7;Gnal;Gabra5;Ncald;Tspan7;Mapk1;Nptn;Adcy9;Nrgn;Gng2;Camkk1;Cacng8;Camk2g;Rps6ka2
prerank,COPII-mediated Vesicle Transport R-HSA-204005,0.8034836847266486,1.4514204150243437,0.01735357917570499,0.9336189013140235,0.999,5/63,2.21%,Gria1;Nsf;Cnih3;Tgfa;Sec24d
prerank,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.8278665431056537,1.4479228909184678,0.026378896882494004,0.9395186564706431,1.0,3/37,2.75%,Nr3c2;Fkbp5;Dync1i2
prerank,Oxidative Stress Induced Senescence R-HSA-2559580,0.7832219472858825,1.4477189322442028,0.02050113895216401,0.8955411874443577,1.0,17/78,6.67%,Tnik;Tnrc6c;Map2k6;Mapk1;Jun;Ago1;Tnrc6b;Mapk10;Mink1;Map2k4;Mapk3;Cbx6;Ezh2;Mapk14;Cbx4;Suz12;Map3k5
prerank,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.8486632598125161,1.444014049744614,0.049783549783549784,0.9073327653136892,1.0,1/31,0.57%,Sgip1
prerank,Interleukin-7 Signaling R-HSA-1266695,-0.8522533906483583,-1.438771025890088,0.04006677796327212,1.0,0.999,3/25,1.12%,Socs2;Stat5b;Pik3r1
prerank,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.8375635093693384,1.4373362725945311,0.05054945054945055,0.9626886039948225,1.0,1/33,0.57%,Sgip1
prerank,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.7256280662803275,-1.4360573838429977,0.02040816326530612,1.0,1.0,32/119,10.20%,Pcdh7;Prkcb;Fn1;Phactr2;Igf1;Sgpp2;Cyrib;Vcl;Prkcg;App;Sparc;Tmx3;Selenop;Sccpdh;Clu;Cd109;Scg3;Vegfd;Vegfa;Prkca;Calu;Tgfb1;Lamp2;Tgfb3;Plek;Cd63;Itih3;Anxa5;Flna;Endod1;Habp4;Gas6
prerank,Cardiac Conduction R-HSA-5576891,0.7021936636994281,1.4346995039943802,0.023965141612200435,0.9595627351152817,1.0,24/120,2.95%,Cacna1c;Cacnb2;Kcnip4;Ryr2;Fgf14;Kcnd2;Camk2a;Camk2b;Scn3a;Kcnd3;Slc8a2;Scn2a;Atp2b1;Scn8a;Kcnk10;Orai2;Scn3b;Kcnip2;Atp2b3;Ryr1;Cacng8;Kcnk1;Camk2g;Scn9a
prerank,Pre-NOTCH Expression And Processing R-HSA-1912422,0.7702193578452929,1.4342479388363376,0.0343980343980344,0.9267127173365688,1.0,9/65,3.84%,Maml2;Maml3;Tnrc6c;Notch2;B4galt1;Jun;Ago1;Tnrc6b;Ago2
prerank,Protein-protein Interactions At Synapses R-HSA-6794362,0.7406699048205574,1.4328534733584801,0.02968036529680365,0.9085345305657603,1.0,19/86,2.14%,Dlgap2;Ntrk3;Dlgap1;Lrrtm4;Grm1;Il1rap;Grin2a;Ppfia2;Gria1;Il1rapl1;Grin2b;Gria3;Syt7;Grm5;Sipa1l1;Nlgn1;Epb41l1;Lrfn2;Syt10
prerank,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.887497493817289,1.4324219027904765,0.09944751381215469,0.8789727528723918,1.0,3/15,2.80%,Maml2;Maml3;Onecut1
prerank,Interleukin-1 Signaling R-HSA-9020702,0.7277040605395306,1.4323961685721085,0.02795698924731183,0.8468809323643475,1.0,13/109,5.79%,Il1rap;Map2k6;Il1r1;Map2k1;Tnip2;Fbxw11;Peli1;Btrc;Peli2;Map2k4;Ripk2;Map3k3;Cul1
prerank,GABA Receptor Activation R-HSA-977443,0.7743909223121195,1.4301890825795256,0.04405286343612335,0.8414885230993476,1.0,18/57,2.29%,Gabrb3;Kcnj6;Gabra2;Kcnj3;Gabrb1;Adcy1;Gabrb2;Gabra4;Adcy2;Gabrg2;Gabbr2;Arhgef9;Gng7;Gnal;Gabra5;Nptn;Adcy9;Gng2
prerank,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.8782032032808528,1.4221768493970202,0.08157894736842106,0.9107833784136954,1.0,2/15,1.87%,Foxo1;Bcl6
prerank,Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.8838129887700136,1.420792421788302,0.079155672823219,0.8969987740124639,1.0,1/18,0.57%,Cyp7b1
prerank,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.8631787406529745,1.4156233945211427,0.06233062330623306,0.9327882336999416,1.0,1/27,0.34%,Ak5
prerank,Activation Of GABAB Receptors R-HSA-991365,0.7980820116395956,1.412857987365317,0.06787330316742081,0.9371761066290443,1.0,9/40,2.29%,Kcnj6;Kcnj3;Adcy1;Adcy2;Gabbr2;Gng7;Gnal;Adcy9;Gng2
prerank,Metabolism Of Nucleotides R-HSA-15869,0.7386869846116191,1.4102751356106709,0.02727272727272727,0.93728495237926,1.0,6/86,3.20%,Ak5;Dpyd;Gda;Adk;Nt5c2;Upp2
prerank,Cargo Concentration In ER R-HSA-5694530,0.8391107136772592,1.4086895022303547,0.06361323155216285,0.928458146630309,1.0,6/29,5.23%,Gria1;Cnih3;Tgfa;Sec24d;Lman2l;Sec23a
prerank,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.7669837721289798,1.4084414711019324,0.04295942720763723,0.9045722748336844,1.0,16/57,3.69%,Cacna1c;Cacnb2;Cacna1d;Gfra1;Ncam1;Sptb;Cacna1h;Mapk1;Sptbn1;Ptk2;Ptpra;Sptbn4;St8sia4;Gfra2;Sptan1;Fyn
prerank,HIV Life Cycle R-HSA-162587,0.6916498850139597,1.4064737374187914,0.026905829596412557,0.9005108635527576,1.0,16/138,7.90%,Sgip1;Nedd4l;Gtf2h2;Vps37b;Gtf2f2;Nmt1;Ccnh;Gtf2h5;Ssrp1;Ndc1;Ranbp2;Xpo1;Ncbp1;Mnat1;Ccnt2;Nup93
prerank,PTEN Regulation R-HSA-6807070,0.6840316151646165,1.4018044481643268,0.02591792656587473,0.9248302358422387,1.0,31/136,9.02%,Tnrc6c;Akt3;Mapk1;Hdac7;Prex2;Chd4;Chd3;Cnot6l;Gatad2b;Jun;Rragd;Ago1;Tnrc6b;Nedd4;Tnks;Ago2;Hdac1;Mapk3;Mta3;Cbx6;Rptor;Ezh2;Cbx4;Suz12;Rcor1;Rbbp7;Psmd13;Phc2;Mta2;Usp7;Slc38a9
prerank,Activation Of Matrix Metalloproteinases R-HSA-1592389,0.8604332950101624,1.3983165261884627,0.09814323607427056,0.9376774944898777,1.0,3/20,1.79%,Mmp16;Spock3;Mmp17
prerank,Muscle Contraction R-HSA-397014,0.6513989779715434,1.3950266451652384,0.023809523809523808,0.9485204548363092,1.0,33/186,3.92%,Cacna1c;Cacnb2;Kcnip4;Ryr2;Fgf14;Kcnd2;Camk2a;Sorbs1;Camk2b;Scn3a;Kcnd3;Slc8a2;Scn2a;Cald1;Atp2b1;Scn8a;Kcnk10;Orai2;Cacna1h;Scn3b;Kcnip2;Atp2b3;Ryr1;Cacng8;Kcnk1;Camk2g;Scn9a;Tmod1;Anxa6;Atp1b1;Gucy1b1;Itpr1;Actn2
prerank,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.8415089705862882,-1.393207849424067,0.038834951456310676,1.0,1.0,9/33,7.15%,Dlc1;Colec12;Apoe;Masp1;Sparc;Col1a2;Col4a2;Col4a1;Col3a1
prerank,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.7424109501031285,1.392867951663512,0.05010893246187364,0.9466087739912161,1.0,10/73,1.48%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Fgd4;Arhgef9;Arhgef4
prerank,FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.8277487152153039,-1.3916958715019998,0.07885906040268456,1.0,1.0,5/28,2.15%,Gab2;Stat5b;Cux1;Pik3r1;Fgf1
prerank,COPI-mediated Anterograde Transport R-HSA-6807878,0.7280673934319739,1.3879959799469455,0.051111111111111114,0.9748664004219261,1.0,9/76,4.10%,Ank3;Nsf;Sptb;Sptbn1;Sptbn4;Ank2;Dync1i2;Sptan1;Arf3
prerank,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.773409202728656,-1.3864977567969017,0.04878048780487805,1.0,1.0,13/53,3.54%,Gpc6;Xylt1;Hs6st2;Hs3st2;Ext1;Hs3st5;Hs6st3;Ndst3;Hs3st4;Gpc5;Bcan;Dcn;Cspg5
prerank,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.8700290614982106,-1.386277796771168,0.07804878048780488,1.0,1.0,4/15,6.83%,Prkcb;Prkcg;Ap2b1;Prkca
prerank,Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.7234219267999934,-1.3861241075761948,0.03747870528109029,1.0,1.0,10/95,9.23%,Ldb2;Or51d1;Or52i2;Or51e1;Or52k2;Reep1;Ebf1;Or52m1;Or51e2;Or2t1
prerank,Signaling By ALK R-HSA-201556,-0.8206636951476463,-1.3842433828075897,0.0681063122923588,1.0,1.0,3/26,1.12%,Alk;Ptn;Pik3r1
prerank,Signaling By FGFR1 In Disease R-HSA-5655302,-0.8124270313677083,-1.3802354075533538,0.08061749571183534,1.0,1.0,5/34,2.15%,Gab2;Stat5b;Cux1;Pik3r1;Fgf1
prerank,Signaling By KIT In Disease R-HSA-9669938,-0.8472782366646692,-1.3780843384057118,0.08374384236453201,1.0,1.0,5/19,6.36%,Kit;Stat5b;Pik3r1;Jak2;Lyn
prerank,Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.8579930263210728,-1.3775028907880982,0.08892355694227769,1.0,1.0,3/15,1.12%,Gab2;Stat5b;Pik3r1
prerank,Cellular Senescence R-HSA-2559583,0.6820944992047895,1.375947100151399,0.05652173913043478,1.0,1.0,26/138,8.02%,Tnik;Tnrc6c;Map2k6;Mapk1;Jun;Rps6ka2;Ago1;Tnrc6b;Mapk10;Mink1;Map2k4;Rad50;Mapk3;Cbx6;Ehmt1;Hira;Ezh2;Mapk14;Ube2d1;Cbx4;Suz12;Map3k5;Rbbp7;Cebpb;Nfkb1;Phc2
prerank,Complement Cascade R-HSA-166658,-0.7701783841962729,-1.3752697590810046,0.07450331125827815,1.0,1.0,11/40,13.09%,Cpne2;Masp1;Cfh;Clu;C1qa;Vtn;C1qb;Cd81;C1qc;Cr2;C8a
prerank,Platelet Degranulation R-HSA-114608,-0.6941169295121407,-1.3731477415027762,0.04275092936802974,1.0,1.0,29/115,10.20%,Pcdh7;Fn1;Phactr2;Igf1;Sgpp2;Cyrib;Vcl;App;Sparc;Tmx3;Selenop;Sccpdh;Clu;Cd109;Scg3;Vegfd;Vegfa;Calu;Tgfb1;Lamp2;Tgfb3;Plek;Cd63;Itih3;Anxa5;Flna;Endod1;Habp4;Gas6
prerank,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.8650865486659931,1.3729531848071281,0.13695090439276486,1.0,1.0,7/16,7.95%,Map2k1;Tnip2;Fbxw11;Btrc;Map2k4;Cul1;Nfkb1
prerank,Interleukin-1 Family Signaling R-HSA-446652,0.6704607098172445,1.3720104709184244,0.04,1.0,1.0,13/140,4.69%,Il1rap;Il1rapl1;Map2k6;Il1r1;Map2k1;Tnip2;Smad3;Fbxw11;Peli1;Btrc;Peli2;Map2k4;Ripk2
prerank,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.7842149375736444,-1.3686300029243155,0.08585858585858586,1.0,1.0,15/41,8.56%,Dmd;Nrxn1;Lama4;Ntn4;Lamc2;Itgb5;Lama1;Vtn;Ddr2;Prkca;Lama2;Tgfb1;Itgb1;Itga6;Lamc3
prerank,Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.8323309183848295,-1.3654181115713948,0.09180327868852459,1.0,1.0,4/18,1.26%,Gab2;Stat5b;Pik3r1;Etv6
prerank,ISG15 Antiviral Mechanism R-HSA-1169408,0.7347455709024948,1.3609313326086174,0.0847457627118644,1.0,1.0,10/69,7.90%,Sgip1;Pdzd2;Nedd4;Mapk3;Eif4g2;Ndc1;Eif4e3;Ranbp2;Eif4a1;Nup93
prerank,Meiotic Synapsis R-HSA-1221632,0.761973915303133,1.3606518344592857,0.09691629955947137,1.0,1.0,1/46,0.44%,Syne1
prerank,PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.8496045535667173,1.3600535513582122,0.15113350125944586,1.0,1.0,4/18,2.02%,Nbea;Adcy1;Adcy2;Adcy9
prerank,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.7514938062930676,-1.359934045371376,0.07508532423208192,1.0,1.0,19/54,8.90%,Lama4;Col6a1;Col6a5;Col8a1;Lamc2;Col27a1;Col6a2;Col11a1;Col1a2;Col4a2;Col24a1;Ctss;Col4a1;Col3a1;Col4a5;Pcolce;Itga6;Loxl2;Mmp28
prerank,Signaling By FGFR In Disease R-HSA-1226099,-0.742170312961371,-1.3596461352951423,0.09090909090909091,1.0,1.0,5/59,2.15%,Gab2;Stat5b;Cux1;Pik3r1;Fgf1
prerank,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.8219334598865914,-1.3586509448903088,0.07679180887372014,1.0,1.0,4/28,2.15%,Flrt2;Pik3r1;Flrt1;Fgf1
prerank,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.8083415914786342,1.357862056094217,0.10784313725490197,1.0,1.0,7/26,10.40%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Mnat1;Polr2e;Rngtt
prerank,Scavenging By Class A Receptors R-HSA-3000480,-0.8557523098422469,-1.3565517407572638,0.08868501529051988,1.0,1.0,7/17,7.15%,Colec12;Apoe;Masp1;Col1a2;Col4a2;Col4a1;Col3a1
prerank,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.7682265517649282,-1.3540528711955868,0.08934707903780069,1.0,1.0,8/40,5.13%,Tbl1x;Hmgcs1;Smarcd3;Srebf2;Hmgcr;Sqle;Elovl6;Fdft1
prerank,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.8059000474859838,-1.3506283660263105,0.08605851979345955,1.0,1.0,6/28,7.15%,Gab2;Stat5b;Hck;Jak2;Lyn;Csf3r
prerank,mRNA Capping R-HSA-72086,0.8054543718517477,1.3498597476978664,0.1125,1.0,1.0,8/28,10.40%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Ncbp1;Mnat1;Polr2e;Rngtt
prerank,FGFR2 Alternative Splicing R-HSA-6803529,0.7996858459821913,1.3486667135795305,0.12745098039215685,1.0,1.0,7/25,9.93%,Rbfox2;Gtf2f2;Hnrnpm;Ncbp1;Hnrnph1;Tia1;Polr2e
prerank,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.8275725741387071,1.347937501703798,0.1323529411764706,1.0,1.0,7/27,3.99%,Map2k6;Pdzd2;Akt3;Chd4;Chd3;Gatad2b;Hdac1
prerank,PKA Activation R-HSA-163615,0.8541478633018478,1.3477043538021771,0.15326633165829145,1.0,1.0,4/16,2.02%,Nbea;Adcy1;Adcy2;Adcy9
prerank,Cholesterol Biosynthesis R-HSA-191273,-0.7993914546005907,-1.3468263048802551,0.09878682842287695,1.0,1.0,7/25,6.66%,Hmgcs1;Msmo1;Srebf2;Hmgcr;Sqle;Fdft1;Dhcr24
prerank,Assembly Of HIV Virion R-HSA-175474,0.830815298076599,1.3447355611770648,0.16180371352785147,1.0,1.0,2/17,3.48%,Sgip1;Vps37b
prerank,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.6098319538019707,-1.3445226396375105,0.03374777975133215,1.0,1.0,59/263,11.77%,Chrm3;Rxfp1;Htr1f;Htr2c;Htr7;Chrm2;Adra1a;Qrfpr;Htr2a;Tacr3;Cckbr;Drd2;Npsr1;Oprk1;Adra1b;Ntsr1;Ptger3;Lpar1;App;Hrh2;Hrh3;Opn3;Npffr1;S1pr1;Tac1;Ednrb;Sst;Hcrt;Cx3cr1;Plppr3;Gpr37l1;Ucma;Ccr5;P2ry6;Htr1b;Nmbr;Prok2;Lhcgr;Bdkrb2;Ffar4;Adra2a;Tacr2;Chga;Cxcr4;Adrb1;Adrb3;Oprd1;P2ry13;Rxfp3;Pnoc;Tshb;Tacr1;Ntsr2;Npy;Edn1;Gpr17;Ptgdr;P2ry12;Cxcr2
prerank,Peptide Ligand-Binding Receptors R-HSA-375276,-0.65339119367279,-1.3419430548629527,0.05698529411764706,1.0,1.0,32/153,12.20%,Rxfp1;Qrfpr;Tacr3;Cckbr;Npsr1;Oprk1;Ntsr1;App;Npffr1;Tac1;Ednrb;Sst;Hcrt;Cx3cr1;Gpr37l1;Ucma;Ccr5;Nmbr;Prok2;Bdkrb2;Tacr2;Cxcr4;Oprd1;Rxfp3;Pnoc;Tacr1;Ntsr2;Npy;Edn1;Cxcr2;Edn3;Cxcl16
prerank,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.8271922237165507,-1.3412945732342114,0.10476190476190476,1.0,1.0,3/20,6.79%,Stx1a;App;Cyb5a
prerank,HS-GAG Biosynthesis R-HSA-2022928,-0.7999463687480185,-1.3407965442090772,0.08667736757624397,1.0,1.0,9/30,1.03%,Gpc6;Hs6st2;Hs3st2;Ext1;Hs3st5;Hs6st3;Ndst3;Hs3st4;Gpc5
prerank,NCAM1 Interactions R-HSA-419037,0.7678582767695444,1.3393154221671588,0.11165048543689321,1.0,1.0,8/37,2.27%,Cacna1c;Cacnb2;Cacna1d;Gfra1;Ncam1;Cacna1h;St8sia4;Gfra2
prerank,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.84055965179454,1.339073604155665,0.16172506738544473,1.0,1.0,2/15,3.48%,Sgip1;Vps37b
prerank,NRAGE Signals Death Thru JNK R-HSA-193648,0.7514812334271007,1.3379395821286693,0.07029478458049887,1.0,1.0,10/56,1.48%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Fgd4;Arhgef9;Arhgef4
prerank,Interleukin-20 Family Signaling R-HSA-8854691,-0.8137118309992029,-1.336864666921721,0.1331168831168831,1.0,1.0,3/18,7.29%,Stat5b;Jak2;Ifnlr1
prerank,Regulation Of Complement Cascade R-HSA-977606,-0.7668210055632579,-1.3347650016429546,0.12395309882747069,1.0,1.0,10/33,13.09%,Cpne2;Cfh;Clu;C1qa;Vtn;C1qb;Cd81;C1qc;Cr2;C8a
prerank,Degradation Of DVL R-HSA-4641258,0.7498178617431281,1.3340247072482658,0.08726415094339622,1.0,1.0,1/55,0.66%,Hecw1
prerank,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.8083463904714749,1.3315974835888644,0.15053763440860216,1.0,1.0,2/24,0.39%,Maml2;Maml3
prerank,Purine Catabolism R-HSA-74259,0.847624997137995,1.3315059907882294,0.18571428571428572,1.0,1.0,2/15,2.65%,Gda;Nt5c2
prerank,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.7552471883210937,1.3307705924034583,0.10981308411214953,1.0,1.0,9/47,4.03%,Nbea;Maml2;Maml3;Tle1;Ncor1;Hdac7;Tle4;Hdac1;Hdac8
prerank,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.7428533414125367,-1.3257479002680328,0.11627906976744186,1.0,1.0,3/50,2.85%,Satb2;Hdac4;Satb1
prerank,"Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",-0.8172567155067341,-1.3227669964921822,0.1358609794628752,1.0,1.0,5/17,11.62%,Pcsk1;Igf1;Ache;Pla2g7;Mboat4
prerank,"Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.8176992778760039,1.3181766623809783,0.16458852867830423,1.0,1.0,4/21,2.95%,Grm1;Scn3a;Scn2a;Scn9a
prerank,Inwardly Rectifying K+ Channels R-HSA-1296065,0.7668209545899005,1.3162290476688598,0.14950980392156862,1.0,1.0,6/33,2.37%,Kcnj6;Kcnj3;Gabbr2;Gng7;Gng2;Abcc8
prerank,Zinc Transporters R-HSA-435354,0.8295351004534719,1.3161713229568788,0.19373219373219372,1.0,1.0,2/17,2.38%,Slc39a6;Slc30a3
prerank,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.7529398810772987,1.3142279621237316,0.12705882352941175,1.0,1.0,13/41,13.41%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Ssrp1;Ncbp1;Mnat1;Ccnt2;Polr2e;Ccnk;Cdk9;Ctdp1;Tcea1
prerank,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.693612544587764,1.313649617478108,0.10273972602739725,1.0,1.0,19/72,2.82%,Nbea;Grin2a;Gria1;Lrrc7;Grin2b;Camk2a;Camk2b;Gria2;Adcy1;Rasgrf1;Ppm1e;Gria3;Prkag2;Rasgrf2;Mapk1;Nrgn;Camkk1;Camk2g;Rps6ka2
prerank,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.820992925213361,1.3115162308172792,0.16120906801007556,1.0,1.0,6/22,4.10%,Tiam1;Grin2b;Ntf3;Dock3;Fyn;Cdk5r1
prerank,Signaling By TGF-beta Receptor Complex R-HSA-170834,0.6775499980925527,1.3113962921657065,0.0871559633027523,1.0,1.0,15/91,4.74%,Itga8;Nedd4l;Pard3;Ncor1;Mapk1;Ppp1cb;Tgfbr1;Smad3;Itgb8;Usp15;Ski;Tgfb2;Hdac1;Cbl;Mapk3
prerank,"Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.7971134062628833,-1.3107526882199458,0.12641815235008103,1.0,1.0,6/23,7.85%,Pcsk1;Tcf7l2;C1qtnf1;Dpp4;Ucma;Ffar4
prerank,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.7493250358841651,-1.3098362870759204,0.11403508771929824,1.0,1.0,11/42,6.83%,Gab2;Stat5b;Pik3r1;Clstn1;Inpp5d;Hck;Vav1;Jak2;Tec;Lyn;Prkca
prerank,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.7845521685283418,-1.3070644031243335,0.12807881773399016,1.0,1.0,6/24,2.86%,Mgat4c;Chst8;St6gal1;Man2a1;Mgat5;St8sia6
prerank,Peptide Hormone Metabolism R-HSA-2980736,-0.6853328822092849,-1.3061471044963155,0.1105072463768116,1.0,1.0,19/79,9.19%,Cpe;Pcsk1;Stx1a;Igf1;Kif5a;Tcf7l2;C1qtnf1;Ctsd;Ctsz;Dpp4;Ache;Ucma;Aopep;Inhbb;Ffar4;Atp6ap2;Pla2g7;Anpep;Chga
prerank,FOXO-mediated Transcription R-HSA-9614085,0.7100021426142004,1.3059170334729364,0.14251781472684086,1.0,1.0,10/61,5.71%,Plxna4;Foxo1;Akt3;Bcl6;Smad3;Btg1;Hdac1;Ywhaz;Ywhab;Crebbp
prerank,Initial Triggering Of Complement R-HSA-166663,-0.8208117277388627,-1.3047250471513234,0.1507293354943274,1.0,1.0,4/15,8.33%,Masp1;C1qa;C1qb;C1qc
prerank,Interaction Between L1 And Ankyrins R-HSA-445095,0.7899242976388324,1.3035375017803303,0.16580310880829016,1.0,1.0,13/29,3.13%,Ank3;Nrcam;Scn3a;Scn2a;Sptb;Scn8a;Scn3b;Sptbn1;Sptbn4;Ank2;Kcnq3;Scn9a;Sptan1
prerank,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.6899735452293649,-1.3005468610339763,0.08880994671403197,1.0,1.0,1/85,0.10%,Ldb2
prerank,Formation Of Early Elongation Complex R-HSA-113418,0.7664280350507585,1.2997696697909131,0.16216216216216217,1.0,1.0,7/31,9.93%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Ncbp1;Mnat1;Polr2e
prerank,"Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.799738988320478,-1.2993745652303366,0.13687600644122383,1.0,1.0,5/20,7.85%,Pcsk1;Tcf7l2;Dpp4;Ucma;Ffar4
prerank,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.7969765864324139,-1.2955737878475047,0.17592592592592593,1.0,1.0,1/16,1.30%,Enpp2
prerank,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.7450310554059852,1.2945854354579436,0.16267942583732056,1.0,1.0,11/39,13.41%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Ssrp1;Ncbp1;Mnat1;Polr2e;Cdk9;Ctdp1;Tcea1
prerank,Death Receptor Signaling R-HSA-73887,0.6245954095483022,1.293840686552475,0.09876543209876543,1.0,1.0,11/134,2.25%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Fgd4;Arhgef9;Arhgef4;Usp2
prerank,Regulation Of Gene Expression In Beta Cells R-HSA-210745,0.82734968740492,1.2934291327544425,0.21505376344086022,1.0,1.0,3/17,3.38%,Foxo1;Akt3;Neurod1
prerank,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.7399976445897476,1.2918260214687582,0.1367713004484305,1.0,1.0,5/48,0.80%,Epha7;Tiam1;Epha4;Vav3;Epha6
prerank,MAPK6/MAPK4 Signaling R-HSA-5687128,0.6683325575183764,1.2893419279552114,0.1261061946902655,1.0,1.0,8/87,3.84%,Kalrn;Foxo1;Tnrc6c;Jun;Ago1;Tnrc6b;Arhgef7;Ago2
prerank,Amine Ligand-Binding Receptors R-HSA-375280,-0.7643931306538215,-1.2879132121114885,0.14453781512605043,1.0,1.0,11/34,4.41%,Chrm3;Htr1f;Htr2c;Htr7;Chrm2;Adra1a;Htr2a;Drd2;Adra1b;Hrh2;Hrh3
prerank,Interleukin Receptor SHC Signaling R-HSA-912526,-0.7778043820821056,-1.2873449756828945,0.1819672131147541,1.0,1.0,5/25,5.65%,Gab2;Pik3r1;Clstn1;Inpp5d;Jak2
prerank,FLT3 Signaling In Disease R-HSA-9682385,-0.7651588858351115,-1.2855862289847384,0.15862068965517243,1.0,1.0,4/26,1.26%,Gab2;Stat5b;Pik3r1;Etv6
prerank,Insulin Processing R-HSA-264876,-0.759052766490827,-1.2854302865935419,0.16243654822335024,1.0,1.0,4/26,2.05%,Cpe;Pcsk1;Stx1a;Kif5a
prerank,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.7302276306203878,-1.2854216756664225,0.1643598615916955,1.0,1.0,8/45,7.87%,Klf5;Lef1;Rara;E2f1;Fli1;Runx1;Csf3r;Spi1
prerank,P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.6531604626357358,1.2843806120419194,0.08488612836438923,1.0,1.0,10/94,1.48%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Fgd4;Arhgef9;Arhgef4
prerank,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.7734372743935981,1.2843054768857858,0.23173803526448364,1.0,1.0,6/25,0.47%,Nbea;Grin2a;Lrrc7;Grin2b;Camk2a;Camk2b
prerank,PI-3K cascade:FGFR4 R-HSA-5654720,-0.8001346101690491,-1.2825470499305125,0.1624203821656051,1.0,1.0,4/17,9.95%,Pik3r1;Fgf1;Fgf23;Pik3ca
prerank,Depolymerisation Of Nuclear Lamina R-HSA-4419969,-0.8054137925723425,-1.2814617512681945,0.17857142857142858,1.0,1.0,1/15,0.43%,Prkcb
prerank,Signaling By NTRKs R-HSA-166520,0.6349125355640881,1.2807063159835748,0.09594882729211088,1.0,1.0,27/129,5.90%,Ntrk3;Tiam1;Grin2b;Bcl11b;Pcsk5;Ntf3;Mapk1;Rit2;Map2k1;Adcyap1r1;Chd4;Dock3;Mef2c;Rps6ka2;Dnm1;Mef2d;Pik3cb;Fyn;Tcf12;Cdk5r1;Mapk3;Ywhab;Src;Map2k5;Irs1;Mapk14;Irs2
prerank,Early Phase Of HIV Life Cycle R-HSA-162594,0.8201203191852806,1.280284710932041,0.2077562326869806,1.0,1.0,1/15,0.57%,Sgip1
prerank,Spry Regulation Of FGF Signaling R-HSA-1295596,0.825403270831283,1.2796775906186604,0.21606648199445982,1.0,1.0,4/16,5.45%,Mapk1;Cbl;Mapk3;Src
prerank,Post NMDA Receptor Activation Events R-HSA-438064,0.693991804366213,1.2790193812813757,0.14788732394366197,1.0,1.0,16/59,2.82%,Grin2a;Gria1;Lrrc7;Grin2b;Camk2a;Camk2b;Gria2;Adcy1;Rasgrf1;Prkag2;Rasgrf2;Mapk1;Nrgn;Camkk1;Camk2g;Rps6ka2
prerank,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.7831288827351606,1.2788520581307965,0.19638242894056848,1.0,1.0,4/26,3.99%,Plxna4;Foxo1;Smad3;Hdac1
prerank,G Alpha (12/13) Signaling Events R-HSA-416482,0.680110974204346,1.2779455786614855,0.11946902654867257,1.0,1.0,12/76,2.29%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Fgd4;Arhgef9;Gng7;Arhgef4;Gng2
prerank,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.6522162529803068,-1.277919738607953,0.10849909584086799,1.0,1.0,16/114,8.84%,Satb2;Maf;Itgbl1;Hdac4;Smurf1;Dlx5;Wwtr1;Esr1;Smad1;Runx1;Ucma;Smad6;Ccnd1;Sox9;Ppargc1a;Gli3
prerank,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.7899086466707191,1.277121833029778,0.2273972602739726,1.0,1.0,4/18,2.34%,Grin2a;Grin2b;Gria2;Fkbp5
prerank,Signaling By NOTCH R-HSA-157118,0.600251346219292,1.2770069643138748,0.07066381156316917,1.0,1.0,26/186,6.00%,Nbea;Maml2;Maml3;Tnrc6c;Cntn1;Tle1;Ncor1;Notch2;B4galt1;Hdac7;Smad3;Tle4;Jun;Ago1;Tnrc6b;Ago2;Hdac1;Hdac8;Ywhaz;Psen1;Tbl1xr1;Mib1;Jag1;Crebbp;Cul1;Ncor2
prerank,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.7761637906515492,-1.2739250215391498,0.17470881863560733,1.0,1.0,1/21,0.17%,Asap1
prerank,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.7910307370602905,1.2735911405614448,0.21683673469387754,1.0,1.0,5/21,2.13%,Grin2a;Gria1;Grin2b;Gria3;Lrfn2
prerank,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.7685009786451086,1.2728194435139688,0.18461538461538463,1.0,1.0,5/27,2.29%,Kcnj6;Kcnj3;Gabbr2;Gng7;Gng2
prerank,Ca2+ Pathway R-HSA-4086398,0.7017461619415584,1.2722731429435994,0.16203703703703703,1.0,1.0,12/60,3.86%,Ppp3ca;Prkg1;Camk2a;Tnrc6c;Plcb1;Gng7;Gng2;Ppp3r1;Ago1;Tnrc6b;Ago2;Itpr1
prerank,Sensory Perception Of Taste R-HSA-9717189,0.779767439570853,1.2674918894636547,0.2185929648241206,1.0,1.0,5/26,4.42%,Grm1;Scn3a;Scn2a;Scn9a;Scnn1a
prerank,Inflammasomes R-HSA-622312,-0.7817596580239126,-1.2667805833500763,0.19166666666666668,1.0,1.0,4/19,7.17%,Bcl2;P2rx7;App;Casp1
prerank,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,0.6711492579244777,1.2634990986335386,0.15991471215351813,1.0,1.0,11/75,7.90%,Sgip1;Pdzd2;Nedd4;Mapk3;Eif4g2;Ndc1;Eif4e3;Ranbp2;Eif4a1;Abce1;Nup93
prerank,Signaling By TGFB Family Members R-HSA-9006936,0.6281668827539847,1.2625809989712637,0.13544018058690746,1.0,1.0,18/116,4.74%,Itga8;Nedd4l;Pard3;Acvr2a;Ncor1;Mapk1;Ppp1cb;Tgfbr1;Smad3;Itgb8;Usp15;Ski;Bmpr1a;Tgfb2;Hdac1;Cbl;Acvr1c;Mapk3
prerank,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.75892110624348,-1.26064910864529,0.18612521150592218,1.0,1.0,5/23,7.15%,Stat5b;Hck;Jak2;Lyn;Csf3r
prerank,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.6569551716555176,1.2600741332201892,0.1452991452991453,1.0,1.0,22/80,4.74%,Prkce;Vav3;Wipf3;Wasf1;Baiap2;Nckap1;Abi2;Mapk1;Ptk2;Actr3;Arpc2;Abi1;Plpp4;Pik3cb;Plcg2;Elmo2;Fyn;Itpr1;Cyfip2;Myo5a;Cyfip1;Mapk3
prerank,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.7776577283795647,1.259392341289627,0.25064599483204136,1.0,1.0,3/23,2.36%,Dapk1;Dcc;Unc5a
prerank,Mitochondrial Calcium Ion Transport R-HSA-8949215,0.7561654819181284,1.2590825999826176,0.2398989898989899,1.0,1.0,3/21,3.66%,Mcu;Micu1;Yme1l1
prerank,Signaling By NOTCH3 R-HSA-9012852,0.7078006716353145,1.2570664135148144,0.18396226415094338,1.0,1.0,2/47,0.39%,Maml2;Maml3
prerank,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.7458591122835336,1.2559294152617673,0.21513002364066194,1.0,1.0,11/32,11.24%,Chd4;Chd3;Gatad2b;Hdac1;Mta3;Rbbp7;Mta2;Cbx3;H2bc4;H2ax;H2ac6
prerank,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.7701969801251589,1.2555855001726157,0.24242424242424243,1.0,1.0,3/22,4.10%,Erc2;Jun;Cdk5r1
prerank,N-Glycan Antennae Elongation R-HSA-975577,-0.7761653588553983,-1.255368751717806,0.20447284345047922,1.0,1.0,5/15,5.10%,Mgat4c;St6gal1;Mgat5;St8sia6;St8sia2
prerank,Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.7578453895669801,-1.2546849602887056,0.17789291882556132,1.0,1.0,9/27,11.85%,Smad2;Sall1;Sox2;Epas1;Nr6a1;Pbx1;Hhex;Epha1;Foxp1
prerank,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.7273811385246485,-1.2534157361761076,0.21122112211221122,1.0,1.0,8/34,9.19%,Kit;Apoe;Esr1;Kctd1;Wwox;Vegfa;Egfr;Chga
prerank,Intracellular Signaling By Second Messengers R-HSA-9006925,0.5581370311167322,1.253073723744248,0.06153846153846154,1.0,1.0,39/294,3.99%,Nbea;Il1rap;Pip5k1b;Prkce;Camk2a;Camk2b;Adcy1;Nrg2;Foxo1;Adcy2;Tnrc6c;Nrg3;Akt3;Mapk1;Tgfa;Pde1b;Hdac7;Adcy9;Prex2;Chd4;Camkk1;Chd3;Pip5k1a;Cnot6l;Camk2g;Gatad2b;Jun;Flt3;Rragd;Pik3cb;Ago1;Tnrc6b;Nedd4;Tnks;Fyn;Fgf5;Ago2;Itpr1;Hdac1
prerank,Nucleotide Catabolism R-HSA-8956319,0.7457650483572202,1.250467139910125,0.2169576059850374,1.0,1.0,4/30,3.20%,Dpyd;Gda;Nt5c2;Upp2
prerank,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.7629308802242709,1.248675089452596,0.22807017543859648,1.0,1.0,4/25,7.87%,Atf6;Khsrp;Cebpb;Exosc8
prerank,RUNX2 Regulates Bone Development R-HSA-8941326,-0.7418612625723641,-1.247611681142558,0.22468354430379747,1.0,1.0,7/28,6.67%,Satb2;Maf;Hdac4;Wwtr1;Smad1;Ucma;Smad6
prerank,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.6974213149778379,-1.2475705331974138,0.18198874296435272,1.0,1.0,8/53,5.88%,Pcdh15;Kcnn2;Epb41l3;Whrn;Myo1e;Gsn;Ezr;Clic5
prerank,Other Interleukin Signaling R-HSA-449836,-0.7648074221247864,-1.2470473008853207,0.20064724919093851,1.0,1.0,5/20,7.29%,Il34;Stx1a;Csf1r;Csf3r;Ifnlr1
prerank,RHOJ GTPase Cycle R-HSA-9013409,-0.6982206279447998,-1.2450584964144713,0.17217391304347826,1.0,1.0,13/53,7.11%,Fnbp1l;Cpne8;Pik3r1;Arhgap26;Prex1;Wwp2;Fnbp1;Gja1;Rhoj;Cav1;Dock8;Ophn1;Stom
prerank,Neurexins And Neuroligins R-HSA-6794361,0.6825409478144885,1.2433740024429667,0.18912529550827423,1.0,1.0,12/55,2.14%,Dlgap2;Dlgap1;Lrrtm4;Grm1;Grin2a;Grin2b;Syt7;Grm5;Sipa1l1;Nlgn1;Epb41l1;Syt10
prerank,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.7523070733303417,1.240916794650963,0.23785166240409208,1.0,1.0,9/26,2.82%,Lrrc7;Grin2b;Camk2a;Camk2b;Rasgrf1;Rasgrf2;Mapk1;Camk2g;Rps6ka2
prerank,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.7569847168383271,-1.239712925795776,0.2129032258064516,1.0,1.0,4/23,9.95%,Pik3r1;Fgf1;Fgf23;Pik3ca
prerank,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.6832547785080002,1.237973794492729,0.18058690744920994,1.0,1.0,13/56,6.00%,Maml2;Maml3;Ncor1;Hdac7;Hdac1;Hdac8;Psen1;Tbl1xr1;Mib1;Jag1;Crebbp;Cul1;Ncor2
prerank,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.7719712945722359,1.2374481013595164,0.2649350649350649,1.0,1.0,3/20,4.10%,Erc2;Jun;Cdk5r1
prerank,Diseases Of Programmed Cell Death R-HSA-9645723,0.6898941112165536,1.2368145479700348,0.19817767653758542,1.0,1.0,7/57,7.38%,Erc2;Jun;Cdk5r1;Ezh2;Suz12;Ywhae;Rbbp7
prerank,TP53 Regulates Metabolic Genes R-HSA-5628897,0.6428884397510974,1.2356172452512109,0.14316239316239315,1.0,1.0,12/79,6.13%,Tnrc6c;Prkag2;Akt3;Rragd;Ago1;Tnrc6b;Ago2;Ywhaz;Ywhab;Rptor;Txnrd1;Ywhah
prerank,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.7727572799713939,1.2345770691384697,0.23697916666666666,1.0,1.0,8/21,0.73%,Grin2a;Gria1;Lrrc7;Grin2b;Camk2a;Camk2b;Gria2;Gria3
prerank,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.7652475013699849,-1.2304496768788842,0.22884012539184953,1.0,1.0,5/18,7.64%,Prkcb;Itpr2;Vegfa;Prkca;Prkcd
prerank,Regulation Of KIT Signaling R-HSA-1433559,-0.7612835259416247,-1.2289416068565358,0.22843450479233227,1.0,1.0,3/15,6.83%,Kit;Lyn;Prkca
prerank,Ion Channel Transport R-HSA-983712,0.5805781359909593,1.2276777210964747,0.1400437636761488,1.0,1.0,21/162,3.62%,Ano3;Trpc6;Trpm3;Ryr2;Camk2a;Camk2b;Nedd4l;Unc79;Unc80;Atp2b1;Atp2b3;Atp8a1;Ano2;Ryr1;Atp6v1a;Best3;Camk2g;Nalcn;Atp2c1;Atp1b1;Ano6
prerank,Signaling By NOTCH1 R-HSA-1980143,0.6504791876697015,1.2273707816876676,0.14782608695652175,1.0,1.0,17/72,6.00%,Nbea;Maml2;Maml3;Cntn1;Tle1;Ncor1;Hdac7;Tle4;Hdac1;Hdac8;Psen1;Tbl1xr1;Mib1;Jag1;Crebbp;Cul1;Ncor2
prerank,Notch-HLH Transcription Pathway R-HSA-350054,0.7395467260024999,1.2261812587908876,0.26649746192893403,1.0,1.0,10/28,6.00%,Maml2;Maml3;Ncor1;Notch2;Hdac7;Hdac1;Hdac8;Tbl1xr1;Crebbp;Ncor2
prerank,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.6775815929794267,1.226134964250925,0.20659340659340658,1.0,1.0,16/55,4.74%,Vav3;Wipf3;Wasf1;Baiap2;Nckap1;Abi2;Mapk1;Ptk2;Actr3;Arpc2;Abi1;Elmo2;Cyfip2;Myo5a;Cyfip1;Mapk3
prerank,Stimuli-sensing Channels R-HSA-2672351,0.6249313921812039,1.2255590712315643,0.174496644295302,1.0,1.0,11/91,2.96%,Ano3;Trpc6;Trpm3;Ryr2;Nedd4l;Unc79;Unc80;Ano2;Ryr1;Best3;Nalcn
prerank,Processing Of SMDT1 R-HSA-8949664,0.7754489077211891,1.2239476156894864,0.27717391304347827,1.0,1.0,3/15,3.66%,Mcu;Micu1;Yme1l1
prerank,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.7763258719990616,1.2234668450786272,0.289544235924933,1.0,1.0,7/17,5.45%,Tnrc6c;Ago1;Tnrc6b;Ago2;Ccnd2;Cbfb;Src
prerank,MAPK Family Signaling Cascades R-HSA-5683057,0.5443916412775371,1.2234420005176527,0.08695652173913043,1.0,1.0,43/300,3.92%,Kalrn;Lrrc7;Grin2b;Camk2a;Camk2b;Rasal2;Nrg2;Rasgrf1;Foxo1;Tnrc6c;Nrg3;Rasgrf2;Gfra1;Rapgef2;Ncam1;Cnksr2;Sptb;Mapk1;Ksr2;Tgfa;Map2k1;Sptbn1;Ptk2;Ptpn3;Ppp1cb;Ptpra;Sptbn4;Gfra2;Rasgef1a;Camk2g;Jun;Flt3;Pik3cb;Sptan1;Ago1;Tnrc6b;Abhd17c;Fyn;Arhgef7;Syngap1;Fgf5;Ago2;Actn2
prerank,PI-3K cascade:FGFR3 R-HSA-5654710,-0.7598613738739755,-1.2224548737312324,0.2302839116719243,1.0,1.0,5/16,9.95%,Pik3r1;Fgf1;Fgfr3;Fgf23;Pik3ca
prerank,Transcriptional Regulation By RUNX3 R-HSA-8878159,0.6232204145606266,1.2222763378475436,0.15765765765765766,1.0,1.0,9/93,5.71%,Maml2;Maml3;Tead1;Smad3;Itga4;Cbfb;Src;Jag1;Crebbp
prerank,Growth Hormone Receptor Signaling R-HSA-982772,-0.7422173128701625,-1.221910940666706,0.24208860759493672,1.0,1.0,7/21,8.61%,Socs2;Stat5b;Cish;Jak2;Lyn;Adam17;Prlr
prerank,Nephrin Family Interactions R-HSA-373753,0.7453700070801391,1.2213081001481771,0.2853717026378897,1.0,1.0,12/21,6.25%,Kirrel3;Magi2;Sptbn1;Nck2;Pik3cb;Sptan1;Fyn;Actn2;Actn1;Actn4;Cd2ap;Nck1
prerank,SLC Transporter Disorders R-HSA-5619102,0.6447155155678915,1.2208289657056137,0.16515837104072398,1.0,1.0,9/91,7.90%,Slc4a4;Slc24a4;Slc1a1;Slc9a7;Slc12a6;Ndc1;Ranbp2;Slc9a9;Nup93
prerank,Phase 0 - Rapid Depolarisation R-HSA-5576892,0.7328485930080255,1.2190485814975613,0.24285714285714285,1.0,1.0,12/32,2.95%,Cacna1c;Cacnb2;Fgf14;Camk2a;Camk2b;Scn3a;Scn2a;Scn8a;Scn3b;Cacng8;Camk2g;Scn9a
prerank,RORA Activates Gene Expression R-HSA-1368082,-0.7559666640836269,-1.2185614098868205,0.25636942675159236,1.0,1.0,2/18,2.80%,Tbl1x;Smarcd3
prerank,Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.7331159272168624,-1.2163687476944307,0.2471169686985173,1.0,1.0,1/19,2.02%,Serpine2
prerank,Effects Of PIP2 Hydrolysis R-HSA-114508,0.7479891056408589,1.215156994342524,0.27925531914893614,1.0,1.0,6/27,2.01%,Trpc6;Dgkh;Prkce;Dgki;Dgkg;Dagla
prerank,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.7238171185771777,-1.2145988829600485,0.24332810047095763,1.0,1.0,3/25,2.80%,Tbl1x;Npas2;Smarcd3
prerank,Arachidonic Acid Metabolism R-HSA-2142753,-0.6939761567295927,-1.2138351155654343,0.23442622950819672,1.0,1.0,12/41,9.94%,Fa2h;Tbxas1;Ptgs1;Ptgds;Alox12b;Pon2;Pla2g4a;Hpgd;Ggt5;Hpgds;Abcc1;Ptges
prerank,RHO GTPase Effectors R-HSA-195258,0.5589757842465519,1.2135387381903955,0.13800904977375567,1.0,1.0,38/249,6.91%,Iqgap2;Diaph2;Wipf3;Wasf1;Baiap2;Nckap1;Pdzd2;Abi2;Mrtfa;Mapk1;Cenpp;Ppp1r12b;Ptk2;Ppp1cb;Fmnl2;Actr3;Arpc2;Abi1;Dync1i2;Diaph1;Arhgef7;Cyfip2;Ywhaz;Cyfip1;Mapk3;Calm1;Ywhab;Src;Taok1;Mapk14;Ywhah;Arpc1a;Nck1;Wasf3;Ctnnb1;Ranbp2;Xpo1;Ywhae
prerank,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.6988967584591483,1.2135376975383418,0.22418136020151133,1.0,1.0,9/44,4.22%,Itga8;Nedd4l;Ppp1cb;Tgfbr1;Smad3;Itgb8;Usp15;Tgfb2;Cbl
prerank,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.7553029618206191,1.211822083979053,0.2810945273631841,1.0,1.0,6/19,0.85%,Lrrc7;Grin2b;Camk2a;Camk2b;Rasgrf1;Rasgrf2
prerank,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.7074588448931654,-1.2105719477446166,0.2363013698630137,1.0,1.0,6/35,8.21%,Agbl4;Tubb3;Ttll7;Ttl;Tubb4a;Vash2
prerank,Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.7459537062911985,1.2096495556885107,0.2869822485207101,1.0,1.0,4/18,2.78%,Ppfia2;Rims1;Syn2;Syn3
prerank,Beta-catenin Independent WNT Signaling R-HSA-3858494,0.6012181793156561,1.2096298202734739,0.15777777777777777,1.0,1.0,14/141,3.86%,Ppp3ca;Prkg1;Camk2a;Tnrc6c;Plcb1;Prickle1;Gng7;Gng2;Ppp3r1;Ago1;Tnrc6b;Vangl2;Ago2;Itpr1
prerank,Glycogen Metabolism R-HSA-8982491,-0.7419104039510216,-1.209029281203288,0.2235294117647059,1.0,1.0,6/22,11.09%,Ugp2;Phkb;Gbe1;Gys1;Phkg1;Gaa
prerank,Surfactant Metabolism R-HSA-5683826,-0.7368785006245624,-1.2081018134069212,0.23861852433281006,1.0,1.0,10/22,17.85%,Zdhhc2;Ctsh;Lmcd1;Adgrf5;Adra2a;Slc34a1;Abca3;Sftpb;Sftpc;Gata6
prerank,TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.7609051370965886,-1.2056838491868558,0.25774877650897227,1.0,1.0,9/16,18.70%,Tnfrsf11a;Traf3;Birc3;Ltb;Cd40;Tnfsf12;Ltbr;Cd40lg;Tnfsf11
prerank,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.7403195256960066,-1.204184115549996,0.2520064205457464,1.0,1.0,3/22,3.40%,Satb2;Maf;Wwtr1
prerank,Signaling By PDGFR In Disease R-HSA-9671555,-0.7477329786482093,-1.2040231986975178,0.2663316582914573,1.0,1.0,6/19,9.95%,Pik3r1;Etv6;Pdgfra;Kank1;Bin2;Pik3ca
prerank,RNA Polymerase I Transcription Initiation R-HSA-73762,0.6864187581463119,1.2031145435851387,0.2045977011494253,1.0,1.0,12/45,8.46%,Chd4;Chd3;Gatad2b;Gtf2h2;Hdac1;Mta3;Ccnh;Gtf2h5;Ubtf;Rbbp7;Mnat1;Mta2
prerank,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.6949777537370314,-1.1988527958257627,0.24482758620689654,1.0,1.0,10/40,5.01%,Kcnc2;Kcns3;Gng4;Prkar1b;Itpr2;Iqgap1;Gnas;Rapgef3;Gng12;Gnb4
prerank,Signaling To RAS R-HSA-167044,-0.7308694456262406,-1.1975728277210307,0.2626582278481013,1.0,1.0,4/19,6.23%,Shc3;Ngf;Mapk11;Ralb
prerank,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.7119414539457282,1.1973342768033166,0.2729528535980149,1.0,1.0,9/31,6.43%,Nedd4l;Ncor1;Mapk1;Smad3;Ski;Hdac1;Mapk3;Ncor2;Ube2d1
prerank,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.7096509188831343,-1.1961442006438454,0.2565359477124183,1.0,1.0,8/26,5.36%,Gpc6;Xylt1;Gpc5;Bcan;Dcn;Cspg5;Vcan;Cspg4
prerank,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.6002223703884959,1.1960168373766698,0.17713004484304934,1.0,1.0,10/109,2.41%,Dock10;Zfpm2;Kif26b;Carmil1;Dock4;Dock11;Ehd3;Phf21a;Dock3;Ehd1
prerank,Metal Ion SLC Transporters R-HSA-425410,0.7013259464680731,1.1944792483814235,0.27225130890052357,1.0,1.0,2/26,2.38%,Slc39a6;Slc30a3
prerank,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.6613795353172504,1.1937204485018234,0.22321428571428573,1.0,1.0,14/51,8.41%,Nedd4l;Ncor1;Mapk1;Smad3;Ski;Hdac1;Mapk3;Ncor2;Ube2d1;Cdk8;Parp1;Ybx1;Ccnt2;Ube2d3
prerank,Gene Silencing By RNA R-HSA-211000,0.6096862330475081,1.188959443186569,0.19747899159663865,1.0,1.0,16/92,12.10%,Tnrc6c;Ago1;Tnrc6b;Ago2;Dicer1;Ndc1;Ranbp2;Nup93;Polr2e;H2bc4;H2ax;H2ac6;Tdrkh;Nup160;Henmt1;Dgcr8
prerank,CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.6065976909935661,1.188481522341492,0.18872017353579176,1.0,1.0,10/98,6.43%,Ppp3ca;Ppp3r1;Fbxw11;Btrc;Plcg2;Itpr1;Calm1;Src;Cul1;Ube2d1
prerank,Nuclear Envelope Breakdown R-HSA-2980766,-0.6775109355771594,-1.1882694602897659,0.24587155963302754,1.0,1.0,2/49,1.05%,Prkcb;Vrk2
prerank,Signaling By FGFR3 In Disease R-HSA-5655332,-0.7370484152097473,-1.1878106111956226,0.2717041800643087,1.0,1.0,5/19,9.95%,Pik3r1;Fgf1;Fgfr3;Fgf23;Pik3ca
prerank,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.6034119247959046,-1.1874451213141393,0.19964028776978418,1.0,1.0,13/110,8.06%,Tbl1x;Npas2;Arnt2;Hmgcs1;Fhl2;Abca1;Smarcd3;Srebf2;Hmgcr;Fdft1;Pparg;Cdk19;Ppargc1a
prerank,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.5085625978261377,1.1869820596657668,0.08849557522123894,1.0,1.0,67/478,4.75%,Gabrb3;Ntrk3;Prkce;Tiam1;Grin2b;Gabrb1;Vav3;Ptk2b;Nrg2;Bcl11b;Pcsk5;Gabrb2;Wasf1;Nrg3;Nrp1;Gabrg2;Ptprj;Ntf3;Baiap2;Nckap1;Nrp2;Abi2;Ptprk;Ncor1;Akt3;Mapk1;Rit2;Tgfa;Map2k1;Adcyap1r1;Ptk2;Ptpn3;Chd4;Atp6v1a;Dock3;Abi1;Mef2c;Flt3;Rps6ka2;Dnm1;Nck2;Mef2d;Pik3cb;Lamc1;Rbfox2;Diaph1;Sh3gl1;Elmo2;Nedd4;Gtf2f2;Fyn;Arhgef7;Syngap1;Fgf5;Thbs3;Itpr1;Hdac1;Lamb1;Cyfip2;Tcf12;Cdk5r1;Cbl;Spred2;Cyfip1;Cul5;Mapk3;Bcar1
prerank,Deadenylation-dependent mRNA Decay R-HSA-429914,0.654763605546623,1.1849675561919815,0.23404255319148937,1.0,1.0,23/54,13.89%,Cnot2;Cnot6l;Dcp1b;Pan3;Cnot4;Eif4b;Edc3;Eif4a1;Nt5c3b;Lsm7;Exosc8;Dcp1a;Cnot1;Cnot3;Eif4e;Skic8;Eif4a2;Pabpc1;Edc4;Exosc2;Tnks1bp1;Exosc1;Skic3
prerank,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.7429079678068345,1.184824285798087,0.32386363636363635,1.0,1.0,7/15,15.34%,Dcp1b;Edc3;Lsm7;Dcp1a;Edc4;Lsm4;Patl1
prerank,PPARA Activates Gene Expression R-HSA-1989781,-0.6044540312812059,-1.1846851804725433,0.2115732368896926,1.0,1.0,13/108,8.06%,Tbl1x;Npas2;Arnt2;Hmgcs1;Fhl2;Abca1;Smarcd3;Srebf2;Hmgcr;Fdft1;Pparg;Cdk19;Ppargc1a
prerank,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.6128940482462223,1.1841561804122345,0.21140142517814728,1.0,1.0,8/80,3.49%,Slc2a13;Slc44a5;Slc16a7;Slc39a6;Slc6a15;Slc30a3;Slc44a1;Slc6a6
prerank,Azathioprine ADME R-HSA-9748787,0.7314484150197061,1.1839158398820004,0.29427792915531337,1.0,1.0,1/19,0.43%,Vav3
prerank,MAP Kinase Activation R-HSA-450294,0.643517559847777,1.1833628802611833,0.23851203501094093,1.0,1.0,16/61,6.40%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Btrc;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4
prerank,Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.7058379493630346,1.1825575547644824,0.3101449275362319,1.0,1.0,4/23,2.81%,Ppfia2;Rims1;Slc17a7;Slc1a1
prerank,FCGR3A-mediated Phagocytosis R-HSA-9664422,0.6647409479895764,1.1804939925391336,0.2311212814645309,1.0,1.0,21/55,6.33%,Vav3;Wipf3;Wasf1;Baiap2;Nckap1;Abi2;Mapk1;Ptk2;Actr3;Arpc2;Abi1;Elmo2;Fyn;Cyfip2;Myo5a;Cyfip1;Mapk3;Src;Arpc1a;Nck1;Wasf3
prerank,Metabolism Of Carbohydrates R-HSA-71387,-0.5366641024438217,-1.1773994125406653,0.17063492063492064,1.0,1.0,27/263,5.36%,Gpc6;Xylt1;Hs6st2;Hs3st2;Ext1;Hs3st5;Hs6st3;Pfkp;Ndst3;Hs3st4;Gpc5;Ugp2;Bcan;Phkb;St3gal6;Cd44;Dcn;Pck2;Aldh1a1;Cspg5;Map4k2;Manba;Pfkfb4;Vcan;Gbe1;Pgm2;Cspg4
prerank,Long-term Potentiation R-HSA-9620244,0.726910080109001,1.1766634173612318,0.29396984924623115,1.0,1.0,7/23,0.48%,Grin2a;Gria1;Lrrc7;Grin2b;Camk2a;Camk2b;Gria2
prerank,PI-3K cascade:FGFR2 R-HSA-5654695,-0.7200053507849493,-1.1736573134921142,0.2836065573770492,1.0,1.0,4/21,9.95%,Pik3r1;Fgf1;Fgf23;Pik3ca
prerank,Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.7411507599926711,1.1729722050339029,0.35638297872340424,1.0,1.0,4/16,3.72%,Plxna4;Nrp1;Fyn;Arhgef7
prerank,Regulation Of PTEN Gene Transcription R-HSA-8943724,0.6476414893697395,1.1714543011193514,0.25952380952380955,1.0,1.0,22/58,9.69%,Mapk1;Hdac7;Chd4;Chd3;Gatad2b;Jun;Rragd;Hdac1;Mapk3;Mta3;Cbx6;Rptor;Ezh2;Cbx4;Suz12;Rcor1;Rbbp7;Phc2;Mta2;Slc38a9;Rnf2;Rragb
prerank,PKMTs Methylate Histone Lysines R-HSA-3214841,0.674180692996344,1.1705615328722638,0.2635294117647059,1.0,1.0,17/46,10.10%,Nsd1;Rbbp5;Dot1l;Ash1l;Kmt5a;Ehmt1;Ezh2;Smyd2;Suz12;Rbbp7;Aebp2;Setd7;Nfkb1;Kmt2c;Setdb1;Kmt5b;Setd2
prerank,SLC-mediated Transmembrane Transport R-HSA-425407,0.5306719365764957,1.1698519832673162,0.14058956916099774,1.0,1.0,19/227,3.49%,Slc4a4;Ahcyl2;Slc2a13;Slc44a5;Slc16a2;Slc8a2;Slc29a4;Slc16a10;Slc16a7;Slc39a6;Slc4a7;Slc6a15;Slc24a4;Slc17a7;Slc30a3;Slc4a10;Slc1a1;Slc44a1;Slc6a6
prerank,RNA Polymerase I Promoter Clearance R-HSA-73854,0.6346036064226138,1.1696303439818032,0.24263038548752835,1.0,1.0,18/65,11.24%,Chd4;Chd3;Gatad2b;Gtf2h2;Hdac1;Mapk3;Mta3;Ccnh;Gtf2h5;Ubtf;Rbbp7;Mnat1;Mta2;Cbx3;Polr2e;H2bc4;H2ax;H2ac6
prerank,Synthesis Of PC R-HSA-1483191,0.7043202099640322,1.1695797514651383,0.3253968253968254,1.0,1.0,2/27,3.06%,Slc44a5;Slc44a1
prerank,HIV Elongation Arrest And Recovery R-HSA-167287,0.7027046918398869,1.1692789099463725,0.3283582089552239,1.0,1.0,10/29,15.60%,Gtf2f2;Ssrp1;Ccnt2;Polr2e;Ccnk;Cdk9;Ctdp1;Tcea1;Gtf2f1;Polr2k
prerank,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.7237937250856454,-1.1691421214809763,0.28618421052631576,1.0,1.0,5/22,9.95%,Pik3r1;Fgf1;Fgfr3;Fgf23;Pik3ca
prerank,PERK Regulates Gene Expression R-HSA-381042,0.6996071889005013,1.1681577265182495,0.32587064676616917,1.0,1.0,4/29,7.87%,Atf6;Khsrp;Cebpb;Exosc8
prerank,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.6979466465719555,-1.1671651495739022,0.30084033613445377,1.0,1.0,4/25,4.40%,Elmo1;Dock2;Hck;Ap2b1
prerank,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.7366076046435394,1.167062527812793,0.3424242424242424,1.0,1.0,2/18,0.46%,Ppfia2;Rims1
prerank,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.6643062515122312,-1.1664854211889724,0.28109028960817717,1.0,1.0,4/47,2.15%,Gab2;Pik3r1;Igf1;Fgf1
prerank,Signaling By Erythropoietin R-HSA-9006335,-0.7077737275460831,-1.1663741674970487,0.2896890343698854,1.0,1.0,6/24,6.36%,Stat5b;Pik3r1;Clstn1;Vav1;Jak2;Lyn
prerank,RAC1 GTPase Cycle R-HSA-9013149,0.5456222752528611,1.1641001103756707,0.1734475374732334,1.0,1.0,30/175,4.07%,Kalrn;Dock10;Tiam1;Iqgap2;Vav3;Wipf3;Wasf1;Rasgrf2;Abr;Baiap2;Dock4;Nckap1;Arhgap20;Cdc42bpa;Dock11;Arhgef4;Abi2;Arhgap15;Arhgap21;Arhgap39;Arhgef25;Prex2;Dock3;Abi1;Abl2;Spata13;Arhgef7;Nisch;Cyfip2;Fam13a
prerank,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.7095535545890421,1.1640667724408018,0.3393316195372751,1.0,1.0,6/21,0.66%,Grin2a;Lrrc7;Grin2b;Camk2a;Camk2b;Ppm1e
prerank,Chromatin Modifying Enzymes R-HSA-3247509,0.5357358655284084,1.1633921609788829,0.19015659955257272,1.0,1.0,53/218,10.54%,Arid1b;Kat6b;Ncor1;Kdm7a;Chd4;Phf21a;Smarca2;Chd3;Gatad2b;Nsd1;Hdac1;Hdac8;Rbbp5;Dot1l;Brwd1;Trrap;Mta3;Smarca4;Ash1l;Kmt5a;Smarcd2;Ehmt1;Ncoa1;Tbl1xr1;Zzz3;Ezh2;Elp2;Crebbp;Arid5b;Ncor2;Smyd2;Suz12;Rcor1;Rbbp7;Kdm4a;Aebp2;Setd7;Nfkb1;Kmt2c;Setdb1;Mta2;Epc1;Kmt5b;Tada1;Taf5l;Kat7;Eny2;H2bc4;Msl2;Setd2;Kdm2b;Actl6b;Dr1
prerank,Integrin Signaling R-HSA-354192,-0.6952606364732962,-1.1615162854457624,0.2845786963434022,1.0,1.0,6/26,4.79%,Fn1;Rasgrp1;Apbb1ip;Rapgef3;Rasgrp2;Rap1b
prerank,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.6592650807762807,-1.1607312486055978,0.2874354561101549,1.0,1.0,4/49,2.15%,Gab2;Pik3r1;Igf1;Fgf1
prerank,FLT3 Signaling R-HSA-9607240,-0.6704173814190136,-1.1604330780332581,0.2847341337907376,1.0,1.0,6/36,3.77%,Socs2;Gab2;Stat5b;Pik3r1;Grb10;Hck
prerank,IGF1R Signaling Cascade R-HSA-2428924,-0.6600903360351813,-1.1600002742793063,0.2910958904109589,1.0,1.0,4/48,2.15%,Gab2;Pik3r1;Igf1;Fgf1
prerank,PKA Activation In Glucagon Signaling R-HSA-164378,0.7317320824190628,1.1591790301498293,0.34464751958224543,1.0,1.0,3/15,2.02%,Adcy1;Adcy2;Adcy9
prerank,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.7286584271764133,1.1583396055068815,0.3489010989010989,1.0,1.0,3/16,5.81%,Mtmr12;Inpp4a;Inpp4b
prerank,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.7166231730188856,1.15792150652714,0.37333333333333335,1.0,1.0,5/20,5.60%,Cntn1;Notch2;Psen1;Mib1;Jag1
prerank,Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.6544790883738553,1.1573869161659962,0.27713625866050806,1.0,1.0,19/53,15.60%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Ssrp1;Ncbp1;Aff4;Mnat1;Ccnt2;Rtf1;Polr2e;Skic8;Ccnk;Cdk9;Ctdp1;Tcea1;Cdc73;Gtf2f1;Polr2k
prerank,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.6481708061467357,-1.1566165271482411,0.26573426573426573,1.0,1.0,2/50,3.46%,Asap1;Smox
prerank,Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.7067961597293106,1.1553978713018394,0.3405994550408719,1.0,1.0,7/23,5.53%,Ppfia2;Rims1;Syn2;Syn3;Tspoap1;Lin7c;Syt1
prerank,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.6962830155873091,1.1553020919720238,0.34545454545454546,1.0,1.0,13/29,13.09%,Ube2w;Ube2e3;Ube2k;Ube2q2;Ube2d1;Ube2g2;Ube2b;Ube2r2;Usp7;Ube2h;Uchl3;Ube2t;Ube2l3
prerank,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.6721297368039026,-1.155020947697365,0.3064516129032258,1.0,1.0,6/35,4.79%,Fn1;Rasgrp1;Apbb1ip;Rapgef3;Rasgrp2;Rap1b
prerank,Striated Muscle Contraction R-HSA-390522,-0.6694255941197491,-1.1549548896017983,0.2877442273534636,1.0,1.0,5/32,5.96%,Dmd;Tnnt2;Tcap;Neb;Tmod3
prerank,Oncogene Induced Senescence R-HSA-2559585,0.6768293433456816,1.1546540435961041,0.3301204819277108,1.0,1.0,5/32,4.74%,Tnrc6c;Mapk1;Ago1;Tnrc6b;Mapk3
prerank,RAB Geranylgeranylation R-HSA-8873719,-0.6251133714295041,-1.1531101410358866,0.24958402662229617,1.0,1.0,3/57,1.76%,Rab3c;Rab3b;Rab31
prerank,Olfactory Signaling Pathway R-HSA-381753,-0.5977776004108266,-1.1524064097280238,0.2495697074010327,1.0,1.0,10/103,9.23%,Ldb2;Or51d1;Or52i2;Or51e1;Or52k2;Reep1;Ebf1;Or52m1;Or51e2;Or2t1
prerank,FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.7209716327232203,1.1506243161564262,0.3438320209973753,1.0,1.0,3/17,3.23%,Foxo1;Smad3;Btg1
prerank,Gluconeogenesis R-HSA-70263,-0.6926698024950242,-1.1500276455883771,0.30743243243243246,1.0,1.0,7/27,13.16%,Pck2;Slc25a13;Aldoc;Eno1;G6pc3;Mdh1;Fbp1
prerank,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.7122653876002947,1.1490634044027235,0.3391959798994975,1.0,1.0,5/27,2.29%,Cacna1c;Cacnb2;Cacna1d;Gng7;Gng2
prerank,Basigin Interactions R-HSA-210991,-0.6935475903699954,-1.1486019471587383,0.2984126984126984,1.0,1.0,9/24,8.14%,L1cam;Atp1b3;Mag;Cav1;Itga3;Slc16a1;Itgb1;Itga6;Slc7a11
prerank,Sphingolipid Metabolism R-HSA-428157,0.5985831443774488,1.1474442823616344,0.26057906458797325,1.0,1.0,9/80,5.56%,Prkd1;Cers6;Arsb;Arsj;Spns2;Ppm1l;Samd8;Acer3;Esyt3
prerank,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.6840588619842469,-1.146104999286833,0.29716193656093487,1.0,1.0,9/22,16.43%,App;Trim25;Rnf135;Nkiras1;Rigi;S100b;Ifih1;Map3k1;Nfkbia
prerank,RAF/MAP Kinase Cascade R-HSA-5673001,0.5182453203526387,1.1458188465247576,0.2028985507246377,1.0,1.0,45/257,5.45%,Lrrc7;Grin2b;Camk2a;Camk2b;Rasal2;Nrg2;Rasgrf1;Nrg3;Rasgrf2;Gfra1;Rapgef2;Ncam1;Cnksr2;Sptb;Mapk1;Ksr2;Tgfa;Map2k1;Sptbn1;Ptk2;Ptpn3;Ppp1cb;Ptpra;Sptbn4;Gfra2;Rasgef1a;Camk2g;Flt3;Pik3cb;Sptan1;Abhd17c;Fyn;Syngap1;Fgf5;Actn2;Ksr1;Spred2;Mapk3;Mras;Mpp3;Calm1;Ywhab;Paqr3;Gprin1;Src
prerank,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,0.6929646784586194,1.1457045837278899,0.34177215189873417,1.0,1.0,5/28,3.86%,Ppp3ca;Vav3;Ppp3r1;Plcg2;Itpr1
prerank,Signaling By ERBB4 R-HSA-1236394,0.6332100577462878,1.145333967803244,0.28824833702882485,1.0,1.0,7/56,1.66%,Gabrb3;Gabrb1;Nrg2;Gabrb2;Nrg3;Gabrg2;Ncor1
prerank,LDL Clearance R-HSA-8964038,-0.71293487456387,-1.1453251714161095,0.33547351524879615,1.0,1.0,6/16,20.40%,Ap2b1;Npc2;Soat1;Cltc;Ldlr;Ldlrap1
prerank,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.6927474948622008,-1.1441908923419553,0.31442463533225284,1.0,1.0,3/23,2.95%,Pde5a;Rhobtb1;Myo6
prerank,MAPK1/MAPK3 Signaling R-HSA-5684996,0.5169132264248291,1.1439842268173357,0.205761316872428,1.0,1.0,45/262,5.45%,Lrrc7;Grin2b;Camk2a;Camk2b;Rasal2;Nrg2;Rasgrf1;Nrg3;Rasgrf2;Gfra1;Rapgef2;Ncam1;Cnksr2;Sptb;Mapk1;Ksr2;Tgfa;Map2k1;Sptbn1;Ptk2;Ptpn3;Ppp1cb;Ptpra;Sptbn4;Gfra2;Rasgef1a;Camk2g;Flt3;Pik3cb;Sptan1;Abhd17c;Fyn;Syngap1;Fgf5;Actn2;Ksr1;Spred2;Mapk3;Mras;Mpp3;Calm1;Ywhab;Paqr3;Gprin1;Src
prerank,mRNA Splicing - Minor Pathway R-HSA-72165,0.6569761033430157,1.1425821558871778,0.29930394431554525,1.0,1.0,13/49,12.93%,Gtf2f2;Eftud2;Srsf1;Snrnp40;Sf3b3;Ncbp1;Ybx1;Ddx42;Polr2e;Snrnp48;Snrpd3;Snrpb;Srsf7
prerank,GPCR Ligand Binding R-HSA-500792,-0.5045803293216723,-1.1419605383791482,0.161231884057971,1.0,1.0,74/358,11.01%,Chrm3;Rxfp1;Htr1f;Htr2c;Grm8;Htr7;Grm3;Chrm2;Adra1a;Qrfpr;Gng4;Htr2a;Tacr3;Cckbr;Drd2;Npsr1;Oprk1;Adra1b;Grm4;Ntsr1;Ptger3;Lpar1;Gnas;App;Smox;Wnt2;Gng12;Hrh2;Hrh3;Opn3;Npffr1;S1pr1;Gnb4;Crhr1;C1qtnf1;Crhbp;Tac1;Ednrb;Sst;Hcrt;Cx3cr1;Plppr3;Gpr37l1;Ucma;Ccr5;P2ry6;Pth2r;Htr1b;Nmbr;Fzd2;Prok2;Lhcgr;Bdkrb2;Ffar4;Gng3;Sctr;Adra2a;Tacr2;Chga;Cxcr4;Adrb1;Adrb3;Oprd1;P2ry13;Rxfp3;Pnoc;Adgre1;Tshb;Tacr1;Calcr;Ntsr2;Wnt3a;Calcb;Npy
prerank,RAC2 GTPase Cycle R-HSA-9013404,0.5868770641984987,1.1415357728744493,0.2557077625570776,1.0,1.0,11/86,2.56%,Dock10;Tiam1;Vav3;Abr;Dock4;Nckap1;Abi2;Arhgap21;Arhgap39;Dock3;Abi1
prerank,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.6257316478784963,-1.1403628300403885,0.2980599647266314,1.0,1.0,8/53,5.13%,Tbl1x;Hmgcs1;Smarcd3;Srebf2;Hmgcr;Sqle;Elovl6;Fdft1
prerank,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.7170000970175882,1.1397344635089497,0.3470031545741325,1.0,1.0,2/17,0.46%,Ppfia2;Rims1
prerank,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.6535780592292297,-1.1367802464903187,0.3148148148148148,1.0,1.0,8/39,5.36%,Gpc6;Ext1;Gpc5;Bcan;Dcn;Cspg5;Vcan;Cspg4
prerank,Signaling By ERBB2 ECD Mutants R-HSA-9665348,-0.7123804244564876,-1.1363157547616518,0.33070866141732286,1.0,1.0,3/15,9.95%,Pik3r1;Egfr;Pik3ca
prerank,Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.6519924098877431,1.134129004305625,0.35,1.0,1.0,6/44,5.44%,Prkd1;Cers6;Spns2;Ppm1l;Samd8;Acer3
prerank,RNA Polymerase I Transcription R-HSA-73864,0.613807948195735,1.1336161015636002,0.2692307692307692,1.0,1.0,18/66,11.24%,Chd4;Chd3;Gatad2b;Gtf2h2;Hdac1;Mapk3;Mta3;Ccnh;Gtf2h5;Ubtf;Rbbp7;Mnat1;Mta2;Cbx3;Polr2e;H2bc4;H2ax;H2ac6
prerank,NLRP3 Inflammasome R-HSA-844456,-0.7103201277928397,-1.1331589586272899,0.3520900321543408,1.0,1.0,5/15,14.63%,P2rx7;App;Casp1;Txnip;Nlrp3
prerank,PI-3K cascade:FGFR1 R-HSA-5654689,-0.6982644660479104,-1.1318118110717876,0.3198707592891761,1.0,1.0,4/19,9.95%,Pik3r1;Fgf1;Fgf23;Pik3ca
prerank,Disorders Of Transmembrane Transporters R-HSA-5619115,0.5394584049962482,1.1310190541838976,0.23203285420944558,1.0,1.0,15/168,8.98%,Slc4a4;Slc24a4;Abcc8;Slc1a1;Slc9a7;Slc12a6;Ndc1;Ranbp2;Slc9a9;Derl1;Psmd13;Nup93;Kcnj11;Slc26a3;Slco2a1
prerank,Laminin Interactions R-HSA-3000157,-0.6903236807896375,-1.1297514496702552,0.33818770226537215,1.0,1.0,9/22,8.87%,Lama4;Lamc2;Lama1;Itga3;Lama2;Itgb1;Itga6;Lamc3;Itga1
prerank,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.6928127259782304,1.128447537323826,0.3805774278215223,1.0,1.0,1/20,1.91%,B4galt1
prerank,Glycosaminoglycan Metabolism R-HSA-1630316,-0.567301714711021,-1.1271221827878881,0.2811918063314711,1.0,1.0,15/117,3.54%,Gpc6;Xylt1;Hs6st2;Hs3st2;Ext1;Hs3st5;Hs6st3;Ndst3;Hs3st4;Gpc5;Bcan;St3gal6;Cd44;Dcn;Cspg5
prerank,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.6840423064818562,-1.1265738762769295,0.3367003367003367,1.0,1.0,4/27,9.95%,Pik3r1;Fgf1;Fgf23;Pik3ca
prerank,C-type Lectin Receptors (CLRs) R-HSA-5621481,0.5576202235351646,1.1265031219867103,0.24152542372881355,1.0,1.0,14/124,6.43%,Ppp3ca;Ppp3r1;Fbxw11;Btrc;Plcg2;Fyn;Arhgef7;Itpr1;Calm1;Src;Crebbp;Cul1;Prkacb;Ube2d1
prerank,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.6791439183222877,1.1261085099045824,0.36180904522613067,1.0,1.0,8/27,15.60%,Gtf2f2;Ssrp1;Polr2e;Cdk9;Ctdp1;Tcea1;Gtf2f1;Polr2k
prerank,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.6825892124572619,-1.1250163443528038,0.3606010016694491,1.0,1.0,9/23,18.86%,P2rx7;Entpd1;P2rx4;Casp1;Entpd5;Txnip;Nlrp3;Il1a;Sugt1
prerank,Signaling By FGFR1 R-HSA-5654736,-0.6371444713462782,-1.11869849666414,0.33154121863799285,1.0,1.0,4/46,2.15%,Flrt2;Pik3r1;Flrt1;Fgf1
prerank,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.7026135234110127,-1.1182344923332281,0.33828382838283827,1.0,1.0,2/22,6.35%,Tubb3;Tubb4a
prerank,Collagen Formation R-HSA-1474290,-0.5918224360072851,-1.118137380908336,0.2939068100358423,1.0,1.0,27/86,8.90%,Col26a1;Lama4;Adamts2;P4ha3;Col6a1;P3h2;Col6a5;Col8a1;Lamc2;Col27a1;Col6a2;Col12a1;Col11a1;Col1a2;Col14a1;Col4a2;Col24a1;Ctss;Col19a1;Col4a1;Col16a1;Col3a1;Col4a5;Pcolce;Itga6;Loxl2;Mmp28
prerank,DAG And IP3 Signaling R-HSA-1489509,0.6410431007134452,1.1179877806173846,0.3592233009708738,1.0,1.0,10/38,2.68%,Nbea;Prkce;Camk2a;Camk2b;Adcy1;Adcy2;Pde1b;Adcy9;Camkk1;Camk2g
prerank,Nicotinamide Salvaging R-HSA-197264,-0.68864096358107,-1.11766348391042,0.34591194968553457,1.0,1.0,1/18,1.24%,Parp8
prerank,Deadenylation Of mRNA R-HSA-429947,0.6757561821020758,1.1175132429370596,0.3594936708860759,1.0,1.0,11/24,10.72%,Cnot2;Cnot6l;Pan3;Cnot4;Eif4b;Eif4a1;Cnot1;Cnot3;Eif4e;Eif4a2;Pabpc1
prerank,RHOV GTPase Cycle R-HSA-9013424,-0.6471018225239928,-1.1157974135238813,0.3298611111111111,1.0,1.0,4/35,2.68%,Sh3rf1;Pik3r1;Peak1;Iqgap1
prerank,Signaling By PDGF R-HSA-186797,-0.6313948609164033,-1.1157524840475386,0.3442028985507246,1.0,1.0,15/52,11.13%,Stat5b;Pik3r1;Col6a1;Col6a5;Pdgfra;Col6a2;Col4a2;Col4a1;Col4a5;Grb7;Stat6;Pdgfrb;Pik3ca;Pdgfd;Pdgfb
prerank,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.6693230130381199,1.1143069942013923,0.3684210526315789,1.0,1.0,4/26,5.14%,Vav3;Akt3;Arhgef7;Calm1
prerank,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.6270253843410241,1.1131528027941304,0.3341584158415842,1.0,1.0,23/59,19.65%,Utp4;Rcl1;Sppl2a;Dkc1;Heatr1;Utp15;Wdr75;Nop58;Wdr43;Wdr36;Mphosph10;Nop56;Dcaf13;Emg1;Nat10;Tbl3;Nol6;Thumpd1;Utp6;Krr1;Utp25;Rps9;Dhx37
prerank,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.5719775663005803,-1.113047087407111,0.29225352112676056,1.0,1.0,30/107,10.59%,Fn1;Pik3r1;Angpt1;Jam3;Mertk;Cd44;L1cam;Inpp5d;Cxadr;Atp1b3;Mag;Jam2;Sirpa;Selenop;Selplg;Cav1;Itgam;Lyn;Itga3;Slc16a1;Grb7;Tgfb1;Itgb1;Itga6;Slc7a11;F11r;Cd74;Pik3ca;Gas6;Epcam
prerank,Amyloid Fiber Formation R-HSA-977225,0.6089668821804206,1.1122788622324888,0.3333333333333333,1.0,1.0,6/58,3.67%,Snca;Calb1;Sorl1;Tspan5;Sncaip;Tspan33
prerank,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.6812470163278358,-1.1110646329626215,0.3814102564102564,1.0,1.0,2/18,0.73%,Alk;Fn1
prerank,Signaling By WNT R-HSA-195721,0.4978410959162333,1.1102849897258762,0.23684210526315788,1.0,1.0,31/277,4.89%,Ppp3ca;Pip5k1b;Prkg1;Camk2a;Hecw1;Tnrc6c;Plcb1;Prickle1;Znrf3;Tle1;Gng7;Gng2;Tle4;Ppp3r1;Btrc;Ago1;Tnrc6b;Vangl2;Pygo1;Tnks;Ago2;Itpr1;Zranb1;Hdac1;Ywhaz;Rspo3;Rbbp5;Porcn;Trrap;Wnt7b;Smarca4
prerank,Collagen Chain Trimerization R-HSA-8948216,-0.639181521349909,-1.1093273466611893,0.3567753001715266,1.0,1.0,17/43,7.18%,Col26a1;Col6a1;Col6a5;Col8a1;Col27a1;Col6a2;Col12a1;Col11a1;Col1a2;Col14a1;Col4a2;Col24a1;Col19a1;Col4a1;Col16a1;Col3a1;Col4a5
prerank,mRNA Splicing - Major Pathway R-HSA-72163,-0.5236791670513071,-1.1087603555413594,0.2822429906542056,1.0,1.0,2/180,2.42%,Elavl2;Colec12
prerank,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.6595908978951784,-1.1086748755291107,0.3681592039800995,1.0,1.0,5/25,12.52%,Wls;Wnt2;Wnt5b;Wnt3a;Wnt5a
prerank,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.6904607270622815,1.1086361631695556,0.38786279683377306,1.0,1.0,3/21,5.23%,Sec24d;Sec14l2;Sec23a
prerank,Interferon Signaling R-HSA-913531,0.5319976292121078,1.10801432856478,0.2809224318658281,1.0,1.0,20/153,7.11%,Camk2a;Camk2b;Bcl11b;Sgip1;Ncam1;Pdzd2;Camk2g;Trim2;Nedd4;Trim46;Mapk3;Ip6k2;Trim17;Pias1;Eif4g2;Ndc1;Eif4e3;Ranbp2;Irf1;Eif4a1
prerank,PIP3 Activates AKT Signaling R-HSA-1257604,0.5021676587344626,1.1070358644958318,0.2394678492239468,1.0,1.0,28/257,3.99%,Il1rap;Pip5k1b;Nrg2;Foxo1;Tnrc6c;Nrg3;Akt3;Mapk1;Tgfa;Hdac7;Prex2;Chd4;Chd3;Pip5k1a;Cnot6l;Gatad2b;Jun;Flt3;Rragd;Pik3cb;Ago1;Tnrc6b;Nedd4;Tnks;Fyn;Fgf5;Ago2;Hdac1
prerank,Signaling By VEGF R-HSA-194138,0.5631325559619571,1.1063476340945928,0.29540481400437635,1.0,1.0,28/100,6.33%,Vav3;Ptk2b;Wasf1;Nrp1;Baiap2;Nckap1;Nrp2;Abi2;Akt3;Ptk2;Abi1;Nck2;Pik3cb;Elmo2;Fyn;Arhgef7;Syngap1;Itpr1;Cyfip2;Cyfip1;Bcar1;Calm1;Src;Mapk14;Pxdn;Prkacb;Nck1;Wasf3
prerank,Transcriptional Regulation By TP53 R-HSA-3700989,0.4814571544781236,1.1037501652428598,0.22371364653243847,1.0,1.0,39/330,6.26%,Tnrc6c;Prkag2;Map2k6;Ppp1r13b;Pdzd2;Akt3;Bcl6;Chd4;Usp2;Cnot2;Chd3;Cnot6l;Gatad2b;Jun;Rragd;Gtf2h2;Ago1;Tnrc6b;Gtf2f2;Steap3;Ago2;Hdac1;Ywhaz;Cdk5r1;Rad50;Cdk12;Kmt5a;Ccnh;Ywhab;Ehmt1;Rptor;Gtf2h5;Crebbp;Txnrd1;Mapk14;Smyd2;Ywhah;Cnot4;Ssrp1
prerank,"Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.6797199228445014,-1.1033153414724517,0.38310708898944196,1.0,1.0,2/17,9.82%,Tcn2;Abcc1
prerank,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.6583478895803501,-1.1018221938750412,0.36666666666666664,1.0,1.0,12/27,6.97%,Utrn;Srebf2;Wwtr1;Hmgcr;Mag;Pou3f1;Pou3f2;Adgrg6;Plppr3;Sox10;Drp2;Lama2
prerank,mRNA Splicing R-HSA-72172,-0.5176453841898709,-1.1014483570056062,0.2886405959031657,1.0,1.0,2/188,2.42%,Elavl2;Colec12
prerank,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.6734276431773141,-1.1014036589780998,0.3573825503355705,1.0,1.0,8/23,18.68%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Xrcc2;Dna2;Bard1
prerank,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.6773283739930216,1.1010253155080532,0.3795811518324607,1.0,1.0,6/21,15.60%,Gtf2f2;Ncbp1;Polr2e;Ctdp1;Gtf2f1;Polr2k
prerank,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.5925870877824697,1.1008400212150347,0.32224532224532226,1.0,1.0,21/70,16.60%,Cdc40;Thoc2;Srsf9;Srsf11;Srsf1;Ndc1;Ranbp2;Ncbp1;Nup93;Fyttd1;Thoc3;Nup160;Nup155;Srsf7;Srsf3;Nup214;Thoc7;U2af1;Eif4a3;Sarnp;Nup210
prerank,Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.6727468995216905,-1.100254016479853,0.37623762376237624,1.0,1.0,1/19,2.02%,Serpine2
prerank,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.6700757139009113,1.1000547977625479,0.4166666666666667,1.0,1.0,1/28,0.57%,Cyp7b1
prerank,Cell-Cell Communication R-HSA-1500931,0.5497620803799761,1.0971733281457263,0.3210412147505423,1.0,1.0,19/111,3.92%,Cadm2;Cdh9;Kirrel3;Cdh8;Ptk2b;Cdh12;Pard3;Magi2;Sptbn1;Ptk2;Cdh13;Cdh2;Cadm1;Nck2;Pik3cb;Sptan1;Fyn;Pals1;Actn2
prerank,Formation Of Incision Complex In GG-NER R-HSA-5696395,0.6244469903106321,1.096534209683656,0.3586206896551724,1.0,1.0,8/42,8.71%,Gtf2h2;Ercc4;Ccnh;Gtf2h5;Pias1;Parp1;Mnat1;Sumo2
prerank,FCERI Mediated MAPK Activation R-HSA-2871796,0.6725122167999011,1.0952451124388025,0.39371980676328505,1.0,1.0,7/28,4.74%,Vav3;Mapk1;Jun;Plcg2;Mapk10;Map2k4;Mapk3
prerank,Aquaporin-mediated Transport R-HSA-445717,0.6335971816070942,1.093503388486533,0.36551724137931035,1.0,1.0,6/42,2.29%,Adcy1;Adcy2;Myo5b;Gng7;Adcy9;Gng2
prerank,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.6397941741455024,1.0933451337889137,0.367816091954023,1.0,1.0,6/38,2.29%,Adcy1;Adcy2;Myo5b;Gng7;Adcy9;Gng2
prerank,CRMPs In Sema3A Signaling R-HSA-399956,0.6915576360605071,1.091858657272626,0.3858267716535433,1.0,1.0,4/16,4.10%,Plxna4;Nrp1;Fyn;Cdk5r1
prerank,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,-0.6583469491745385,-1.0910432966581871,0.3949447077409163,1.0,1.0,7/20,5.36%,Gpc6;Gpc5;Bcan;Dcn;Cspg5;Vcan;Cspg4
prerank,RHOG GTPase Cycle R-HSA-9013408,0.5727951661550414,1.0889676398384076,0.3144208037825059,1.0,1.0,8/72,2.35%,Kalrn;Iqgap2;Vav3;Dock4;Itsn1;Arhgap21;Arhgap39;Dock3
prerank,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.60059358856799,-1.0878173994339466,0.37050359712230213,1.0,1.0,5/64,14.13%,Gpc5;Adam17;Psmb8;Sel1l;Psme4
prerank,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.6587551083428765,1.0875822336210241,0.4198473282442748,1.0,1.0,5/26,2.87%,Nedd4l;Ppp1cb;Tgfbr1;Smad3;Usp15
prerank,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,-0.6562185387654442,-1.0871444657655678,0.39313572542901715,1.0,1.0,7/20,5.36%,Gpc6;Gpc5;Bcan;Dcn;Cspg5;Vcan;Cspg4
prerank,RNA Polymerase I Transcription Termination R-HSA-73863,0.6438631409000336,1.086895005313614,0.3829268292682927,1.0,1.0,6/30,9.93%,Gtf2h2;Ccnh;Gtf2h5;Ubtf;Mnat1;Polr2e
prerank,PI3K Cascade R-HSA-109704,-0.6312863009829724,-1.0866790691985464,0.36683417085427134,1.0,1.0,3/40,2.15%,Gab2;Pik3r1;Fgf1
prerank,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.6581351305585125,-1.0832647988748678,0.39429530201342283,1.0,1.0,8/24,18.68%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Xrcc2;Dna2;Bard1
prerank,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.6791119111528651,1.0830756010926037,0.45187165775401067,1.0,1.0,7/16,13.90%,Ywhab;Exosc8;Dcp1a;Tnpo1;Exosc2;Exosc1;Mapkapk2
prerank,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.48175240542278563,1.0821224564119956,0.2727272727272727,1.0,1.0,41/298,7.54%,Lmo7;Nedd4l;Cblb;Trim9;Ube2e2;Hace1;Fbxl7;Zbtb16;Rnf217;Rnf19a;Hectd2;Herc3;Fbxw11;Btrc;Rnf182;Herc2;Klhl3;Nedd4;Ube2w;Fbxo41;Ube2e3;Huwe1;Cul5;Klhl2;Ube2k;Blmh;Cul1;Klhl22;Pja2;Ube2q2;Ube2d1;Ube2g2;Spsb1;Mex3c;Znrf2;Fbxo11;Ube2b;Fbxl16;Ubr1;Trim11;Asb18
prerank,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",-0.6565569289343578,-1.0820786782077974,0.415748031496063,1.0,1.0,7/20,5.36%,Gpc6;Gpc5;Bcan;Dcn;Cspg5;Vcan;Cspg4
prerank,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.6304591980764844,-1.0818920051513912,0.3836805555555556,1.0,1.0,9/33,26.14%,Serpine2;F3;Thbd;Tfpi;Pros1;F13b;F7;Proc;Vwf
prerank,Interleukin-17 Signaling R-HSA-448424,0.5797490740485414,1.0815980073876714,0.3542116630669546,1.0,1.0,16/68,6.40%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Btrc;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4
prerank,Amino Acids Regulate mTORC1 R-HSA-9639288,0.6042750218574087,1.0805536541109453,0.3862559241706161,1.0,1.0,11/53,9.69%,Atp6v1a;Fnip2;Rragd;Mios;Rptor;Kptn;Atp6v1c2;Atp6v0e2;Nprl3;Slc38a9;Rragb
prerank,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.6477676671764695,-1.0805151900665233,0.3925549915397631,1.0,1.0,11/26,23.36%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Xrcc2;Dna2;Bard1;Xrcc3;Sem1;Blm
prerank,TBC/RABGAPs R-HSA-8854214,-0.6139770304578747,-1.0796790617742786,0.35221238938053095,1.0,1.0,2/42,5.79%,Optn;Tbc1d10c
prerank,IRS-mediated Signaling R-HSA-112399,-0.6233402248722012,-1.079561508202308,0.38215488215488214,1.0,1.0,3/43,2.15%,Gab2;Pik3r1;Fgf1
prerank,Glucose Metabolism R-HSA-70326,-0.5734082116787526,-1.0794504990944396,0.33072407045009783,1.0,1.0,14/79,14.24%,Pfkp;Pck2;Map4k2;Pfkfb4;Pfkfb3;Prkca;Slc25a13;Aldoc;Eno1;Hook2;G6pc3;Mdh1;Fbp1;Hook3
prerank,Activation Of SMO R-HSA-5635838,0.6641723147927322,1.0791403367823633,0.4293193717277487,1.0,1.0,4/18,5.58%,Cdon;Ptch1;Efcab7;Csnk1a1
prerank,RA Biosynthesis Pathway R-HSA-5365859,-0.672199565939103,-1.0775742549867369,0.4084033613445378,1.0,1.0,4/17,8.98%,Aldh1a1;Cyp26b1;Aldh1a2;Dhrs3
prerank,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.5885768075292883,1.076740937194645,0.365702479338843,1.0,1.0,6/63,1.78%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3;Notch2
prerank,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.6660550628565489,-1.0759250678970136,0.3977455716586151,1.0,1.0,1/19,1.05%,Vrk2
prerank,Gap Junction Trafficking R-HSA-190828,-0.6670668480296158,-1.0758664754711054,0.43074324324324326,1.0,1.0,9/20,15.86%,Dab2;Myo6;Gja1;Gjb6;Gjd2;Gja3;Cltc;Gjc2;Gjb2
prerank,NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.663849216979359,-1.0758657812750718,0.3990306946688207,1.0,1.0,2/16,6.00%,Ngf;Mapk8
prerank,RAC3 GTPase Cycle R-HSA-9013423,0.5477007302443516,1.0752175800195598,0.3172866520787746,1.0,1.0,13/90,3.03%,Dock10;Tiam1;Wasf1;Abr;Baiap2;Nckap1;Abi2;Arhgap15;Arhgap21;Arhgap39;Abi1;Abl2;Slitrk3
prerank,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.6443902331842892,1.075146992984144,0.43099273607748184,1.0,1.0,10/32,6.78%,Adcy1;Adcy2;Adcy9;Plcg2;Fyn;Itpr1;Calm1;Src;Prkacb;Prkar2b
prerank,Transcriptional Regulation By MECP2 R-HSA-8986944,0.5983492445787202,1.074295576329388,0.39675174013921116,1.0,1.0,15/60,3.99%,Grin2a;Grin2b;Camk2a;Camk2b;Gria2;Tnrc6c;Rbfox1;Ncor1;Fkbp5;Camk2g;Mef2c;Ago1;Tnrc6b;Ago2;Hdac1
prerank,Regulation Of PTEN Stability And Activity R-HSA-8948751,0.5819568051150982,1.0712066273307728,0.38443935926773454,1.0,1.0,4/67,3.65%,Akt3;Prex2;Nedd4;Tnks
prerank,Transcription Of HIV Genome R-HSA-167172,0.5680118116317374,1.0711961049456558,0.37644341801385683,1.0,1.0,19/64,15.60%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Ssrp1;Ncbp1;Mnat1;Ccnt2;Polr2e;Ccnk;Rngtt;Cdk9;Gtf2a1;Ctdp1;Tcea1;Tbp;Taf5;Gtf2f1;Polr2k
prerank,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.6536053830400623,-1.0701390576630625,0.4432,1.0,1.0,2/20,6.35%,Tubb3;Tubb4a
prerank,G Alpha (Q) Signaling Events R-HSA-416476,0.4973929475503002,1.069114560962766,0.30833333333333335,1.0,1.0,17/193,2.91%,Trpc6;Kalrn;Grm1;Dgkh;Prkce;Dgki;Dgkg;Plcb1;Grm5;Gng7;Gnaq;Mapk1;Arhgef25;Dagla;Gng2;Rps6ka2;Chrm1
prerank,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.4647259074243165,1.068844515187748,0.2962138084632517,1.0,1.0,44/357,7.54%,Lmo7;Nedd4l;Cblb;Trim9;Ube2e2;Hace1;Fbxl7;Zbtb16;Rnf217;Sec24d;Rnf19a;Hectd2;Sec14l2;Herc3;Fbxw11;Btrc;Rnf182;Herc2;Klhl3;Nedd4;Ube2w;Fbxo41;Ube2e3;Huwe1;Cul5;Klhl2;Sec23a;Ube2k;Blmh;Cul1;Klhl22;Pja2;Ube2q2;Ube2d1;Ube2g2;Spsb1;Mex3c;Znrf2;Fbxo11;Ube2b;Fbxl16;Ubr1;Trim11;Asb18
prerank,TRP Channels R-HSA-3295583,0.6630020976426672,1.0686281882986077,0.44146341463414634,1.0,1.0,2/24,0.05%,Trpc6;Trpm3
prerank,Platelet Sensitization By LDL R-HSA-432142,-0.6584152072793842,-1.0682984138940514,0.41770186335403725,1.0,1.0,3/17,7.60%,Ppp2r5a;Ppp2r5c;Pla2g4a
prerank,Diseases Of DNA Repair R-HSA-9675135,-0.6054822023946133,-1.0679770684564545,0.40437158469945356,1.0,1.0,11/49,18.68%,Rbbp8;Rad51b;Neil3;Nthl1;Wrn;Artn;Top3a;Xrcc2;Rrad;Dna2;Bard1
prerank,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.5758060771170521,-1.067635859881022,0.3616636528028933,1.0,1.0,2/66,4.25%,Prkcb;Rel
prerank,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.6182650138519452,-1.0669858705883475,0.3951473136915078,1.0,1.0,9/38,18.68%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Xrcc2;Rrad;Dna2;Bard1
prerank,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.6209744270847837,-1.0656901458330352,0.38188277087033745,1.0,1.0,9/39,18.68%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Xrcc2;Rrad;Dna2;Bard1
prerank,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.6488561849941753,-1.065157574504352,0.39872408293460926,1.0,1.0,3/18,9.95%,Pik3r1;Egfr;Pik3ca
prerank,Signaling By Hippo R-HSA-2028269,-0.6437311759640089,-1.0640896054631475,0.4240924092409241,1.0,1.0,5/20,13.67%,Lats2;Wwtr1;Amot;Tjp2;Sav1
prerank,Metabolism Of Cofactors R-HSA-8978934,-0.6583005756676827,-1.0626979040417746,0.4131147540983607,1.0,1.0,7/19,18.99%,Prkg2;Tacr1;Pdss1;Idh1;Coq3;Hsp90aa1;Dhfr
prerank,SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.6639468725926012,1.0623623313659687,0.45073891625615764,1.0,1.0,3/20,0.80%,Prkce;Nrg2;Nrg3
prerank,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.6088145021689555,1.0617727718893248,0.413716814159292,1.0,1.0,4/44,6.20%,Nsf;Ric1;Rhobtb3;Stx6
prerank,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.5088662511850256,-1.0616925489897222,0.31851851851851853,1.0,1.0,8/171,3.22%,Gpc6;Gpc5;Parp8;Enpp2;Akr1b10;Prkg2;Apoe;Tcn2
prerank,Meiotic Recombination R-HSA-912446,-0.6055473185950285,-1.060426042213789,0.4408014571948998,1.0,1.0,1/42,1.08%,Rbbp8
prerank,Molecules Associated With Elastic Fibres R-HSA-2129379,0.6314822280511986,1.060135738070919,0.41192411924119243,1.0,1.0,4/27,3.85%,Itga8;Itgb8;Mfap3;Tgfb2
prerank,RNA Polymerase I Promoter Escape R-HSA-73772,0.596572458572667,1.0598463813419334,0.3932038834951456,1.0,1.0,10/47,11.24%,Gtf2h2;Ccnh;Gtf2h5;Ubtf;Mnat1;Cbx3;Polr2e;H2bc4;H2ax;H2ac6
prerank,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.5646003188991898,1.0592702373612695,0.3763213530655391,1.0,1.0,17/79,13.23%,Cdc40;Thoc2;Srsf9;Srsf11;Srsf1;Ndc1;Ranbp2;Ncbp1;Nup93;Wdr33;Eif4e;Fyttd1;Thoc3;Nup160;Nup155;Srsf7;Srsf3
prerank,Signaling By FGFR R-HSA-190236,-0.559494891743453,-1.0583461879322364,0.38392857142857145,1.0,1.0,6/80,5.94%,Flrt2;Pik3r1;Flrt1;Fgf1;Spred1;Fgfr3
prerank,Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.6607364015277287,1.0571217134680142,0.4385026737967914,1.0,1.0,5/21,3.86%,Prkce;Plpp4;Pik3cb;Plcg2;Itpr1
prerank,RHO GTPase Cycle R-HSA-9012999,0.4569074687408206,1.0561824645913767,0.3041575492341357,1.0,1.0,60/426,4.38%,Kalrn;Dock10;Tiam1;Iqgap2;Plekhg5;Vav3;Ptk2b;Rasal2;Diaph2;Wipf3;Wasf1;Rasgrf2;Rras2;Abr;Baiap2;Dock4;Nckap1;Gfod1;Arhgap20;Itsn1;Cdc42bpa;Dock11;Fgd4;Arhgef9;Stard13;Arhgef4;Abi2;Arhgap15;Arhgap21;Slc4a7;Filip1;Arhgap39;Arhgef25;Sptbn1;Prex2;Fmnl2;Pkp4;Dock3;Abi1;Dbn1;Nck2;Abl2;Slitrk3;Sptan1;Diaph1;Shkbp1;Spata13;Elmo2;Vangl2;Arhgef7;Nisch;Cdc42se2;Steap3;Add3;Cyfip2;Fam13a;Ralgapa1;Arhgap17;Actn1;Arhgef28
prerank,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.6109549893862666,-1.0556434032854842,0.39572192513368987,1.0,1.0,13/41,24.09%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Xrcc2;Rrad;Dna2;Bard1;Xrcc3;Sem1;Blm;Rfc2
prerank,Regulation Of Signaling By CBL R-HSA-912631,-0.6619952078043213,-1.0541111193077364,0.43537414965986393,1.0,1.0,5/18,6.36%,Pik3r1;Clstn1;Hck;Vav1;Lyn
prerank,Paracetamol ADME R-HSA-9753281,-0.6458115405729045,-1.0533602816657808,0.4373040752351097,1.0,1.0,9/21,23.91%,Ggt5;Slc38a3;Slc38a1;Abcc1;Gstt1;Ggt1;Abcc5;Cyp2e1;Gstp1
prerank,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.5691450392958004,-1.0527079228147511,0.4072072072072072,1.0,1.0,6/57,1.99%,Mgat4c;St6gal1;Parp8;Man2a1;Zdhhc2;Mgat5
prerank,Termination Of O-glycan Biosynthesis R-HSA-977068,0.6712555323398063,1.0526386618629238,0.4527363184079602,1.0,1.0,1/19,0.29%,St6galnac3
prerank,mTORC1-mediated Signaling R-HSA-166208,0.6468092554162936,1.052468655575215,0.4296675191815857,1.0,1.0,7/24,9.83%,Rragd;Ywhab;Rptor;Eif4b;Slc38a9;Rragb;Eif4e
prerank,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.5364658289690326,1.0518663847623786,0.3719512195121951,1.0,1.0,19/100,6.40%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Peli1;Btrc;Peli2;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Eea1;Dusp4
prerank,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.6291202113585352,-1.051087254377339,0.46601941747572817,1.0,1.0,5/26,4.10%,Plch2;Plcb4;Inpp5d;Plcd3;Plch1
prerank,Integration Of Energy Metabolism R-HSA-163685,0.535774529726097,1.0507031746023814,0.38202247191011235,1.0,1.0,15/102,2.71%,Cacna1c;Cacna1e;Cacnb2;Adcy1;Adcy2;Prkag2;Plcb1;Cacna1d;Gng7;Gnaq;Kcng2;Adcy9;Gng2;Abcc8;Rapgef4
prerank,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.5562787902513852,-1.0505731418644275,0.38434163701067614,1.0,1.0,14/80,10.42%,Tbl1x;Klf5;Smarcd3;Srebf2;Nr2f2;Pparg;Lpl;Tgfb1;Ebf1;Cdk19;Ppargc1a;Ccnd3;Ncoa3;Angptl4
prerank,Signaling By FGFR2 In Disease R-HSA-5655253,-0.5970531801741662,-1.0501174961969149,0.42736486486486486,1.0,1.0,2/40,2.15%,Pik3r1;Fgf1
prerank,RHOB GTPase Cycle R-HSA-9013026,-0.5674236402556997,-1.048582293027531,0.40467625899280574,1.0,1.0,13/68,7.11%,Dlc1;Pcdh7;Pik3r1;Arhgap26;Mcf2;Vav2;Akap13;Prex1;Arhgef11;Cav1;Ophn1;Anln;Stom
prerank,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.645314420655979,1.0484981164233649,0.44559585492227977,1.0,1.0,3/19,5.82%,Map2k6;Ripk2;Mapk14
prerank,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.583262079352695,-1.047064119255441,0.42857142857142855,1.0,1.0,7/51,4.14%,Khdrbs3;Erbb4;Nrg1;Elmo1;Dock1;Lrrk2;Epas1
prerank,VEGFA-VEGFR2 Pathway R-HSA-4420097,0.5393769291269627,1.0466002736280817,0.3786848072562358,1.0,1.0,26/91,6.33%,Vav3;Ptk2b;Wasf1;Baiap2;Nckap1;Abi2;Akt3;Ptk2;Abi1;Nck2;Pik3cb;Elmo2;Fyn;Arhgef7;Syngap1;Itpr1;Cyfip2;Cyfip1;Bcar1;Calm1;Src;Mapk14;Pxdn;Prkacb;Nck1;Wasf3
prerank,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.47826642075988685,-1.04581691053358,0.3339622641509434,1.0,1.0,2/237,2.42%,Elavl2;Colec12
prerank,HIV Infection R-HSA-162906,0.4815808754974963,1.0451923296619825,0.3544857768052516,1.0,1.0,25/214,8.92%,Sgip1;Nedd4l;Btrc;Gtf2h2;Vps37b;Gtf2f2;Fyn;Nmt1;Cul5;Ccnh;Gtf2h5;Ap1s2;Ssrp1;Ndc1;Ranbp2;Xpo1;Ncbp1;Mnat1;Ccnt2;Psmd13;Nup93;Npm1;Ap1g1;Psip1;Ap1s3
prerank,Ca-dependent Events R-HSA-111996,0.611990467235717,1.0450735409517724,0.4371859296482412,1.0,1.0,10/34,2.68%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Mapk1;Pde1b;Adcy9;Camkk1;Camk2g
prerank,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.5468511920605355,1.0449714578090126,0.40670859538784065,1.0,1.0,18/90,6.40%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Peli1;Btrc;Peli2;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4
prerank,Telomere Extension By Telomerase R-HSA-171319,-0.6373647684199965,-1.0446096097044995,0.44193548387096776,1.0,1.0,2/22,10.08%,Ankrd28;Pif1
prerank,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.6218584354675133,1.0445069249079801,0.43301435406698563,1.0,1.0,10/31,2.68%,Gria1;Camk2a;Nsf;Camk2b;Gria2;Gria3;Epb41l1;Tspan7;Cacng8;Camk2g
prerank,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.6664517330574514,1.0443088144633843,0.4517766497461929,1.0,1.0,5/17,1.67%,Gria1;Nsf;Gria2;Gria3;Tspan7
prerank,Plasma Lipoprotein Clearance R-HSA-8964043,-0.6057251755719949,-1.0441300339568864,0.44481605351170567,1.0,1.0,9/33,21.72%,Apoe;Ap2b1;Mylip;Npc2;Soat1;Cltc;Ldlr;Ldlrap1;Apoc1
prerank,L1CAM Interactions R-HSA-373760,0.5331767109311153,1.0426761660794959,0.3685393258426966,1.0,1.0,23/95,3.28%,Ank3;Nrcam;Scn3a;Nrp1;Cntn1;Nrp2;Ncam1;Scn2a;Sptb;Scn8a;Mapk1;Scn3b;Map2k1;Sptbn1;Sptbn4;Ank2;Kcnq3;Rps6ka2;Dnm1;Scn9a;Lamc1;Sptan1;Sdcbp
prerank,Elastic Fibre Formation R-HSA-1566948,0.60623646946446,1.041723309592233,0.45618556701030927,1.0,1.0,4/37,3.85%,Itga8;Itgb8;Mfap3;Tgfb2
prerank,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.6098405088587482,-1.040540040134169,0.452991452991453,1.0,1.0,7/33,18.68%,Rbbp8;Wrn;Artn;Top3a;Rrad;Dna2;Bard1
prerank,Downstream Signal Transduction R-HSA-186763,-0.6244556336510427,-1.0403432348229686,0.4463373083475298,1.0,1.0,8/28,11.13%,Stat5b;Pik3r1;Pdgfra;Grb7;Stat6;Pdgfrb;Pik3ca;Pdgfb
prerank,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.6210244773222707,-1.0386485113728292,0.4519685039370079,1.0,1.0,2/20,3.24%,Rspo2;Lgr5
prerank,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.5696361398735065,-1.037584065772478,0.4714285714285714,1.0,1.0,21/66,7.34%,Col26a1;Adamts2;P4ha3;Col6a1;P3h2;Col6a5;Col8a1;Col27a1;Col6a2;Col12a1;Col11a1;Col1a2;Col14a1;Col4a2;Col24a1;Col19a1;Col4a1;Col16a1;Col3a1;Col4a5;Pcolce
prerank,UCH Proteinases R-HSA-5689603,0.5329021628853267,1.0373341406278478,0.4129032258064516,1.0,1.0,4/90,2.87%,Mbd5;Tgfbr1;Foxk1;Usp15
prerank,Clathrin-mediated Endocytosis R-HSA-8856828,-0.5164262141298389,-1.0358463864865937,0.41412213740458015,1.0,1.0,15/131,5.76%,Fnbp1l;Synj2;Chrm2;Syt9;Grk3;Hip1;Dab2;Eps15;Hip1r;Syt12;Sh3gl2;Fnbp1;Ap2b1;Stam2;Cftr
prerank,Netrin-1 Signaling R-HSA-373752,0.6010226833536128,1.0349924160489021,0.45215311004784686,1.0,1.0,11/47,3.69%,Trpc6;Slit3;Dscam;Dscaml1;Ablim3;Dcc;Ptk2;Unc5a;Ablim1;Agap2;Fyn
prerank,G-protein Mediated Events R-HSA-112040,0.5777084824271921,1.0349026132749415,0.44844124700239807,1.0,1.0,13/51,2.68%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gnaq;Gnal;Mapk1;Pde1b;Adcy9;Camkk1;Camk2g
prerank,O-linked Glycosylation R-HSA-5173105,0.5349039645697182,1.0347314397504461,0.4127310061601643,1.0,1.0,15/98,4.52%,Sema5a;Thsd7a;St6galnac3;Adamts17;Spon1;Adamts3;Galnt18;Galnt14;B4galt5;Sema5b;B3gnt2;Adamts18;St3gal1;Large1;Adamts1
prerank,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.6121586928923151,-1.0343960720261585,0.45348837209302323,1.0,1.0,9/29,17.34%,Traf3;Unc93b1;S100a1;Ticam1;Btk;Tlr6;Tlr3;Nfkbia;Ndufa2
prerank,Reproduction R-HSA-1474165,0.5320229279970686,1.0341876918652113,0.40421052631578946,1.0,1.0,5/90,5.92%,Syne1;B4galt1;Rad50;Hspa2;Dido1
prerank,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.5342031090719626,1.0338189507255262,0.40325865580448067,1.0,1.0,18/95,6.40%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Peli1;Btrc;Peli2;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4
prerank,Signal Transduction By L1 R-HSA-445144,0.6350841720190833,1.0334555222515116,0.4508670520231214,1.0,1.0,4/20,1.87%,Nrp1;Ncam1;Mapk1;Map2k1
prerank,HS-GAG Degradation R-HSA-2024096,-0.6171763351599487,-1.0333256642762265,0.448,1.0,1.0,2/21,1.03%,Gpc6;Gpc5
prerank,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.4601647948979037,-1.0332477387692356,0.37142857142857144,1.0,1.0,63/340,22.10%,Slc6a7;Gadl1;Smox;Glul;Gatm;Folh1;Bcat1;Ckb;Dhtkd1;Cdo1;Heca;Pcbd1;Aspa;Atat1;Ass1;Rpl3l;Bckdhb;Hnmt;Slc25a13;Carns1;Chga;Slc38a1;Glud1;Agxt2;Tshb;Gls2;Amdhd1;Gpt2;Ftcd;Soat1;Psmb8;Acadsb;Hykk;Ldhd;Tph1;Serinc2;Asrgl1;Psme4;Dio2;Qdpr;Ckm;Aass;Bbox1;Slc25a2;Enoph1;Rps11;Mat1a;Naalad2;Ido2;Hibadh;Sqor;Crym;Asl;Slc6a12;Sepsecs;Th;Kyat1;Arg2;Pxmp2;Aldh6a1;Psme2;Sem1;Psma1
prerank,Signaling By ROBO Receptors R-HSA-376176,0.4787863971737663,1.0322765416981772,0.3722943722943723,1.0,1.0,11/201,3.72%,Slit3;Robo2;Nell2;Nrp1;Dcc;Lhx9;Arhgap39;Nck2;Abl2;Cap1;Arhgef7
prerank,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.6069127295988987,1.032105899605974,0.4592760180995475,1.0,1.0,5/38,0.90%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3
prerank,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.5338230261845684,1.0315891626310256,0.40329218106995884,1.0,1.0,18/97,6.40%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Peli1;Btrc;Peli2;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4
prerank,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.5340158289819988,1.031309008184336,0.4036885245901639,1.0,1.0,18/96,6.40%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Peli1;Btrc;Peli2;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4
prerank,Transport To Golgi And Subsequent Modification R-HSA-948021,0.4933207417591412,1.0298516434978535,0.3900414937759336,1.0,1.0,15/156,3.13%,Gria1;Ank3;Nsf;Sptb;Cnih3;Tgfa;B4galt1;Sptbn1;B4galt5;Sec24d;Sptbn4;Ank2;Fut8;Dync1i2;Sptan1
prerank,Signaling By NODAL R-HSA-1181150,0.6329644110265519,1.0297350003247232,0.46875,1.0,1.0,5/20,4.74%,Acvr2a;Mapk1;Smad3;Acvr1c;Mapk3
prerank,tRNA Aminoacylation R-HSA-379724,0.6033100839360788,1.0294033525874247,0.44835680751173707,1.0,1.0,5/26,8.07%,Fars2;Dtd1;Farsa;Rars2;Lars2
prerank,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.5485050741464781,1.027867501115576,0.4236111111111111,1.0,1.0,18/65,16.18%,Gtf2h2;Hdac1;Ccnh;Gtf2h5;Ubtf;Mnat1;Smarca5;Polr2e;H2bc4;H2ax;H2ac6;Sap30bp;Tbp;Sin3b;Arid4b;Polr2k;Baz2a;H2ac4
prerank,Interleukin-37 Signaling R-HSA-9008059,-0.6202653729707589,-1.0276345249010752,0.46709470304975925,1.0,1.0,5/20,9.30%,Ptpn14;Ptpn9;Ptpn5;Casp1;Ptpn4
prerank,CaM Pathway R-HSA-111997,0.606639853582825,1.0272537749432336,0.47146401985111663,1.0,1.0,9/32,2.68%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Pde1b;Adcy9;Camkk1;Camk2g
prerank,Ion Homeostasis R-HSA-5578775,0.5797206564672521,1.0272197918991373,0.4593967517401392,1.0,1.0,11/48,3.86%,Ryr2;Camk2a;Camk2b;Slc8a2;Atp2b1;Orai2;Atp2b3;Ryr1;Camk2g;Atp1b1;Itpr1
prerank,Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.6302401219566484,1.0259584637152959,0.4693333333333333,1.0,1.0,3/19,3.55%,Chst9;Csgalnact1;Chst15
prerank,Opioid Signaling R-HSA-111885,0.5368197569244436,1.0255529028600967,0.4370860927152318,1.0,1.0,18/86,2.68%,Nbea;Ppp3ca;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gng7;Gnaq;Gnal;Mapk1;Pde1b;Adcy9;Gng2;Camkk1;Pde4a;Ppp3r1;Camk2g
prerank,Asparagine N-linked Glycosylation R-HSA-446203,0.45991084553081907,1.025037355422933,0.3724279835390947,1.0,1.0,18/273,3.13%,Gria1;St6galnac3;Ank3;Nsf;St6galnac5;Sptb;Cnih3;Tgfa;B4galt1;Sptbn1;B4galt5;Sec24d;Sptbn4;St8sia4;Ank2;Fut8;Dync1i2;Sptan1
prerank,NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.5506622316463481,1.024619308612437,0.4295774647887324,1.0,1.0,18/62,16.18%,Gtf2h2;Hdac1;Ccnh;Gtf2h5;Ubtf;Mnat1;Smarca5;Polr2e;H2bc4;H2ax;H2ac6;Sap30bp;Tbp;Sin3b;Arid4b;Polr2k;Baz2a;H2ac4
prerank,Viral Messenger RNA Synthesis R-HSA-168325,0.5981371884886201,1.0236098546530634,0.48299319727891155,1.0,1.0,13/43,17.22%,Gtf2f2;Ndc1;Ranbp2;Nup93;Polr2e;Gnl3;Nup160;Nup155;Gtf2f1;Nup214;Polr2k;Nup210;Nup153
prerank,Regulation Of TP53 Activity R-HSA-5633007,0.48960070161165015,1.0235553556713117,0.42391304347826086,1.0,1.0,17/143,6.26%,Prkag2;Map2k6;Ppp1r13b;Pdzd2;Akt3;Chd4;Usp2;Chd3;Gatad2b;Hdac1;Cdk5r1;Rad50;Kmt5a;Ehmt1;Mapk14;Smyd2;Ssrp1
prerank,Defective B3GALTL Causes PpS R-HSA-5083635,0.6069184867550368,1.0231258070211537,0.4680365296803653,1.0,1.0,5/37,0.90%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3
prerank,Cell-cell Junction Organization R-HSA-421270,0.5642871489160437,1.0229647574164729,0.4408352668213457,1.0,1.0,8/56,2.83%,Cadm2;Cdh9;Cdh8;Cdh12;Pard3;Cdh13;Cdh2;Cadm1
prerank,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.5717219067712337,1.0227387513373005,0.4457831325301205,1.0,1.0,12/56,10.23%,Jun;Gtf2h2;Gtf2f2;Cdk12;Ccnh;Gtf2h5;Ssrp1;Mnat1;Ccnt2;Polr2e;Ccnk;Atm
prerank,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.5760221000208313,1.0226115209927609,0.4513064133016627,1.0,1.0,6/50,9.93%,Gtf2h2;Ccnh;Gtf2h5;Mnat1;Usp7;Polr2e
prerank,PLC Beta Mediated Events R-HSA-112043,0.5781361496978115,1.021779459079894,0.454320987654321,1.0,1.0,12/46,2.68%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gnaq;Mapk1;Pde1b;Adcy9;Camkk1;Camk2g
prerank,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.543045501875038,1.0214881100577655,0.45217391304347826,1.0,1.0,2/72,0.49%,Nsf;Kif26b
prerank,Keratan Sulfate Biosynthesis R-HSA-2022854,0.6149518268084702,1.021042856410803,0.5011990407673861,1.0,1.0,8/27,6.44%,B4galt1;B4galt5;Chst1;B3gnt2;St3gal1;B4galt4;Ogn;B4galt6
prerank,Leishmania Infection R-HSA-9658195,0.4737506793441871,1.0208032865088155,0.4064516129032258,1.0,1.0,37/216,6.33%,Vav3;Adcy1;Htr4;Adcy2;Wipf3;Wasf1;Baiap2;Nckap1;Gng7;Abi2;Mapk1;Adcyap1r1;Ptk2;Adcy9;Actr3;Gng2;Arpc2;Abi1;Jun;Ramp1;Plcg2;Elmo2;Fyn;Itpr1;Cyfip2;Myo5a;Cyfip1;Mapk3;Calm1;Src;Glp2r;Mapk14;Prkacb;Arpc1a;Nck1;Vipr1;Wasf3
prerank,Mitochondrial tRNA Aminoacylation R-HSA-379726,0.6260451779505339,1.0205532304952571,0.47368421052631576,1.0,1.0,4/18,8.07%,Fars2;Dtd1;Rars2;Lars2
prerank,RHO GTPases Activate CIT R-HSA-5625900,0.6363172187837527,1.0205102676934341,0.47058823529411764,1.0,1.0,2/19,2.11%,Ppp1r12b;Ppp1cb
prerank,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.6396195310732075,1.019731639013326,0.49612403100775193,1.0,1.0,2/16,2.14%,Pard3;Tgfbr1
prerank,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.6077705124907902,-1.0196501737110584,0.47088186356073214,1.0,1.0,3/28,1.90%,Sv2b;Stx1a;Antxr1
prerank,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.5718371572536872,1.0183273392247707,0.471563981042654,1.0,1.0,4/54,8.23%,Fbxl7;Cul1;Psmd13;Fbxl18
prerank,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.6286487990360294,-1.018061883120928,0.5047619047619047,1.0,1.0,2/17,6.35%,Tubb3;Tubb4a
prerank,Semaphorin Interactions R-HSA-373755,0.5526105010626888,1.016873466659335,0.44273127753303965,1.0,1.0,4/64,1.16%,Sema5a;Plxna4;Nrp1;Sema6d
prerank,PI Metabolism R-HSA-1483255,0.537742056259417,1.016788996434859,0.437219730941704,1.0,1.0,12/81,6.06%,Pip5k1b;Mtmr12;Plekha5;Plekha2;Pip5k1a;Sbf1;Pik3cb;Arf3;Inpp4a;Inpp5j;Inpp4b;Mtmr1
prerank,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.5583573963816699,-1.0162938351301527,0.4578096947935368,1.0,1.0,3/65,6.35%,Vrk2;Tubb3;Tubb4a
prerank,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.5081595128288131,1.0162125344020794,0.43326039387308535,1.0,1.0,11/102,3.49%,Slc4a4;Ahcyl2;Slc8a2;Slc16a10;Slc4a7;Slc6a15;Slc24a4;Slc17a7;Slc4a10;Slc1a1;Slc6a6
prerank,RHOQ GTPase Cycle R-HSA-9013406,-0.5636445322845802,-1.0153728756333928,0.46332737030411447,1.0,1.0,16/58,7.11%,Cpne8;Dlc1;Arhgap26;Srgap2;Cdc42ep3;Iqgap1;Rhoq;Prex1;Wwp2;Fnbp1;Gja1;Cav1;Cftr;Arhgap33;Ophn1;Stom
prerank,Signaling To ERKs R-HSA-187687,0.6013052272802278,1.0152549593227955,0.4552058111380145,1.0,1.0,8/33,5.82%,Bcl11b;Mapk1;Rit2;Map2k1;Mapk3;Ywhab;Src;Mapk14
prerank,Meiosis R-HSA-1500620,0.5384737260217585,1.0146701764304014,0.4442105263157895,0.9996435303537744,1.0,1/72,0.44%,Syne1
prerank,Cellular Response To Heat Stress R-HSA-3371556,0.5217272793648001,1.01322080136147,0.43507972665148065,1.0,1.0,13/92,6.91%,Camk2a;Camk2b;Mapk1;Camk2g;Bag4;Mapk3;Hspa2;Rptor;Crebbp;Dnajb6;Ndc1;Ranbp2;Ywhae
prerank,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.6123708904867927,-1.0129013088092333,0.49756888168557534,1.0,1.0,6/24,14.35%,Elovl6;Hsd17b12;Elovl7;Acsl3;Acsbg1;Tecr
prerank,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.6071009426232883,-1.0126337662663272,0.50814332247557,1.0,1.0,5/25,18.48%,Gadl1;Cdo1;Enoph1;Mat1a;Sqor
prerank,RND2 GTPase Cycle R-HSA-9696270,-0.5737587212368618,-1.0122294313613749,0.4861111111111111,1.0,1.0,14/41,16.83%,Pik3r1;Prag1;Plxnd1;Fnbp1;Cav1;Arhgap1;Fam83b;Depdc1b;Ptpn13;Ktn1;Kidins220;Dst;Epha2;Tfrc
prerank,Apoptosis R-HSA-109581,0.48656165955961334,1.0121726325616045,0.4199134199134199,0.9991880860358532,1.0,17/161,5.20%,Dapk1;Ppp1r13b;Akt3;Mapk1;Dcc;Ptk2;Ocln;Unc5a;Ppp3r1;Sptan1;Ywhaz;Stk26;Nmt1;Mapk3;Dsg2;Tjp1;Ywhab
prerank,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.5695389875820762,1.011901242943556,0.4416475972540046,0.9963056859640917,1.0,13/50,7.18%,Ralgapa2;Prkag2;Exoc4;Ywhaz;Myo5a;Calm1;Ywhab;Exoc6;Ywhah;Stxbp3;C2cd5;Ywhae;Rab10
prerank,Other Semaphorin Interactions R-HSA-416700,0.6376071091190436,1.0107000329398157,0.49193548387096775,0.9959608585746529,1.0,3/19,1.16%,Sema5a;Plxna4;Sema6d
prerank,Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.6115123781335574,1.0093424106966102,0.4743276283618582,0.9964993556392453,1.0,5/31,2.29%,Adcy1;Adcy2;Gng7;Adcy9;Gng2
prerank,Retinoid Metabolism And Transport R-HSA-975634,-0.5867438003483125,-1.0088480741067058,0.49169435215946844,1.0,1.0,4/37,2.76%,Gpc6;Gpc5;Akr1b10;Apoe
prerank,Interferon Alpha/Beta Signaling R-HSA-909733,-0.5708025712055096,-1.0086528573818614,0.47676419965576594,1.0,1.0,16/48,20.42%,Egr1;Rnasel;Irf2;Xaf1;Ptpn1;Ifi27;Ifitm1;Psmb8;Ifitm3;Oas2;Irf3;Bst2;Ifit3;Irf6;Irf4;Irf8
prerank,Glycolysis R-HSA-70171,-0.5513822246765381,-1.008108316658118,0.44680851063829785,1.0,1.0,8/62,11.73%,Pfkp;Map4k2;Pfkfb4;Pfkfb3;Prkca;Aldoc;Eno1;Hook2
prerank,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.5712187003764533,-1.0079120062865574,0.48500881834215165,1.0,1.0,7/41,12.48%,Alpk1;App;Irak2;Casp8;Nkiras1;Usp14;S100b
prerank,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.4782793263681905,-1.006364869392424,0.429097605893186,1.0,1.0,16/184,8.39%,Ldb2;Prkcb;Nr4a3;Nfatc2;Smarcd3;Kat2b;Esr1;Pcgf5;Prkcq;Runx1;Tcf7l1;Ccnd1;Hipk2;Zfpm1;Spi1;Ccnd3
prerank,Syndecan Interactions R-HSA-3000170,-0.6301913944586911,-1.0062738062690006,0.5147540983606558,1.0,1.0,12/20,21.99%,Itgb5;Vtn;Prkca;Tgfb1;Itgb1;Itga6;Itga2;Sdc1;Itgb3;Sdc2;Cask;Sdc4
prerank,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.5469419199568575,-1.0056785946580933,0.48257839721254353,1.0,1.0,14/72,5.94%,Kit;Erbb4;Gab2;Nrg1;Pik3r1;Fgf1;Clstn1;Esr1;Esr2;Vav1;Pdgfra;Pik3ap1;Erbb3;Fgfr3
prerank,Phase II - Conjugation Of Compounds R-HSA-156580,-0.5451259000297763,-1.0055336846129936,0.4594594594594595,1.0,1.0,22/74,25.74%,Ugp2;Podxl2;As3mt;Ggt5;Hpgds;Slc38a3;Glyat;Slc38a1;Mgst3;Ugdh;Gstt1;Gstm2;Mat1a;Ggt1;Gsta3;Mgst2;Gstm5;Tpmt;Gstp1;Gclm;Gclc;Acsm4
prerank,RNA Polymerase III Transcription Initiation R-HSA-76046,0.5874003819713834,1.0054859287376068,0.4760820045558087,1.0,1.0,11/34,15.70%,Pou2f1;Gtf3c1;Polr2e;Gtf3c2;Gtf3c4;Polr3gl;Polr3g;Tbp;Polr3e;Polr2k;Snapc4
prerank,Adherens Junctions Interactions R-HSA-418990,0.6082341724137357,1.0053527230868224,0.49476439790575916,1.0,1.0,7/29,2.83%,Cadm2;Cdh9;Cdh8;Cdh12;Cdh13;Cdh2;Cadm1
prerank,FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.632930286061252,-1.005306670250652,0.5015974440894568,1.0,1.0,2/18,9.27%,Fgf1;Fgf23
prerank,Signaling By ERBB2 R-HSA-1227986,0.5721474087664159,1.0050231088414951,0.4916864608076009,0.9981629884482299,1.0,6/48,3.69%,Prkce;Nrg2;Nrg3;Akt3;Diaph1;Fyn
prerank,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.5790934223635106,-1.003640292797386,0.4975369458128079,1.0,1.0,7/33,14.35%,Elovl6;Hsd17b12;Elovl7;Acsl3;Acaca;Acsbg1;Tecr
prerank,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.5806869956474888,-1.0032985573197302,0.515650741350906,1.0,1.0,4/41,2.76%,Gpc6;Gpc5;Akr1b10;Apoe
prerank,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.5892145946838311,1.0028644363553565,0.4976635514018692,1.0,1.0,8/32,6.44%,B4galt1;B4galt5;Chst1;B3gnt2;St3gal1;B4galt4;Ogn;B4galt6
prerank,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.6018236785246902,-1.002835638233642,0.5115131578947368,1.0,1.0,2/24,6.35%,Tubb3;Tubb4a
prerank,Endogenous Sterols R-HSA-211976,0.6152301109545276,1.0025410480153696,0.4889502762430939,0.9980354963300447,1.0,3/21,5.31%,Cyp7b1;Cyp11a1;Ncoa1
prerank,Neurotransmitter Release Cycle R-HSA-112310,0.5643512550404525,1.0017419296069245,0.5076923076923077,0.9966988683788196,1.0,6/50,2.81%,Ppfia2;Rims1;Syn2;Slc17a7;Syn3;Slc1a1
prerank,PCP/CE Pathway R-HSA-4086400,-0.5205743058630657,-1.0009277071089946,0.46880570409982175,1.0,1.0,14/88,14.13%,Prkcb;Prkcg;Smurf1;Ap2b1;Prkca;Wnt5b;Fzd2;Ncoa3;Rac2;Wnt5a;Psmb8;Cltc;Fzd6;Psme4
prerank,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.5959641040152533,-1.0006875985683212,0.5155482815057283,1.0,1.0,2/26,6.35%,Tubb3;Tubb4a
prerank,Phospholipid Metabolism R-HSA-1483257,0.46503843111586257,0.9998844812110185,0.43897216274089934,0.9985585839871916,1.0,13/203,3.06%,Pip5k1b;Pitpnm2;Slc44a5;Mtmr12;Plekha5;Plekha2;Pla2g4e;Cpne6;Pip5k1a;Dgat2;Sbf1;Pik3cb;Slc44a1
prerank,RND3 GTPase Cycle R-HSA-9696264,0.581865834081297,0.9988396297900587,0.4975369458128079,0.9979764690212781,1.0,6/40,3.74%,Plekhg5;Rasal2;Arhgap21;Pkp4;Vangl2;Nisch
prerank,Phototransduction Cascade R-HSA-2514856,-0.5865998705598476,-0.998027255123763,0.4933993399339934,1.0,1.0,8/28,13.74%,Camkmt;Prkcq;Slc24a1;Nmt2;Prkca;Gucy2f;Rho;Ppef1
prerank,RHOBTB GTPase Cycle R-HSA-9706574,-0.581077879200451,-0.9977967013422927,0.5057283142389526,1.0,1.0,5/35,9.37%,Pde5a;Rhobtb1;Myo6;Tmod3;Msi2
prerank,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.5369777727139112,-0.997126821599738,0.48484848484848486,1.0,1.0,22/73,18.67%,Colec12;Cxadr;Lair1;Kir3dl2;Cd33;Cd81;Tyrobp;Itgb1;Cd200;Slamf6;Nectin2;Slamf7;Ifitm1;Cd200r1;Clec2d;Cd300a;Vcam1;Trem2;B2m;Cd40;Cd300e;Cd40lg
prerank,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.5133141586234343,0.9961273274998749,0.45358649789029537,1.0,1.0,18/106,6.40%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Peli1;Btrc;Peli2;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4
prerank,SHC-mediated cascade:FGFR4 R-HSA-5654719,-0.6311637400857355,-0.9952122519316712,0.5258215962441315,1.0,1.0,2/16,9.27%,Fgf1;Fgf23
prerank,Golgi-to-ER Retrograde Transport R-HSA-8856688,0.49071485274778814,0.9950569594180015,0.4557235421166307,1.0,1.0,5/105,4.55%,Nsf;Kif26b;Dync1i2;Arf3;Kif1c
prerank,Diseases Of Metabolism R-HSA-5668914,0.457313676419381,0.9945232387457122,0.45472837022132795,0.9993971484770799,1.0,18/225,4.52%,Sema5a;Thsd7a;Adamts17;Cyp7b1;Gpc4;Spon1;Adamts3;Arsb;Notch2;Lct;B4galt1;Sema5b;Gpc3;Hlcs;Galns;Adamts18;Large1;Adamts1
prerank,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.6014321217945533,0.9942446127624033,0.5056947608200456,0.9967048755003173,1.0,4/32,7.90%,Nek6;Ndc1;Ranbp2;Nup93
prerank,p75NTR Signals Via NF-kB R-HSA-193639,-0.6076017913511718,-0.9941405957187052,0.5008665511265165,1.0,1.0,1/16,1.83%,Ngf
prerank,Acyl Chain Remodelling Of PG R-HSA-1482925,-0.6141553010501217,-0.9922413463991515,0.5071315372424723,1.0,1.0,4/17,12.08%,Lpgat1;Pla2g4a;Pla2r1;Pla2g5
prerank,Smooth Muscle Contraction R-HSA-445355,0.5740959642107748,0.9917841741046467,0.49627791563275436,1.0,1.0,8/40,6.40%,Sorbs1;Cald1;Cacna1h;Anxa6;Gucy1b1;Calm1;Pxdn;Tpm1
prerank,Signaling By Retinoic Acid R-HSA-5362517,-0.5877333839780255,-0.9910029272548336,0.5034722222222222,1.0,1.0,8/35,13.21%,Rara;Aldh1a1;Rxrg;Cyp26b1;Aldh1a2;Dhrs3;Pdk4;Ldhd
prerank,Cell-extracellular Matrix Interactions R-HSA-446353,-0.6140155615522986,-0.99088664256777,0.49065420560747663,1.0,1.0,6/16,13.89%,Lims1;Arhgef6;Itgb1;Flna;Lims2;Flnc
prerank,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.583757712798516,-0.9900281052608105,0.49825783972125437,1.0,1.0,8/28,19.90%,Ppp2r5a;Cav1;Ppp2r5c;Fzd2;Wnt3a;Ppp2r5e;Lrp5;Amer1
prerank,Interferon Gamma Signaling R-HSA-877300,0.5456951380520906,0.9898284472835586,0.4782608695652174,1.0,1.0,6/64,2.89%,Camk2a;Camk2b;Bcl11b;Ncam1;Camk2g;Trim2
prerank,Insulin Receptor Signaling Cascade R-HSA-74751,-0.5644575141182525,-0.9889283059894761,0.5042444821731749,1.0,1.0,4/48,2.47%,Gab2;Pik3r1;Fgf1;Grb10
prerank,Potassium Channels R-HSA-1296071,0.49155307452123226,0.9876943617625201,0.47702407002188185,1.0,1.0,20/99,3.10%,Kcnd2;Kcnj6;Kcnj3;Kcnh1;Kcnab1;Kcnd3;Kcnc3;Gabbr2;Gng7;Kcng2;Kcnk10;Kcnc4;Gng2;Abcc8;Kcnq3;Kcna4;Kcnk1;Kcng1;Kcng3;Kcna1
prerank,MyD88 Deficiency (TLR2/4) R-HSA-5602498,-0.6121085964211903,-0.9876811531777927,0.5316455696202531,1.0,1.0,8/16,31.91%,S100a1;Btk;Tlr6;Ndufa2;Ly96;Cd36;Fgg;Tirap
prerank,Programmed Cell Death R-HSA-5357801,0.46294709872278644,0.9863604964006354,0.4891304347826087,1.0,1.0,19/188,5.20%,Dapk1;Ppp1r13b;Akt3;Mapk1;Dcc;Ptk2;Ocln;Unc5a;Ppp3r1;Peli1;Sptan1;Sdcbp;Ywhaz;Stk26;Nmt1;Mapk3;Dsg2;Tjp1;Ywhab
prerank,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.4716345934297037,0.9856760537433289,0.4956896551724138,1.0,1.0,3/161,1.72%,Slit3;Robo2;Lhx9
prerank,Lewis Blood Group Biosynthesis R-HSA-9037629,0.6346398716777101,0.9846568917976916,0.5401662049861495,1.0,1.0,2/15,1.72%,B3galt5;B3galt1
prerank,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.550399295194337,-0.9842872235372955,0.5116279069767442,1.0,1.0,6/53,2.23%,Alk;Fn1;Pik3r1;Rrbp1;Hip1;Vcl
prerank,MicroRNA (miRNA) Biogenesis R-HSA-203927,0.6009865527683006,0.9841904418967529,0.5246753246753246,1.0,1.0,8/24,15.60%,Ago1;Ago2;Dicer1;Polr2e;Dgcr8;Ago3;Ago4;Polr2k
prerank,Resolution Of D-Loop Structures R-HSA-5693537,-0.5741925542789387,-0.9829292626505889,0.5077186963979416,1.0,1.0,9/32,18.68%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Eme1;Xrcc2;Dna2;Bard1
prerank,RNA Polymerase II Pre-transcription Events R-HSA-674695,0.5176206435626125,0.982667732269442,0.4955357142857143,1.0,1.0,22/74,15.60%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Ssrp1;Ncbp1;Aff4;Mnat1;Ccnt2;Rtf1;Polr2e;Skic8;Ccnk;Cdk9;Gtf2a1;Ctdp1;Tcea1;Tbp;Cdc73;Taf5;Gtf2f1;Polr2k
prerank,HDACs Deacetylate Histones R-HSA-3214815,0.5604511879667071,0.9813204520878134,0.4975845410628019,1.0,1.0,12/48,7.38%,Ncor1;Chd4;Phf21a;Chd3;Gatad2b;Hdac1;Hdac8;Mta3;Tbl1xr1;Ncor2;Rcor1;Rbbp7
prerank,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.4988952318591829,-0.9805095713829793,0.497196261682243,1.0,1.0,23/113,20.40%,Parp8;Enpp2;Tcn2;Cyb5a;Aldh1l1;Tpk1;Mthfd1l;Abcc1;Nadsyn1;Acp5;Folr2;Acaca;Parp4;Aox1;Bst1;Pank4;Ppcs;Parp14;Slc22a13;Pnpo;Dhfr;Slc19a2;Ldlrap1
prerank,Metabolism Of Steroids R-HSA-8957322,-0.4828433912677551,-0.9803985986628083,0.47338403041825095,1.0,1.0,18/136,9.46%,Osbpl1a;Tbl1x;Hmgcs1;Msmo1;Smarcd3;Lgmn;Srebf2;Hmgcr;Sqle;Elovl6;Hsd17b12;Stard4;Fdft1;Dhcr24;Osbpl9;Chga;Osbpl3;Insig1
prerank,Transcriptional Regulation By E2F6 R-HSA-8953750,-0.5710435887228154,-0.9788096721915026,0.5278688524590164,1.0,1.0,3/33,7.22%,Rbbp8;E2f1;Pcgf2
prerank,Metabolism Of Porphyrins R-HSA-189445,-0.6008526474256908,-0.9787119868051372,0.5493421052631579,1.0,1.0,3/22,9.82%,Slco2b1;Gusb;Abcc1
prerank,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.6124285124510167,-0.9777161610040341,0.5313531353135313,1.0,1.0,3/15,4.96%,Eps15;Sh3gl2;Stam2
prerank,HATs Acetylate Histones R-HSA-3214847,0.5014669544772584,0.9769820672510457,0.4700460829493088,1.0,1.0,25/92,14.18%,Kat6b;Trrap;Ncoa1;Zzz3;Elp2;Crebbp;Rbbp7;Epc1;Tada1;Taf5l;Kat7;Eny2;H2bc4;Msl2;Dr1;Brpf3;H2ac6;Jade3;Kansl1;Msl1;Kat2a;Kat6a;Hcfc1;Elp6;H2ac25
prerank,ECM Proteoglycans R-HSA-3000178,0.5332551360709588,0.9768825005807354,0.5174129353233831,1.0,1.0,6/54,3.99%,Itga8;Tnr;Ncam1;Lamc1;Tgfb2;Lamb1
prerank,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.5701694969716311,-0.9768265109593466,0.5166374781085814,1.0,1.0,4/37,10.52%,Kif13a;Fkbp9;Arfgef2;Kifc3
prerank,Blood Group Systems Biosynthesis R-HSA-9033658,0.6190560530989733,0.9758378860223897,0.5197889182058048,1.0,1.0,2/18,1.72%,B3galt5;B3galt1
prerank,GPER1 Signaling R-HSA-9634597,0.5628725314190669,0.9747602013168923,0.5193621867881549,1.0,1.0,5/41,2.29%,Adcy1;Adcy2;Gng7;Adcy9;Gng2
prerank,MET Activates PTK2 Signaling R-HSA-8874081,-0.6097035546826206,-0.9744814091561657,0.553968253968254,1.0,1.0,7/17,8.56%,Lama4;Lamc2;Lama1;Itga3;Lama2;Itgb1;Lamc3
prerank,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.5742473420455021,-0.9736035476656598,0.5229202037351444,1.0,1.0,9/31,18.68%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Eme1;Xrcc2;Dna2;Bard1
prerank,Signaling By Nuclear Receptors R-HSA-9006931,-0.45213958045216734,-0.9733999119033695,0.5076628352490421,1.0,1.0,36/229,9.48%,Erbb4;Tbl1x;Pik3r1;Arl4c;Bcl2;Gng4;Rara;Abca1;Apoe;Tle3;Gnai1;Kat2b;Aldh1a1;Rxrg;Esr1;Esr2;Gng12;Nrip1;Kcnh8;Gnb4;Kank1;Cav1;Ctsd;Runx1;Kdm3a;Cyp26b1;Ccnd1;Apod;Gng3;Gnai2;Cav2;Aldh1a2;Egfr;Dhrs3;Mylip;Ncoa3
prerank,"Platelet Activation, Signaling And Aggregation R-HSA-76002",0.44159700330035634,0.9728062952310151,0.5208791208791209,1.0,1.0,23/241,4.06%,Trpc6;Dgkh;Prkce;Dgki;Vav3;Dgkg;Gng7;Gnaq;Mapk1;Ptk2;Dagla;Gng2;Rapgef4;Pik3cb;Plcg2;Fam3c;Dgkd;Cap1;Fyn;Tgfb2;Itpr1;Actn2;Ywhaz
prerank,Mitotic Prophase R-HSA-68875,-0.5144688513236744,-0.972468724000971,0.5120593692022264,1.0,1.0,2/95,1.05%,Prkcb;Vrk2
prerank,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.587137953278504,-0.9718848110669562,0.534621578099839,1.0,1.0,8/16,30.89%,Traf3;Ticam1;Irf3;Ndufa2;Sarm1;Ubb;Ly96;Ubc
prerank,Phase 4 - Resting Membrane Potential R-HSA-5576886,0.5996060686387794,0.9717612219283265,0.5232558139534884,1.0,1.0,6/18,6.91%,Kcnk10;Kcnk1;Kcnk9;Kcnj4;Kcnj2;Kcnk12
prerank,SARS-CoV-2 Infection R-HSA-9694516,-0.4438944812909713,-0.9712227463241797,0.525,1.0,1.0,14/252,5.49%,Mgat4c;Gpc6;St6gal1;Gpc5;Parp8;Man2a1;Zdhhc2;Mgat5;Masp1;Ywhaq;Traf3;Gja1;Cav1;Il17ra
prerank,Translation Of Structural Proteins R-HSA-9683701,0.5678134782498875,0.969938804829586,0.5269320843091335,1.0,1.0,1/29,0.29%,St6galnac3
prerank,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.4840643003489595,0.968721235298023,0.5254237288135594,1.0,1.0,15/127,5.14%,Ppp3ca;Vav3;Mapk1;Ppp3r1;Jun;Fbxw11;Btrc;Pik3cb;Plcg2;Fyn;Mapk10;Itpr1;Map2k4;Mapk3;Calm1
prerank,Fatty Acid Metabolism R-HSA-8978868,-0.4700814165936385,-0.9650039888999546,0.5102420856610801,1.0,1.0,32/147,14.58%,Prkab2;Prkaa2;Fa2h;Tbxas1;Elovl6;Hsd17b12;Elovl7;Ptgs1;Acadl;Phyh;Ptgds;Crot;Alox12b;Acsl3;Pon2;Pla2g4a;Hpgd;Acot9;Ggt5;Hpgds;Pctp;Abcc1;Ptges;Dbi;Acot7;Acaca;Acot11;Acsbg1;Acsm3;Cyp4b1;Tecr;Abcd1
prerank,IRAK4 Deficiency (TLR2/4) R-HSA-5603041,-0.5935570665521959,-0.9649019808179604,0.5499207606973059,1.0,1.0,8/17,31.91%,S100a1;Btk;Tlr6;Ndufa2;Ly96;Cd36;Fgg;Tirap
prerank,Cilium Assembly R-HSA-5617833,-0.4598638013916725,-0.9635975322125191,0.5386064030131826,1.0,1.0,30/183,17.08%,Asap1;Sclt1;Smox;Cep83;Plk4;Ift88;Tubb4a;Prkca;Atat1;Nedd1;Bbs9;Nde1;Alms1;Ccp110;Dync1h1;Bbs5;Bbs2;Cnga4;Dync2i1;Rho;Akap9;Cep290;Cep164;Csnk1e;Rpgrip1l;Mchr1;Cep43;Ift172;Kif24;Pafah1b1
prerank,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.5401055746479505,0.9624406266130074,0.5149425287356322,1.0,1.0,5/51,3.00%,Pip5k1b;Plekha5;Plekha2;Pip5k1a;Pik3cb
prerank,PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.4997397787993023,-0.9617568682225894,0.5507246376811594,1.0,1.0,15/99,5.94%,Kit;Erbb4;Gab2;Nrg1;Nr4a1;Pik3r1;Fgf1;Clstn1;Esr1;Esr2;Vav1;Pdgfra;Pik3ap1;Erbb3;Fgfr3
prerank,HIV Transcription Initiation R-HSA-167161,0.5411485421473688,0.9611481573604185,0.5075757575757576,1.0,1.0,6/45,9.93%,Gtf2h2;Gtf2f2;Ccnh;Gtf2h5;Mnat1;Polr2e
prerank,Gap Junction Trafficking And Regulation R-HSA-157858,-0.5930657632074662,-0.9609283582288898,0.5403087478559176,1.0,1.0,9/22,15.86%,Dab2;Myo6;Gja1;Gjb6;Gjd2;Gja3;Cltc;Gjc2;Gjb2
prerank,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.5563643322699547,-0.9603076742117893,0.5378151260504201,1.0,1.0,6/30,8.61%,Dner;Jag2;Dlk1;Numb;Adam10;Adam17
prerank,Regulation Of RAS By GAPs R-HSA-5658442,0.5278060543577675,0.9597650413913996,0.5381263616557734,1.0,1.0,3/65,4.37%,Rasal2;Syngap1;Spred2
prerank,CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,-0.5842003515925824,-0.9594694545595617,0.545016077170418,1.0,1.0,2/15,6.39%,Ppp2r5a;Ppp2r5c
prerank,MTOR Signaling R-HSA-165159,0.5542018955006278,0.9587421983613725,0.5745192307692307,1.0,1.0,6/41,6.49%,Prkag2;Rragd;Strada;Ywhab;Rptor;Eif4b
prerank,Insulin Receptor Recycling R-HSA-77387,0.5831008764553436,0.9581072833230543,0.516209476309227,1.0,1.0,6/23,13.13%,Atp6v1a;Atp6v1c2;Atp6v0e2;Atp6v0a1;Atp6v0a4;Atp6v1d
prerank,RHO GTPases Activate ROCKs R-HSA-5627117,0.6015353023454033,0.9579071411226395,0.5657894736842105,1.0,1.0,2/19,2.11%,Ppp1r12b;Ppp1cb
prerank,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.5385315491573182,-0.9575377523476364,0.5670103092783505,1.0,1.0,2/46,3.02%,Myo1e;Kat2b
prerank,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.5753948173908111,-0.9571998789733244,0.552547770700637,1.0,1.0,10/21,33.80%,Mfn1;Map1lc3a;Tomm7;Mterf3;Ubb;Pink1;Tomm5;Ubc;Atg12;Tomm40
prerank,Hedgehog Off State R-HSA-5610787,0.4833230990561228,0.9564123276120373,0.5505154639175258,1.0,1.0,12/97,7.12%,Adcy1;Adcy2;Adcy9;Btrc;Dync2h1;Ptch1;Csnk1a1;Cul1;Prkacb;Prkar2b;Ift122;Ift57
prerank,Nicotinate Metabolism R-HSA-196807,-0.565507250534509,-0.9561905387567751,0.5557432432432432,1.0,1.0,6/30,17.83%,Parp8;Nadsyn1;Parp4;Bst1;Parp14;Slc22a13
prerank,Signaling By NTRK3 (TRKC) R-HSA-9034015,0.6165889393024562,0.9558038440568654,0.554945054945055,1.0,1.0,2/16,1.00%,Ntrk3;Ntf3
prerank,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.5632563481938997,-0.9557900364693923,0.546191247974068,1.0,1.0,11/30,23.91%,Gpx8;Atp7a;Ncf2;Cyba;Glyat;Sod3;Ncf1;Nox4;Gpx7;Sod1;Gstp1
prerank,Cell Junction Organization R-HSA-446728,0.498832206051549,0.9549331405197907,0.5239179954441914,1.0,1.0,8/81,2.83%,Cadm2;Cdh9;Cdh8;Cdh12;Pard3;Cdh13;Cdh2;Cadm1
prerank,RND1 GTPase Cycle R-HSA-9696273,0.5471162945786338,0.9548818305295304,0.5283018867924528,1.0,1.0,5/41,3.58%,Plekhg5;Rasal2;Rras2;Pkp4;Vangl2
prerank,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.520801987318613,0.9545195756486905,0.5333333333333333,1.0,1.0,16/59,5.45%,Camk2a;Camk2b;Ap3b1;Cnksr2;Mapk1;Kdm7a;Ksr2;Map2k1;Camk2g;Mprip;Fam114a2;Ksr1;Mapk3;Calm1;Ywhab;Src
prerank,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.5600808871423978,0.95417117929959,0.5452380952380952,1.0,1.0,4/36,2.29%,Rgs7;Gng7;Gnaq;Gng2
prerank,Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,0.6001619912083752,0.9540967177605044,0.5660847880299252,1.0,1.0,3/21,6.79%,Napepld;Stra6;Rdh10
prerank,Processive Synthesis On Lagging Strand R-HSA-69183,-0.5973390888884039,-0.9535269625746189,0.5777439024390244,1.0,1.0,4/15,20.85%,Lrig1;Dna2;Pold4;Prim2
prerank,CDC42 GTPase Cycle R-HSA-9013148,0.4621431723827812,0.953022209342317,0.5578512396694215,1.0,1.0,21/144,2.17%,Dock10;Tiam1;Iqgap2;Vav3;Wipf3;Rasgrf2;Abr;Baiap2;Arhgap20;Itsn1;Cdc42bpa;Dock11;Fgd4;Arhgef9;Stard13;Arhgef4;Arhgap21;Arhgap39;Arhgef25;Prex2;Fmnl2
prerank,VLDLR Internalisation And Degradation R-HSA-8866427,-0.5936466732139836,-0.9526408125047132,0.5566343042071198,1.0,1.0,3/16,13.45%,Ap2b1;Mylip;Cltc
prerank,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.5697267689712219,0.9516965246678819,0.5253807106598984,1.0,1.0,4/29,5.43%,Prkag2;Rragd;Strada;Rptor
prerank,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.5536512004966861,0.9515017065977628,0.5586734693877551,1.0,1.0,7/36,10.74%,Arsb;Arsj;Tpst1;Fn3krp;Eef2;Dph6;Dph5
prerank,Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.5191662645535486,0.9476215706499871,0.5620767494356659,1.0,1.0,2/62,3.58%,Prickle1;Vangl2
prerank,RHOC GTPase Cycle R-HSA-9013106,-0.5178292509461833,-0.9475693377524828,0.5824175824175825,1.0,1.0,22/72,11.41%,Dlc1;Pik3r1;Arhgap26;Mcf2;Arhgap18;Vav2;Iqgap1;Akap13;Prex1;Arhgef11;Cav1;Ophn1;Anln;Stom;Arhgef40;Fmnl3;Flot1;Arhgef10;Arhgap1;Cavin1;Arhgdia;Tjp2
prerank,Degradation Of Extracellular Matrix R-HSA-1474228,0.4845310006582376,0.9471628510091831,0.565121412803532,1.0,1.0,10/95,4.02%,Erc2;Mmp16;Spock3;Col25a1;Mmp17;Lamc1;Bmp1;Capn3;Lamb1;Adamts18
prerank,MET Promotes Cell Motility R-HSA-8875878,-0.5742591904187642,-0.945488520135459,0.5819397993311036,1.0,1.0,9/28,10.68%,Lama4;Lamc2;Rap1b;Lama1;Itga3;Lama2;Itgb1;Lamc3;Dock7
prerank,Interleukin-2 Family Signaling R-HSA-451927,-0.5449730868383007,-0.9453317107464769,0.5535714285714286,1.0,1.0,8/40,5.82%,Gab2;Stat5b;Pik3r1;Clstn1;Inpp5d;Il15;Jak2;Havcr2
prerank,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.4342109414355062,-0.9451917728156394,0.6036036036036037,1.0,1.0,24/256,9.34%,Asap1;Camk4;Tbl1x;Sclt1;Prkab2;Prkaa2;Smarcd3;Mapk11;Smox;Cep83;Plk4;Ift88;Tubb4a;Prkca;Atat1;Chchd6;Nedd1;Ppargc1a;Bbs9;Idh2;Nde1;Alms1;Ccp110;Dync1h1
prerank,FRS-mediated FGFR3 Signaling R-HSA-5654706,-0.597906893075064,-0.9437449333600314,0.5882352941176471,1.0,1.0,3/17,9.27%,Fgf1;Fgfr3;Fgf23
prerank,RAF Activation R-HSA-5673000,0.5604056081700622,0.9421630313734022,0.5885057471264368,1.0,1.0,12/30,6.30%,Camk2a;Camk2b;Map2k1;Ppp1cb;Camk2g;Ksr1;Mras;Calm1;Ywhab;Src;Araf;Mark3
prerank,Visual Phototransduction R-HSA-2187338,-0.49692779954674027,-0.941856905016816,0.5601436265709157,1.0,1.0,10/83,6.83%,Gpc6;Gpc5;Akr1b10;Apoe;Camkmt;Prkcq;Slc24a1;Nmt2;Lpl;Prkca
prerank,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.5141327788487755,0.9403440625225027,0.5599173553719008,1.0,1.0,12/71,9.38%,Hdac7;Herc2;Rad52;Pias1;Ndc1;Cbx4;Ranbp2;Parp1;Nup93;Phc2;Sumo2;Rnf2
prerank,RHOA GTPase Cycle R-HSA-8980692,0.45303238008501134,0.9391848368483573,0.5424430641821946,1.0,1.0,13/144,2.06%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Arhgap20;Stard13;Arhgef4;Arhgap21;Arhgap39;Arhgef25;Prex2
prerank,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.5469223870108637,-0.939077775357224,0.5863309352517986,1.0,1.0,7/34,13.76%,Acadl;Acot9;Pctp;Dbi;Acot7;Acot11;Acsm3
prerank,RHOD GTPase Cycle R-HSA-9013405,-0.5339533140374536,-0.9378171214212994,0.5813953488372093,1.0,1.0,6/49,2.44%,Cpne8;Vrk2;Pik3r1;Arhgap26;Plxna1;Akap12
prerank,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.499792790253531,-0.937215611837749,0.575591985428051,1.0,1.0,4/76,6.36%,Rasgrp1;Prkcq;Rasgrp2;Lyn
prerank,TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.5719015062757065,-0.9371319484769851,0.5676100628930818,1.0,1.0,7/15,30.89%,Irak2;Ticam1;Ndufa2;Sarm1;Ubb;Ly96;Ubc
prerank,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.5621854842522441,-0.9367737607226152,0.5683229813664596,1.0,1.0,1/19,2.15%,Fgf1
prerank,HSF1-dependent Transactivation R-HSA-3371571,0.5501147328282877,0.9366915608535423,0.5396419437340153,1.0,1.0,3/34,2.68%,Camk2a;Camk2b;Camk2g
prerank,SHC-mediated cascade:FGFR3 R-HSA-5654704,-0.5966632296403432,-0.9350737751211571,0.5996860282574569,1.0,1.0,3/15,9.27%,Fgf1;Fgfr3;Fgf23
prerank,Nucleotide Salvage R-HSA-8956321,0.5746702802034381,0.9344598919478165,0.5853018372703412,1.0,1.0,6/21,11.32%,Adk;Upp2;Upp1;Ampd2;Adal;Dguok
prerank,Inositol Phosphate Metabolism R-HSA-1483249,-0.5298041072223857,-0.934355192563324,0.5858407079646017,1.0,1.0,5/47,4.10%,Plch2;Plcb4;Inpp5d;Plcd3;Plch1
prerank,MyD88-independent TLR4 Cascade R-HSA-166166,0.48547927857580375,0.934182158531067,0.5546038543897216,1.0,1.0,17/100,6.43%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Btrc;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4;Ube2d1
prerank,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.5109889091316175,0.9339612158338756,0.5733634311512416,1.0,1.0,12/66,11.24%,Mapk1;Jun;Rps6ka2;Mapk3;Ehmt1;Ube2d1;Cebpb;Nfkb1;Cdc26;H2bc4;H2ax;H2ac6
prerank,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.5670091714045601,-0.9338920861584908,0.5654362416107382,1.0,1.0,2/17,6.39%,Ppp2r5a;Ppp2r5c
prerank,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.48659282666692677,0.9327770146899537,0.5584415584415584,1.0,1.0,17/97,6.43%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Fbxw11;Btrc;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4;Ube2d1
prerank,Extension Of Telomeres R-HSA-180786,-0.5201694438203428,-0.9326351689631008,0.5746527777777778,1.0,1.0,10/49,24.09%,Ankrd28;Lrig1;Pif1;Wrn;Dna2;Pold4;Prim2;Cdk2;Blm;Rfc2
prerank,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.562529919444396,0.9323485441287397,0.5571095571095571,1.0,1.0,9/27,15.60%,Gtf3c1;Polr2e;Gtf3c2;Gtf3c4;Polr3gl;Polr3g;Tbp;Polr3e;Polr2k
prerank,Sensory Perception R-HSA-9709957,-0.42325477637953657,-0.9315554198518441,0.6292947558770343,1.0,1.0,22/280,4.18%,Ldb2;Gpc6;Pcdh15;Kcnn2;Epb41l3;Cacna2d2;Gpc5;Whrn;Stx1a;Akr1b10;Myo1e;Trpm4;Grm4;Or51d1;Apoe;Or52i2;Cabp1;Or51e1;Gsn;Camkmt;Or52k2;Prkcq
prerank,RHO GTPases Activate Formins R-HSA-5663220,0.46833767228399814,0.9311534381422841,0.5697940503432495,1.0,1.0,11/114,7.29%,Diaph2;Mrtfa;Cenpp;Fmnl2;Dync1i2;Diaph1;Src;Taok1;Ranbp2;Xpo1;Fmnl1
prerank,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.48038264693523325,-0.9309205257122266,0.5812274368231047,1.0,1.0,13/95,7.94%,Fn1;Pik3r1;Bcl2;Sox2;S1pr1;Col1a2;Itgam;Jak2;Vegfa;Ccnd1;Tgfb1;Stat6;Itgb1
prerank,DAP12 Interactions R-HSA-2172127,0.5534130788188378,0.9295270732991923,0.5739348370927319,1.0,1.0,4/30,3.69%,Vav3;Pik3cb;Plcg2;Fyn
prerank,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.5640811807385963,0.9288599977660917,0.5576470588235294,1.0,1.0,9/26,15.60%,Gtf3c1;Polr2e;Gtf3c2;Gtf3c4;Polr3gl;Polr3g;Tbp;Polr3e;Polr2k
prerank,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.4014264778797722,0.9286873124227429,0.6402569593147751,1.0,1.0,57/409,6.04%,Maml2;Camk2a;Maml3;Camk2b;Nrg2;Lmo7;Foxo1;Nrg3;Ap3b1;Cnksr2;Ncor1;Akt3;Mapk1;Eml4;Kdm7a;Ksr2;Tgfa;Map2k1;Hdac7;Sptbn1;Ppp1cb;Tgfbr1;Smad3;Camk2g;Flt3;Pik3cb;Mprip;Fam114a2;Birc6;Gtf2f2;Tnks;Fyn;Fgf5;Bag4;Hdac1;Hdac8;Ksr1;Cbl;Spred2;Porcn;Mapk3;Mras;Psen1;Calm1;Zmym2;Ywhab;Tbl1xr1;Src;Csnk1a1;Mib1;Jag1;Crebbp;Irs1;Cul1;Irs2;Ncor2;Araf
prerank,Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.47527235754171937,0.9285172190520993,0.576036866359447,1.0,1.0,12/106,3.81%,Il1rap;Pip5k1b;Nrg2;Nrg3;Akt3;Mapk1;Tgfa;Pip5k1a;Flt3;Pik3cb;Fyn;Fgf5
prerank,Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,-0.57809565899583,-0.9284741292821557,0.6022187004754358,1.0,1.0,2/16,9.27%,Fgf1;Fgf23
prerank,FGFR2 Ligand Binding And Activation R-HSA-190241,-0.5787469386536537,-0.9277650968360627,0.6129032258064516,1.0,1.0,2/17,9.27%,Fgf1;Fgf23
prerank,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.5464917664076054,-0.9275765875028869,0.5822368421052632,1.0,1.0,7/27,13.74%,Camkmt;Prkcq;Nmt2;Prkca;Gucy2f;Rho;Ppef1
prerank,G Alpha (Z) Signaling Events R-HSA-418597,0.5338966310206072,0.9272126908941059,0.5795724465558195,1.0,1.0,6/46,2.29%,Prkce;Adcy1;Adcy2;Gng7;Adcy9;Gng2
prerank,DAP12 Signaling R-HSA-2424491,0.5581978649397974,0.9269604588706177,0.58679706601467,1.0,1.0,4/26,3.69%,Vav3;Pik3cb;Plcg2;Fyn
prerank,Dual Incision In TC-NER R-HSA-6782135,0.49914821200558296,0.926504434216065,0.5675675675675675,1.0,1.0,7/63,9.93%,Gtf2h2;Ercc4;Ccnh;Gtf2h5;Mnat1;Usp7;Polr2e
prerank,Activated Point Mutants Of FGFR2 R-HSA-2033519,-0.5803349908998486,-0.9254075349335462,0.6006339144215531,1.0,1.0,2/15,9.27%,Fgf1;Fgf23
prerank,RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.5563559589589882,-0.925318283188973,0.6038034865293186,1.0,1.0,8/23,9.61%,Prkcb;Mapk11;Nox3;Prkca;Prkcd;Ncf2;Cyba;Rac2
prerank,RMTs Methylate Histone Arginines R-HSA-3214858,0.5272469320229325,0.9243259150305141,0.5929411764705882,1.0,1.0,4/43,5.23%,Arid1b;Smarca2;Smarca4;Smarcd2
prerank,ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.5749352505413535,-0.9243248163225597,0.590032154340836,1.0,1.0,6/17,17.95%,Abca9;Abca7;Abca6;Abca3;Abcd1;Abca12
prerank,G Alpha (I) Signaling Events R-HSA-418594,0.41852689489472694,0.9241687749559337,0.6118143459915611,1.0,1.0,23/246,2.68%,Nbea;Ppp3ca;Camk2a;Camk2b;Adcy1;Rgs7;Adcy2;Plcb1;Grm7;Gabbr2;Gng7;Gnaq;Gnal;Mapk1;Pde1b;Adcy9;Gng2;Camkk1;Pde4a;Npy2r;Grm2;Ppp3r1;Camk2g
prerank,SUMOylation Of Transcription Cofactors R-HSA-3899300,0.5353947635258633,0.9234521668367626,0.5930521091811415,1.0,1.0,13/40,9.38%,Mrtfa;Uhrf2;Ncoa1;Crebbp;Ncor2;Pias1;Ddx5;Cbx4;Safb;Phc2;Npm1;Sumo2;Rnf2
prerank,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.566963067273691,-0.922893998475126,0.5922480620155038,1.0,1.0,5/18,23.36%,Lrig1;Wrn;Dna2;Pold4;Blm
prerank,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.5015923384134866,0.922173836164358,0.6004842615012107,1.0,1.0,19/71,12.49%,Rprd1a;Gtf2f2;Pou2f1;Ints6;Pou2f2;Ints10;Rprd1b;Ncbp1;Ccnt2;Nabp1;Ints2;Polr2e;Ccnk;Ice2;Rprd2;Srrt;Cdk9;Ints3;Gtf2a1
prerank,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.5003261008346794,-0.9220920245316364,0.5966850828729282,1.0,1.0,15/64,24.09%,Rbbp8;Rad51b;Wrn;Artn;Top3a;Eme1;Xrcc2;Rrad;Dna2;Bard1;Pold4;Xrcc3;Sem1;Blm;Rfc2
prerank,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.49501031359592196,0.9219999429639575,0.6190476190476191,1.0,1.0,6/72,2.69%,Negr1;Cntn5;Lsamp;Ntng2;Nrn1;Rtn4rl1
prerank,Hyaluronan Metabolism R-HSA-2142845,0.5866599260343125,0.9218146594040088,0.5919540229885057,0.9987447786727258,1.0,1/15,0.87%,Cemip
prerank,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.568678367429191,0.9213721829591959,0.5869017632241813,0.9968997168885847,1.0,2/26,1.67%,Foxo1;Akt3
prerank,Diseases Of Glycosylation R-HSA-3781865,0.44894755009498316,0.9205688019709578,0.6049382716049383,0.9959326110559854,1.0,8/136,1.91%,Sema5a;Thsd7a;Adamts17;Gpc4;Spon1;Adamts3;Notch2;B4galt1
prerank,Response Of Mtb To Phagocytosis R-HSA-9637690,0.5834556359075221,0.9204683015834536,0.6005509641873278,0.9933336780169079,1.0,2/20,4.74%,Mapk1;Mapk3
prerank,SARS-CoV-1 Infection R-HSA-9678108,0.5155024064272278,0.9188503336880972,0.6127562642369021,0.9942952802667,1.0,1/50,0.29%,St6galnac3
prerank,Antimicrobial Peptides R-HSA-6803157,-0.5340165088767805,-0.9184288665149595,0.613013698630137,1.0,1.0,5/33,11.98%,Clu;Atp7a;Chga;Trim21;Ro60
prerank,Signaling By Insulin Receptor R-HSA-74752,-0.49854181563743366,-0.9178415710463956,0.6052173913043478,1.0,1.0,4/70,2.47%,Gab2;Pik3r1;Fgf1;Grb10
prerank,RAS Processing R-HSA-9648002,-0.573309008058345,-0.916818647602926,0.617363344051447,1.0,1.0,3/17,8.22%,Prkg2;Prkcq;Zdhhc9
prerank,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.5342846368971137,-0.9131963441011252,0.6218057921635435,1.0,1.0,7/35,18.68%,Rbbp8;Wrn;Artn;Top3a;Rrad;Dna2;Bard1
prerank,Transcriptional Regulation By Small RNAs R-HSA-5578749,0.5033610173772283,0.9124646731751047,0.610752688172043,1.0,1.0,17/60,17.22%,Ago1;Ago2;Ndc1;Ranbp2;Nup93;Polr2e;H2bc4;H2ax;H2ac6;Nup160;Nup155;Nup214;Polr2k;H2ac4;Nup210;H2bc21;Nup153
prerank,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.5416334433260167,0.9115830136048018,0.591792656587473,1.0,1.0,11/35,18.43%,Pias1;Ndc1;Ranbp2;Nup93;Vhl;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,-0.555379465312952,-0.910233911808218,0.6127527216174183,1.0,1.0,1/17,0.90%,Slc6a7
prerank,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.5471060565517878,0.9101767629176591,0.6263736263736264,1.0,1.0,11/31,18.43%,Ndc1;Ranbp2;Xpo1;Nup93;Gnl3;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,Oncogenic MAPK Signaling R-HSA-6802957,0.4847221822985567,0.9099245690134996,0.6109785202863962,1.0,1.0,19/74,5.45%,Camk2a;Camk2b;Ap3b1;Cnksr2;Mapk1;Kdm7a;Ksr2;Map2k1;Ppp1cb;Camk2g;Mprip;Fam114a2;Ksr1;Spred2;Mapk3;Mras;Calm1;Ywhab;Src
prerank,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.5466470559849501,0.9094276162511086,0.6291390728476821,1.0,1.0,11/32,18.43%,Ndc1;Ranbp2;Xpo1;Nup93;Gnl3;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.5795414194504461,0.9093027361480394,0.6026666666666667,1.0,1.0,6/15,13.89%,Nt5c3b;Exosc8;Skic8;Exosc2;Exosc1;Skic3
prerank,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.4670871134450198,0.9089997636874252,0.628175519630485,0.9981237288309439,1.0,11/99,3.81%,Il1rap;Pip5k1b;Nrg2;Nrg3;Mapk1;Tgfa;Pip5k1a;Flt3;Pik3cb;Fyn;Fgf5
prerank,Collagen Degradation R-HSA-1442490,-0.5223211634841607,-0.9051286027765945,0.6208530805687204,1.0,1.0,11/34,10.12%,Col26a1;Col12a1;Mmp14;Col14a1;Ctsd;Col19a1;Col16a1;Adam10;Adam17;Mmp28;Mmp11
prerank,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.5424242502345606,-0.904362161064119,0.6186440677966102,1.0,1.0,9/20,27.61%,Ticam1;Nkiras1;Dtx4;Tlr3;Irf3;Nfkbia;Chuk;Ripk1;Rela
prerank,Drug ADME R-HSA-9748784,0.49003213991700256,0.9028797806801673,0.6290726817042607,1.0,1.0,2/55,2.65%,Vav3;Nt5c2
prerank,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.548093393755419,-0.9019948477358943,0.6473429951690821,1.0,1.0,7/21,31.30%,Idh2;Ldhd;Ldlr;Sdha;Sdhb;Cs;Idh3a
prerank,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,0.45628428292070916,0.900714801050298,0.6645569620253164,1.0,1.0,21/132,6.43%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Dnm1;Fbxw11;Peli1;Btrc;Plcg2;Peli2;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Dusp4;Ube2d1
prerank,Glutathione Conjugation R-HSA-156590,-0.5294336984834696,-0.9005018023976135,0.6331058020477816,1.0,1.0,12/32,25.69%,Ggt5;Hpgds;Mgst3;Gstt1;Gstm2;Ggt1;Gsta3;Mgst2;Gstm5;Gstp1;Gclm;Gclc
prerank,Regulation Of Insulin Secretion R-HSA-422356,0.48242914435885875,0.9002111850737048,0.6482758620689655,1.0,1.0,11/74,2.71%,Cacna1c;Cacna1e;Cacnb2;Plcb1;Cacna1d;Gng7;Gnaq;Kcng2;Gng2;Abcc8;Rapgef4
prerank,Plasma Lipoprotein Remodeling R-HSA-8963899,0.5386409747110611,0.8990237131906068,0.5910224438902744,1.0,1.0,1/26,0.60%,Pcsk5
prerank,EGFR Downregulation R-HSA-182971,0.5434314420691786,0.8984717691708799,0.6232558139534884,1.0,1.0,6/30,4.22%,Ptprk;Tgfa;Ptpn3;Sh3gl1;Arhgef7;Cbl
prerank,Sensory Processing Of Sound R-HSA-9659379,-0.47615089320757786,-0.8981091963586141,0.6,1.0,1.0,9/73,3.80%,Pcdh15;Kcnn2;Epb41l3;Cacna2d2;Whrn;Stx1a;Myo1e;Cabp1;Gsn
prerank,Extracellular Matrix Organization R-HSA-1474244,-0.4126382632567378,-0.8977430727584356,0.6771929824561403,1.0,1.0,73/269,8.90%,Scube1;Dmd;Col26a1;Fn1;Adamts16;Nrxn1;Lama4;Adamts2;Ntn4;Jam3;Bcan;Adam19;Ltbp1;P4ha3;Col6a1;Itga9;Cd44;P3h2;Col6a5;Col8a1;Dcn;Timp2;Jam2;Lamc2;Sparc;Hapln1;Tnn;Col27a1;Col6a2;Capn2;Col12a1;Lrp4;Ltbp3;Vcan;Mmp14;Itgb5;Col11a1;Col1a2;Col14a1;Bmp7;Fbln2;Itgam;Col4a2;Ctsd;Col24a1;Ctss;Col19a1;Col4a1;Lama1;Vtn;Htra1;Ddr2;Itga3;Prkca;Col16a1;Efemp2;Lama2;Klk7;Col3a1;Col4a5;Pcolce;Tgfb1;Adamts4;Adam12;Itgb1;Itga6;Tgfb3;Adam10;Lamc3;Loxl2;Adam17;Itga1;Mmp28
prerank,SARS-CoV Infections R-HSA-9679506,-0.39930415652773726,-0.8974100345559549,0.7279693486590039,1.0,1.0,21/332,5.65%,Mgat4c;Gpc6;St6gal1;Gpc5;Parp8;Man2a1;Zdhhc2;Mgat5;Atp1b3;Masp1;Vav1;Fxyd7;Atp1a2;Ywhaq;Traf3;Ap2b1;Gja1;S1pr1;Cav1;Il17ra;Jak2
prerank,Regulation Of TLR By Endogenous Ligand R-HSA-5686938,-0.5560422604311094,-0.8973358822366979,0.651017214397496,1.0,1.0,7/17,31.72%,S100a1;Tlr6;Ndufa2;Gsdmd;Ly96;Cd36;Fgg
prerank,Signaling By WNT In Cancer R-HSA-4791275,-0.5145121049299006,-0.8969042197648549,0.6369747899159663,1.0,1.0,7/32,13.78%,Tcf7l2;Ppp2r5a;Dkk2;Ppp2r5c;Wnt3a;Rnf43;Fzd6
prerank,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.5195343204777367,-0.8964049867097751,0.6339285714285714,1.0,1.0,11/41,7.31%,Sox6;Lef1;Tcf7l2;Tle3;Tle2;Sox2;Sox4;Bcl9;Ctnnbip1;Tcf7l1;Sox9
prerank,Lysosome Vesicle Biogenesis R-HSA-432720,0.528545272808588,0.894699744183144,0.6060606060606061,1.0,1.0,6/32,8.92%,Clvs2;Clvs1;Ap1s2;Ap4e1;Ap1g1;Ap1s3
prerank,Presynaptic Function Of Kainate Receptors R-HSA-500657,0.5572566261398684,0.8927166068480458,0.599502487562189,1.0,1.0,3/20,2.29%,Plcb1;Gng7;Gng2
prerank,Dual Incision In GG-NER R-HSA-5696400,0.5122778086971534,0.8923019717698675,0.6228710462287105,1.0,1.0,4/41,7.44%,Gtf2h2;Ercc4;Gtf2h5;Parp1
prerank,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.558737071803677,-0.8895932671534401,0.6543778801843319,1.0,1.0,7/17,24.71%,E2f1;Ccnd1;Ccnd3;Cdkn1c;Cdk2;E2f2;Ccne2
prerank,NGF-stimulated Transcription R-HSA-9031628,-0.5171780380259743,-0.8883677637786607,0.6637478108581436,1.0,1.0,12/38,13.41%,Egr1;Vgf;Trib1;Sgk1;Kcnh8;Id1;Arc;F3;Id3;Id4;Tph1;Fos
prerank,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.5472596528628044,-0.8865863934147524,0.6409395973154363,1.0,1.0,3/19,4.96%,Eps15;Sh3gl2;Stam2
prerank,Myogenesis R-HSA-525793,0.5393422724305335,0.886501470588285,0.6277173913043478,1.0,1.0,6/26,4.07%,Cdon;Map2k6;Cdh2;Mef2c;Mef2d;Tcf12
prerank,Epigenetic Regulation Of Gene Expression R-HSA-212165,0.45320658541163367,0.8863833062275168,0.6442953020134228,1.0,1.0,21/102,10.00%,Chd4;Chd3;Gatad2b;Gtf2h2;Baz1b;Hdac1;Mta3;Ccnh;Gtf2h5;Mtf2;Ezh2;Ubtf;Suz12;Rbbp7;Aebp2;Mnat1;Mta2;Smarca5;Cbx3;Polr2e;H2bc4
prerank,Chaperone Mediated Autophagy R-HSA-9613829,-0.5364969530331487,-0.8860775760187551,0.6693679092382496,1.0,1.0,10/19,30.89%,Cftr;Ift88;Lamp2;Hsp90aa1;Gfap;Hspa8;Arl13b;Ubb;Pcnt;Ubc
prerank,Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,0.5538048794833081,0.8837736743148784,0.6051282051282051,1.0,1.0,2/15,1.58%,Trpc6;Orai2
prerank,G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.5575520975165565,0.8829043947120193,0.6375,1.0,1.0,3/19,2.29%,Plcb1;Gng7;Gng2
prerank,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.4899800247729278,-0.8827490735776796,0.6357827476038339,1.0,1.0,3/49,2.80%,Camk4;Tbl1x;Smarcd3
prerank,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.4110393382478213,0.8824180706129202,0.6846846846846847,1.0,1.0,58/182,17.82%,Utp4;Rcl1;Bop1;Mtrex;Sppl2a;Dkc1;Rrp1b;Rbm28;Exosc8;Heatr1;Rpl15;Riok3;Wdr12;Pelp1;Utp15;Wdr75;Nob1;Xrn2;Dnajc5;Nop58;Wdr43;Rpl4;Wdr36;Gnl3;Nol12;Mphosph10;Rplp0;Rpl10a;Rplp1;Nop56;Tsr1;Rpl3;Mrpl13;Exosc2;Dcaf13;Rpsa;Emg1;Exosc1;Rpl8;Rpl36a;Exosc10;Rsl24d1;Senp3;Riok2;Rpl18;Rpl6;Ebna1bp2;Nat10;Tbl3;Nol6;Tex10;Ftsj3;Thumpd1;Bysl;Rps28;Utp6;Rps3;Krr1
prerank,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",0.5213183962086074,0.8823993501924723,0.6384039900249376,1.0,1.0,3/35,4.20%,Slc16a2;Slc29a4;Slco3a1
prerank,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.5348041620123253,0.8817200294414954,0.6310679611650486,1.0,1.0,8/28,5.14%,Grik4;Plcb1;Gng7;Ncald;Gng2;Grik5;Mpp3;Calm1
prerank,G Alpha (S) Signaling Events R-HSA-418555,-0.4340140632058641,-0.8814725905799693,0.6837294332723949,1.0,1.0,28/133,8.22%,Rxfp1;Pde4d;Pde11a;Htr7;Pde1a;Gng4;Grk3;Prkar1b;Npsr1;Pde3a;Gnas;Gnai1;Pde2a;Pde10a;Gng12;Hrh2;Gnb4;Crhr1;C1qtnf1;Pde8a;Pth2r;Prkca;Grk5;Lhcgr;Itgb1;Gng3;Sctr;Gnai2
prerank,G-protein Beta:Gamma Signaling R-HSA-397795,0.5315497500260313,0.8814484606678258,0.6430260047281324,1.0,1.0,4/31,2.29%,Plcb1;Gng7;Akt3;Gng2
prerank,Signaling By MET R-HSA-6806834,-0.48499795763323283,-0.8805492434413397,0.6325088339222615,1.0,1.0,16/63,11.15%,Lama4;Pik3r1;Eps15;Lamc2;Sh3gl2;Rap1b;Stam2;Lama1;Itga3;Lama2;Itgb1;Lamc3;Lrig1;Pik3ca;Dock7;Ptpn1
prerank,Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.5304658711865642,0.8793133955980853,0.6388261851015802,1.0,1.0,11/31,18.43%,Ndc1;Ranbp2;Ncbp1;Nup93;Eif4e;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,Nuclear Receptor Transcription Pathway R-HSA-383280,-0.48826768873178195,-0.8790930057957929,0.6493955094991365,1.0,1.0,13/51,6.55%,Thrb;Nr4a1;Nr4a3;Nr4a2;Rorb;Rara;Rxrg;Esr1;Esr2;Nr6a1;Pparg;Nr2e1;Esrrg
prerank,RHO GTPases Activate PKNs R-HSA-5625740,0.48953213228439446,0.8790167648452201,0.6523809523809524,1.0,1.0,12/49,11.72%,Ppp1r12b;Ppp1cb;Ywhaz;Ywhab;Ywhah;Ywhae;H2bc4;H2ax;H2ac6;Rhob;Pdpk1;Myh9
prerank,Ion Transport By P-type ATPases R-HSA-936837,0.4886952801652411,0.8772881074457742,0.6570155902004454,1.0,1.0,8/51,3.52%,Camk2a;Camk2b;Atp2b1;Atp2b3;Atp8a1;Camk2g;Atp2c1;Atp1b1
prerank,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.5143610227491228,0.8756124723448715,0.6384039900249376,1.0,1.0,7/34,6.62%,Arid1b;Smarca2;Smarca4;Cbfb;Cbx6;Smarcd2;Cbx4
prerank,rRNA Processing R-HSA-72312,0.4037900865084322,0.8755967851265818,0.7155756207674944,1.0,1.0,58/192,17.82%,Utp4;Rcl1;Bop1;Mtrex;Sppl2a;Dkc1;Rrp1b;Rbm28;Exosc8;Heatr1;Rpl15;Riok3;Wdr12;Pelp1;Utp15;Wdr75;Nob1;Xrn2;Dnajc5;Nop58;Wdr43;Rpl4;Wdr36;Gnl3;Nol12;Mphosph10;Rplp0;Rpl10a;Rplp1;Nop56;Tsr1;Rpl3;Mrpl13;Exosc2;Dcaf13;Rpsa;Emg1;Exosc1;Rpl8;Rpl36a;Exosc10;Rsl24d1;Senp3;Riok2;Rpl18;Rpl6;Ebna1bp2;Nat10;Tbl3;Nol6;Tex10;Ftsj3;Thumpd1;Bysl;Rps28;Utp6;Rps3;Krr1
prerank,Metalloprotease DUBs R-HSA-5689901,-0.5211471330684545,-0.8747500705241196,0.6521739130434783,1.0,1.0,2/27,3.54%,Kat2b;Stambpl1
prerank,Tight Junction Interactions R-HSA-420029,0.5396087783128771,0.8735753204969198,0.6531645569620254,1.0,1.0,2/25,3.72%,Pard3;Pals1
prerank,Signaling By Interleukins R-HSA-449147,0.37795626507757824,0.8733773535256105,0.8147368421052632,1.0,1.0,34/407,4.98%,Il1rap;Il1rapl1;Ptk2b;Foxo1;Map2k6;Il1r1;Mapk1;Crlf1;Map2k1;Bcl6;Tnip2;Smad3;Il16;Jun;Mef2c;Rps6ka2;Fbxw11;Peli1;Btrc;Pik3cb;Pdcd4;Peli2;Fyn;Mapk10;Ywhaz;Cbl;Pou2f1;Map2k4;Cebpd;Ripk2;Mapk3;Brwd1;Smarca4;Hnrnpdl
prerank,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.4737446217061681,0.8731296440972682,0.6584821428571429,1.0,1.0,14/60,11.24%,Chd4;Chd3;Gatad2b;Baz1b;Hdac1;Mta3;Rbbp7;Mta2;Smarca5;Cbx3;Polr2e;H2bc4;H2ax;H2ac6
prerank,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.5237617146627139,0.872171084053332,0.6470588235294118,1.0,1.0,8/26,15.70%,Pou2f1;Polr2e;Polr3gl;Polr3g;Tbp;Polr3e;Polr2k;Snapc4
prerank,Pyroptosis R-HSA-5620971,-0.5418470900726091,-0.8714583535192713,0.6751269035532995,1.0,1.0,8/20,29.31%,Irf2;Casp1;Casp4;Il1a;Gsdmd;Il18;Chmp7;Il1b
prerank,Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.5363872039504918,0.8713544748164075,0.6633416458852868,1.0,1.0,3/29,3.76%,Arsb;Lct;Galns
prerank,Fertilization R-HSA-1187000,0.5349014736600266,0.8708048644924432,0.6108108108108108,1.0,1.0,1/18,1.91%,B4galt1
prerank,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.48643190474244935,-0.8701269510489807,0.651705565529623,1.0,1.0,12/50,13.19%,Bcl2;P2rx7;Mapk11;App;Birc3;Casp1;Cyld;Irak2;Tnfaip3;Casp8;Txnip;Casp4
prerank,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.5023211644546136,0.8698978004877383,0.687793427230047,1.0,1.0,12/38,5.45%,Camk2a;Camk2b;Cnksr2;Mapk1;Ksr2;Map2k1;Camk2g;Ksr1;Mapk3;Calm1;Ywhab;Src
prerank,Miscellaneous Transport And Binding Events R-HSA-5223345,0.5444741690455929,0.8695263670741593,0.6388888888888888,1.0,1.0,2/21,3.78%,Add2;Add3
prerank,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.4077540430915028,0.8682554846822712,0.745958429561201,1.0,1.0,50/172,16.35%,Utp4;Rcl1;Bop1;Mtrex;Sppl2a;Rrp1b;Rbm28;Exosc8;Heatr1;Rpl15;Riok3;Wdr12;Pelp1;Utp15;Wdr75;Nob1;Xrn2;Dnajc5;Nop58;Wdr43;Rpl4;Wdr36;Gnl3;Nol12;Mphosph10;Rplp0;Rpl10a;Rplp1;Nop56;Tsr1;Rpl3;Mrpl13;Exosc2;Dcaf13;Rpsa;Emg1;Exosc1;Rpl8;Rpl36a;Exosc10;Rsl24d1;Senp3;Riok2;Rpl18;Rpl6;Ebna1bp2;Tbl3;Nol6;Tex10;Ftsj3
prerank,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.4481588056615114,-0.867314692914591,0.6766355140186916,1.0,1.0,5/87,7.64%,Enpp2;Mapk11;Zfp36l1;Prkca;Prkcd
prerank,Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.5138287705640026,0.8659999141467793,0.6472019464720195,1.0,1.0,9/31,3.99%,Camk2a;Camk2b;Tnrc6c;Ncor1;Camk2g;Ago1;Tnrc6b;Ago2;Hdac1
prerank,Biological Oxidations R-HSA-211859,-0.42624941511796133,-0.8656710530103767,0.7068645640074211,1.0,1.0,24/141,14.15%,Acss1;Arnt2;Ugp2;Aldh1a1;Smox;Tbxas1;Maob;Ptgs1;Podxl2;Cyp26b1;As3mt;Ggt5;Fmo1;Hpgds;Slc38a3;Glyat;Slc38a1;Cyp27a1;Mgst3;Ugdh;Gstt1;Ahr;Maoa;Cyp4b1
prerank,Cellular Response To Starvation R-HSA-9711097,0.41511454870083114,0.8656070167689933,0.7254004576659039,1.0,1.0,27/145,14.29%,Atp6v1a;Fnip2;Rragd;Mios;Rptor;Kptn;Atp6v1c2;Gcn1;Cebpb;Atp6v0e2;Rpl15;Nprl3;Slc38a9;Rragb;Rpl4;Rplp0;Rpl10a;Castor2;Rplp1;Rpl3;Mrpl13;Asns;Atp6v1d;Rpsa;Rpl8;Atf3;Rpl36a
prerank,Signaling By RAF1 Mutants R-HSA-9656223,0.5037293406732132,0.8643549606147313,0.6834532374100719,1.0,1.0,12/36,5.45%,Camk2a;Camk2b;Cnksr2;Mapk1;Ksr2;Map2k1;Camk2g;Ksr1;Mapk3;Calm1;Ywhab;Src
prerank,trans-Golgi Network Vesicle Budding R-HSA-199992,0.4617833848986392,0.8640263872755733,0.6818181818181818,1.0,1.0,7/66,4.12%,Clvs2;Ap3b1;Tbc1d8b;Tpd52l1;Clvs1;Sort1;Pum1
prerank,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.5199943506354134,0.8632986404613998,0.6515151515151515,1.0,1.0,1/28,0.57%,Cyp7b1
prerank,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.5112903502851511,-0.8617864790515024,0.6721044045676998,1.0,1.0,2/28,3.70%,Colec12;Lsm11
prerank,GPVI-mediated Activation Cascade R-HSA-114604,0.5132083675476578,0.8607275394970021,0.6715686274509803,1.0,1.0,4/32,3.69%,Vav3;Pik3cb;Plcg2;Fyn
prerank,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,0.5147383072924105,0.8598457720336529,0.6575,1.0,1.0,3/33,5.31%,Cyp7b1;Cyp11a1;Ncoa1
prerank,HCMV Early Events R-HSA-9609690,-0.4582047320929471,-0.8581617706411425,0.6804511278195489,1.0,1.0,6/80,9.34%,Tbl1x;Pcsk1;Kcnh8;Itgb1;Egfr;Dync1h1
prerank,SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.5162049820637408,0.8574431192909804,0.6628959276018099,1.0,1.0,10/31,18.43%,Ndc1;Ranbp2;Nup93;Sumo2;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.45665596551134047,-0.8570692808836134,0.6855575868372943,1.0,1.0,7/77,5.10%,St8sia5;St6gal1;St6gal2;St3gal6;St8sia6;Uap1;St8sia2
prerank,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.5025791911812713,0.8568192917998377,0.6593673965936739,1.0,1.0,5/32,5.45%,Mapk1;Fgf5;Cbl;Mapk3;Src
prerank,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.5050697992710006,-0.8561050245882373,0.6826758147512865,1.0,1.0,9/30,11.49%,Pik3r1;Itpr2;Clstn1;Vav1;Pik3ap1;Lyn;Dapp1;Blk;Btk
prerank,mRNA 3-End Processing R-HSA-72187,0.4796461323329179,0.855993133106207,0.6788990825688074,1.0,1.0,17/58,13.23%,Cdc40;Thoc2;Cstf3;Srsf9;Nudt21;Srsf11;Srsf1;Papola;Ncbp1;Cpsf6;Wdr33;Fyttd1;Cstf2t;Thoc3;Pabpn1;Srsf7;Srsf3
prerank,Downregulation Of ERBB2 Signaling R-HSA-8863795,0.5203502976024186,0.855988889218753,0.664179104477612,1.0,1.0,3/28,1.67%,Nrg2;Nrg3;Akt3
prerank,Signaling By Hedgehog R-HSA-5358351,0.4152172716969825,0.853776464262321,0.7442348008385744,1.0,1.0,14/134,7.12%,Adcy1;Adcy2;Cdon;Adcy9;Btrc;Dync2h1;Ptch1;Efcab7;Csnk1a1;Cul1;Prkacb;Prkar2b;Ift122;Ift57
prerank,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.5080053806622673,0.8532751392668875,0.6723716381418093,1.0,1.0,6/31,5.45%,Gng7;Gnaq;Mapk1;Gng2;Mapk3;Src
prerank,Bile Acid And Bile Salt Metabolism R-HSA-194068,0.4997143334487911,0.8531301974698933,0.6578947368421053,1.0,1.0,1/36,0.57%,Cyp7b1
prerank,Toll-like Receptor Cascades R-HSA-168898,0.41918007378044553,0.8530325779843863,0.7541666666666667,1.0,1.0,22/152,6.43%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Mef2c;Rps6ka2;Dnm1;Fbxw11;Peli1;Btrc;Plcg2;Peli2;Mapk10;Map2k4;Ripk2;Mapk3;Cul1;Mapk14;Eea1;Dusp4;Ube2d1
prerank,RET Signaling R-HSA-8853659,-0.4962829642352082,-0.85099617605509,0.6767169179229481,1.0,1.0,10/39,7.35%,Gab2;Pik3r1;Shc3;Grb10;Clstn1;Ret;Nrtn;Gfra3;Prkca;Grb7
prerank,SUMOylation R-HSA-2990846,-0.4095640544114767,-0.8503959388562273,0.758893280632411,1.0,1.0,8/163,3.83%,Satb2;Thrb;Nr4a2;Rara;Hdac4;Satb1;Esr1;Nrip1
prerank,Voltage Gated Potassium Channels R-HSA-1296072,0.4833058936821893,0.8503035167751509,0.6730310262529833,1.0,1.0,13/43,3.75%,Kcnd2;Kcnh1;Kcnab1;Kcnd3;Kcnc3;Kcng2;Kcnc4;Kcnq3;Kcna4;Kcng1;Kcng3;Kcna1;Kcnab2
prerank,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.4109299035759016,-0.8500455687615622,0.7642436149312377,1.0,1.0,8/157,3.83%,Satb2;Thrb;Nr4a2;Rara;Hdac4;Satb1;Esr1;Nrip1
prerank,Intra-Golgi Traffic R-HSA-6811438,0.5111578151842875,0.8488498884406169,0.690176322418136,1.0,1.0,3/35,3.90%,Nsf;Cyth1;Ric1
prerank,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.49908210249245993,-0.8487865423462998,0.6934673366834171,1.0,1.0,2/35,1.03%,Gpc6;Gpc5
prerank,Ephrin Signaling R-HSA-3928664,0.5236009731584612,0.8485778282942894,0.660377358490566,1.0,1.0,7/18,6.06%,Nck2;Sdcbp;Fyn;Arhgef7;Efnb3;Src;Ephb2
prerank,Protein Localization R-HSA-9609507,-0.41913759400908035,-0.8482685136675693,0.7787769784172662,1.0,1.0,13/151,14.58%,Stx1a;App;Phyh;Crot;Pex7;Cyb5a;Cmc2;Slc25a13;Glyat;Ldhd;Ide;Pex13;Abcd1
prerank,Nuclear Import Of Rev Protein R-HSA-180746,0.514494690945734,0.8472126104910666,0.679372197309417,1.0,1.0,10/30,18.43%,Ndc1;Ranbp2;Nup93;Npm1;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,Interleukin-6 Family Signaling R-HSA-6783589,0.5237201310223307,0.8465340857616568,0.6860158311345647,1.0,1.0,2/22,4.22%,Crlf1;Cbl
prerank,Infection With Mycobacterium Tuberculosis R-HSA-9635486,0.5127764675396137,0.8449980212388956,0.6493506493506493,1.0,1.0,2/24,4.74%,Mapk1;Mapk3
prerank,SUMOylation Of Intracellular Receptors R-HSA-4090294,0.5090435412646597,0.8445685686466134,0.6691542288557214,1.0,1.0,1/29,0.12%,Nr3c2
prerank,Costimulation By CD28 Family R-HSA-388841,-0.4673318767629892,-0.8443022539458409,0.7290552584670231,1.0,1.0,15/56,17.54%,Pik3r1;Ppp2r5a;Vav1;Lyn;Ppp2r5c;Cd86;Pik3ca;Icos;Prr5;Cd80;Cdc42;Pkn2;Pdcd1lg2;Cd28;Ppp2r5e
prerank,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.4610398247381209,-0.8418565862974934,0.7071823204419889,1.0,1.0,7/63,5.10%,St8sia5;St6gal1;St6gal2;St3gal6;St8sia6;Uap1;St8sia2
prerank,Platelet Calcium Homeostasis R-HSA-418360,0.506537866890844,0.8415163282592928,0.6578947368421053,1.0,1.0,5/26,1.86%,Trpc6;Slc8a2;Atp2b1;Orai2;Atp2b3
prerank,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.489136350892971,0.8412061430196297,0.6808035714285714,1.0,1.0,12/38,18.43%,Ndc1;Ranbp2;Ncbp1;Nup93;Wdr33;Eif4e;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.5104281334816095,0.8408744277394663,0.6928746928746928,1.0,1.0,10/30,11.18%,Mapk1;Fgf5;Cbl;Mapk3;Src;Kl;Grb2;Frs2;Braf;Fgf10
prerank,Metabolism Of Non-Coding RNA R-HSA-194441,0.4890320947814463,0.8403031467876543,0.7124183006535948,1.0,1.0,14/48,17.22%,Clns1a;Ndc1;Ranbp2;Ncbp1;Nup93;Gemin8;Snrpd3;Snrpb;Nup160;Nup155;Nup214;Wdr77;Nup210;Nup153
prerank,Metabolism Of Folate And Pterines R-HSA-196757,-0.527590147262309,-0.8371593749152976,0.7057877813504824,1.0,1.0,4/15,18.99%,Aldh1l1;Mthfd1l;Folr2;Dhfr
prerank,RHO GTPases Activate PAKs R-HSA-5627123,0.516245723585122,0.8366774848838663,0.6775,1.0,1.0,4/21,5.14%,Ppp1r12b;Ppp1cb;Arhgef7;Calm1
prerank,MHC Class II Antigen Presentation R-HSA-2132295,-0.4397232121283467,-0.8360179734576018,0.7439703153988868,1.0,1.0,19/85,13.45%,Osbpl1a;Kif5a;Lgmn;Sh3gl2;Kif26a;Ap2b1;Ctsh;Ctsc;Ctsd;Ctss;Lag3;Dnm3;Dync1h1;Cd74;Klc3;Dync1li2;Sec24a;Ctso;Cltc
prerank,IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,0.5214394379340062,0.8355548410669604,0.6720867208672087,1.0,1.0,1/16,1.68%,Crlf1
prerank,Chemokine Receptors Bind Chemokines R-HSA-380108,-0.488719192335589,-0.8352481472201521,0.7085514834205934,1.0,1.0,10/35,23.70%,Cx3cr1;Ccr5;Cxcr4;Cxcr2;Cxcl16;Xcr1;Ccl28;Cxcl5;Cxcl11;Ccrl2
prerank,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.3988683776985102,-0.8343092650800388,0.7931726907630522,1.0,1.0,22/182,7.31%,Rspo2;Cxxc4;Ccdc88c;Sox6;Lef1;Tcf7l2;Ppp2r5a;Tle3;Tle2;Lgr5;Wif1;Sox2;Sox4;Dkk2;Cav1;Bcl9;Ctnnbip1;Ppp2r5c;Tcf7l1;Rspo1;Fzd2;Sox9
prerank,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.4431294210641673,0.8337813931899375,0.7342342342342343,1.0,1.0,9/74,7.90%,Mapk1;Bag4;Mapk3;Hspa2;Dnajb6;Ndc1;Ranbp2;Ywhae;Nup93
prerank,Cytoprotection By HMOX1 R-HSA-9707564,-0.461535826151155,-0.8320064211808873,0.7285223367697594,1.0,1.0,5/54,9.82%,Tbl1x;Smarcd3;Cox16;Nfe2l2;Abcc1
prerank,tRNA Processing R-HSA-72306,-0.43113438987700764,-0.831919488513891,0.766798418972332,1.0,1.0,2/96,2.60%,Colec12;Trmt9b
prerank,Signaling By FGFR4 R-HSA-5654743,-0.4820868234133661,-0.8314746875737326,0.7106598984771574,1.0,1.0,2/37,2.15%,Pik3r1;Fgf1
prerank,Potential Therapeutics For SARS R-HSA-9679191,0.42920856547301434,0.8299249296785985,0.7756410256410257,1.0,1.0,20/91,9.51%,Il1r1;Chd4;Phf21a;Chd3;Gatad2b;Itga4;Plcg2;Atp1b1;Hdac1;Mta3;Nck1;Sh3kbp1;Rcor1;Rbbp7;Sos1;Mta2;Grb2;Rock1;Brd4;Tyk2
prerank,Neutrophil Degranulation R-HSA-6798695,-0.3667717989146576,-0.8291060337812429,0.9102564102564102,1.0,1.0,69/395,10.28%,Dlc1;Rab31;Frmpd3;Ptprn2;Vcl;Cst3;Cd44;Dock2;Iqgap1;Timp2;Ostf1;Ptprc;Manba;Gsn;Sirpa;Trpm2;Arhgap45;Ctsh;Lair1;Qpct;Rap1b;Pgm2;Syngr1;Ctsc;Ptprb;Itgam;Ctsd;Tspan14;Ctss;Ctsz;Nckap1l;Tbc1d10c;Cd33;Tom1;Asah1;Plppr3;Nfam1;Rab37;Stom;Gca;Fuca1;Crispld2;Rcan1;Lamp2;Prkcd;Cd53;Tyrobp;Lamp1;Cda;Atp6ap2;Stbd1;Adam10;Slc2a5;Tmem63a;Cd63;Bin2;Mmp28;Anpep;Gusb;Cyba;Ghdc;Dync1h1;Glyat;Abca13;Dnajc13;Aifm2;Aldoc;Cd93;Ampd3
prerank,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.5084157031858677,-0.8284538136856658,0.7252032520325203,1.0,1.0,5/21,13.21%,Bcat1;Bckdhb;Soat1;Acadsb;Ldhd
prerank,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.4417773330038482,-0.827842479056124,0.7616487455197133,1.0,1.0,32/82,17.71%,Gng4;Gnas;Smox;Wnt2;Gng12;Gnb4;Crhr1;C1qtnf1;Crhbp;Pth2r;Fzd2;Gng3;Sctr;Adgre1;Calcr;Wnt3a;Calcb;Ptch2;Wnt5a;Ghrh;Fzd6;Gngt2;Cysltr2;Ucn;Wnt10a;Wnt9b;Gnb2;Fzd10;Vipr2;Calcrl;Pthlh;Gng13
prerank,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.4940318645376614,0.8267348793035739,0.7075892857142857,1.0,1.0,10/31,18.43%,Ndc1;Ranbp2;Nup93;Gnl3;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.5074092400494585,-0.8257472627490456,0.7275693311582382,1.0,1.0,7/20,15.68%,Arhgef11;Plxnb1;Limk1;Myl6;Myh14;Erbb2;Myh10
prerank,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.5093265811617682,0.8255033744120767,0.6713483146067416,1.0,1.0,5/17,10.23%,Kmt5a;Ehmt1;Smyd2;Chek2;Atm
prerank,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.5028566584229307,-0.8234445693105034,0.7253634894991923,1.0,1.0,5/21,23.88%,E2f1;Slc25a2;Prim2;Cdk1;Ccnb1
prerank,Metabolism Of Polyamines R-HSA-351202,-0.4571944223552775,-0.8228470452450639,0.7350877192982456,1.0,1.0,7/57,22.10%,Smox;Slc38a1;Psmb8;Psme4;Psme2;Sem1;Psma1
prerank,GAB1 Signalosome R-HSA-180292,-0.5117105253515817,-0.8225794290373458,0.7047619047619048,1.0,1.0,4/16,9.95%,Pik3r1;Pag1;Egfr;Pik3ca
prerank,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.510289212977847,0.8221437402069447,0.7066326530612245,1.0,1.0,5/23,4.74%,Akt3;Mapk1;Tgfa;Ptk2;Mapk3
prerank,Negative Regulation Of MET Activity R-HSA-6807004,0.505237014794579,0.8216026175654529,0.6909547738693468,1.0,1.0,6/21,7.65%,Ptprj;Sh3gl1;Cbl;Sh3kbp1;Usp8;Sos1
prerank,Heme Signaling R-HSA-9707616,-0.4721636281785042,-0.8212157955425874,0.7360655737704918,1.0,1.0,4/42,3.83%,Tbl1x;Npas2;Smarcd3;Nrip1
prerank,Sialic Acid Metabolism R-HSA-4085001,-0.48246541270556753,-0.8211239353632356,0.7210144927536232,1.0,1.0,5/33,2.86%,St8sia5;St6gal1;St6gal2;St3gal6;St8sia6
prerank,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.4579715034603793,-0.8202186928999599,0.7538200339558574,1.0,1.0,8/48,5.36%,Gpc6;Xylt1;Gpc5;Bcan;Dcn;Cspg5;Vcan;Cspg4
prerank,Platelet Homeostasis R-HSA-418346,-0.43290292791469887,-0.8182533497154658,0.7509225092250923,1.0,1.0,18/82,5.01%,Slc8a1;Pde11a;Pde1a;Trpc3;Gng4;Pde5a;Trpc7;Itpr2;Prkg2;P2rx7;Ppp2r5a;Gnas;Pde2a;Pde10a;Gng12;P2rx4;Irag1;Gnb4
prerank,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.5090428826798287,-0.8179084280761332,0.7333333333333333,1.0,1.0,7/17,27.61%,Ticam1;Nkiras1;Tlr3;Nfkbia;Chuk;Ripk1;Rela
prerank,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.5091912209891638,0.8177907111859767,0.6917293233082706,1.0,1.0,2/20,0.80%,Nrg2;Nrg3
prerank,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.46108407430787557,0.8168819164091576,0.728110599078341,1.0,1.0,6/54,4.94%,Tnrc6c;Ago1;Tnrc6b;Hdac1;Rbbp5;Cbfb
prerank,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.435538926030075,0.8161782017965038,0.7807606263982103,1.0,1.0,4/79,2.97%,Ppp3ca;Ppp3r1;Fbxw11;Btrc
prerank,Regulation Of TP53 Degradation R-HSA-6804757,0.4783449695717838,0.8155713469457148,0.7506361323155216,1.0,1.0,2/35,2.25%,Akt3;Usp2
prerank,Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.47528117584659013,0.8152681911332297,0.7638190954773869,1.0,1.0,2/36,2.25%,Akt3;Usp2
prerank,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.42719277747002726,0.8151910616733302,0.7671232876712328,1.0,1.0,11/84,7.18%,Akt3;Dennd1a;Rab27a;Sbf1;Dennd2b;Rab3ip;Dennd1b;Ric1;Rin1;Ywhae;Rab10
prerank,RHOU GTPase Cycle R-HSA-9013420,-0.4689162431784361,-0.8149013184017899,0.7343485617597293,1.0,1.0,9/39,4.96%,Pik3r1;Peak1;Srgap2;Iqgap1;Arhgap31;Myo6;Arhgef6;Wwp2;Stam2
prerank,HCMV Late Events R-HSA-9610379,-0.4399247876360314,-0.8143908510727477,0.7779783393501805,1.0,1.0,1/74,1.22%,Pcsk1
prerank,Signaling By NTRK1 (TRKA) R-HSA-187037,0.413285921099165,0.8134332652429943,0.8172043010752689,1.0,1.0,20/112,5.90%,Bcl11b;Mapk1;Rit2;Map2k1;Adcyap1r1;Chd4;Mef2c;Rps6ka2;Dnm1;Mef2d;Pik3cb;Tcf12;Cdk5r1;Mapk3;Ywhab;Src;Map2k5;Irs1;Mapk14;Irs2
prerank,Chaperonin-mediated Protein Folding R-HSA-390466,0.424276410967962,0.8128301401075977,0.7828947368421053,1.0,1.0,4/81,2.29%,Rgs7;Gng7;Gnaq;Gng2
prerank,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.47455519722134587,-0.8102747318811638,0.7427597955706985,1.0,1.0,9/32,29.83%,Lrig1;Wrn;Dna2;Pold4;Prim2;Blm;Rfc2;Ctc1;Slc19a1
prerank,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.40717940159199234,-0.8097296928972357,0.8397085610200364,1.0,1.0,12/108,6.46%,Prkcb;Rasgrp1;Pik3r1;Itpr2;Clstn1;Nfatc2;Vav1;Rel;Rasgrp3;Pik3ap1;Lyn;Nfatc1
prerank,Protein Folding R-HSA-391251,0.4167227352339397,0.8085761122364861,0.7861771058315334,1.0,1.0,4/87,2.29%,Rgs7;Gng7;Gnaq;Gng2
prerank,FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.4980193033242326,-0.8084632390221944,0.7471451876019576,1.0,1.0,2/22,9.27%,Fgf1;Fgf23
prerank,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.4428253797416318,-0.8075188197730427,0.7581227436823105,1.0,1.0,15/69,8.89%,Pik3r1;Bcl2;Gng4;Gnai1;Esr1;Esr2;Gng12;Kcnh8;Gnb4;Cav1;Ccnd1;Gng3;Gnai2;Cav2;Egfr
prerank,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.40605232599692853,0.8069336394353708,0.8329519450800915,1.0,1.0,8/111,2.87%,Adcy1;Htr4;Adcy2;Gng7;Adcyap1r1;Adcy9;Gng2;Ramp1
prerank,Glycerophospholipid Biosynthesis R-HSA-1483206,0.3998858227950272,0.8067970604468527,0.8172043010752689,1.0,1.0,6/123,3.06%,Pitpnm2;Slc44a5;Pla2g4e;Cpne6;Dgat2;Slc44a1
prerank,Transcriptional Regulation By VENTX R-HSA-8853884,0.47842386088463534,0.8064053704645464,0.7364864864864865,1.0,1.0,8/37,7.95%,Tnrc6c;Ago1;Tnrc6b;Ehmt1;Ube2d1;Ctnnb1;Cebpb;Nfkb1
prerank,Protein Ubiquitination R-HSA-8852135,0.4352326646632002,0.8045503828481446,0.7374701670644391,1.0,1.0,19/68,10.26%,Ube2w;Ube2e3;Shprh;Ube2k;Ube2q2;Ube2d1;Ube2g2;Wac;Ube2b;Derl1;Ube2r2;Ube2d3;Rad18;Usp7;Ube2h;Rtf1;H2bc4;Skic8;Uchl3
prerank,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.480373954052601,-0.8044918980182478,0.7438825448613376,1.0,1.0,4/24,8.89%,Wwp2;Jag2;Adam10;Egfr
prerank,Signaling By FGFR3 R-HSA-5654741,-0.46897336415641844,-0.8039635934973796,0.7530434782608696,1.0,1.0,5/37,9.95%,Pik3r1;Fgf1;Fgfr3;Fgf23;Pik3ca
prerank,SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.4968503202699906,-0.8038799931491849,0.7428115015974441,1.0,1.0,2/20,9.27%,Fgf1;Fgf23
prerank,Deubiquitination R-HSA-5688426,0.3624148689545655,0.8038046731389884,0.9495614035087719,1.0,1.0,27/246,9.08%,Mbd5;Otud7a;Tgfbr1;Usp2;Tnip2;Smad3;Foxk1;Usp15;Tnks;Rnf128;Usp47;Zranb1;Babam2;Ripk2;Trrap;Otub2;Usp34;Ube2d1;Usp8;Usp32;Psmd13;Mysm1;Usp33;Axin2;Usp7;Otud5;Usp12
prerank,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.42905902797546636,-0.8038008844569414,0.7592592592592593,1.0,1.0,7/65,3.28%,Pcdh15;Epb41l3;Cacna2d2;Whrn;Stx1a;Myo1e;Cabp1
prerank,Mitochondrial Biogenesis R-HSA-1592230,-0.43549192961516847,-0.8031067869473117,0.8044982698961938,1.0,1.0,6/73,3.04%,Camk4;Tbl1x;Prkab2;Prkaa2;Smarcd3;Mapk11
prerank,Hedgehog On State R-HSA-5632684,-0.42013628106294904,-0.8015849822200695,0.7647058823529411,1.0,1.0,12/85,14.13%,Gpr161;Dzip1;Smurf1;Smox;Numb;Gli3;Hhip;Ptch2;Psmb8;Evc2;Gas1;Psme4
prerank,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.477332918504367,0.8009564436294485,0.7175,1.0,1.0,4/32,5.71%,Ppp1r13b;Bcl6;Steap3;Crebbp
prerank,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.48884772551008815,-0.8005834028213005,0.7429048414023373,1.0,1.0,6/21,8.22%,Gng4;Gnai1;Gng12;Gnb4;Gng3;Gnai2
prerank,ESR-mediated Signaling R-HSA-8939211,-0.38515389984271947,-0.8003541926238338,0.8521897810218978,1.0,1.0,22/168,8.89%,Erbb4;Pik3r1;Bcl2;Gng4;Tle3;Gnai1;Kat2b;Esr1;Esr2;Gng12;Nrip1;Kcnh8;Gnb4;Kank1;Cav1;Ctsd;Runx1;Ccnd1;Gng3;Gnai2;Cav2;Egfr
prerank,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.4918497855776246,-0.7990518613456797,0.7545304777594728,1.0,1.0,6/18,17.07%,Ap2b1;Pacs1;B2m;Atp6v1h;Ap1m2;Cd28
prerank,HDMs Demethylate Histones R-HSA-3214842,0.48380221816131774,0.7981453652617946,0.7021276595744681,1.0,1.0,3/21,7.74%,Kdm7a;Arid5b;Kdm4a
prerank,Sema4D In Semaphorin Signaling R-HSA-400685,-0.48056062326786786,-0.7973698362241083,0.7587354409317804,1.0,1.0,7/24,15.68%,Arhgef11;Plxnb1;Limk1;Myl6;Myh14;Erbb2;Myh10
prerank,Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.49177282854839355,-0.7968510820691229,0.7467105263157895,1.0,1.0,5/18,7.96%,Gng4;Gnas;Gng12;Gnb4;Gng3
prerank,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.4981463756778832,-0.7958529482290398,0.7331189710610932,1.0,1.0,4/16,6.83%,Relb;Rps6ka5;Lyn;Prkca
prerank,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.4790114105245059,0.7943675957839733,0.7545454545454545,1.0,1.0,12/33,18.43%,Ndc1;Ranbp2;Xpo1;Nup93;Npm1;Nup160;Nup155;Ranbp1;Nup214;Nup210;Nup153;Tpr
prerank,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.4757235830266862,0.7924367286516099,0.710997442455243,1.0,1.0,5/27,5.45%,Mapk1;Fgf5;Cbl;Mapk3;Src
prerank,DARPP-32 Events R-HSA-180024,-0.47068323971914044,-0.7923922647406474,0.7397708674304418,1.0,1.0,3/23,1.76%,Pde4d;Pde4b;Prkar1b
prerank,Integrin Cell Surface Interactions R-HSA-216083,0.42809524788269016,0.7921981884265581,0.7914572864321608,1.0,1.0,5/64,3.47%,Itga8;Itgb8;Icam5;Itga4;Itga11
prerank,Lagging Strand Synthesis R-HSA-69186,-0.4844641093670218,-0.792086580802296,0.7628205128205128,1.0,1.0,6/20,29.83%,Lrig1;Dna2;Pold4;Prim2;Rfc2;Slc19a1
prerank,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.49527450811848406,-0.7912848514756191,0.7586206896551724,1.0,1.0,3/16,19.68%,Wrn;Dna2;Pold4
prerank,Digestion And Absorption R-HSA-8963743,0.4936910745684974,0.7910598756065014,0.6925207756232687,1.0,1.0,1/17,1.83%,Lct
prerank,NOD1/2 Signaling Pathway R-HSA-168638,0.4617608280065636,0.7909403774405749,0.7013888888888888,1.0,1.0,3/32,5.82%,Map2k6;Ripk2;Mapk14
prerank,SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.45810375864482683,0.7902410689711128,0.7510729613733905,1.0,1.0,17/42,17.22%,Ndc1;Cbx4;Ranbp2;Nup93;Phc2;Hnrnpc;Sumo2;Rnf2;Nop58;Nup160;Hnrnpk;Nup155;Phc3;Cbx2;Nup214;Nup210;Nup153
prerank,Post-translational Protein Phosphorylation R-HSA-8957275,0.401321344006202,0.7883578005397384,0.8732718894009217,1.0,1.0,9/99,4.13%,Ppp3ca;Igfbp5;Sparcl1;Cdh2;Lamc1;Golm1;Gpc3;Lamb1;Tmem132a
prerank,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.47027500061071276,-0.7882215426587724,0.7474916387959866,1.0,1.0,10/21,30.89%,Birc3;Ticam1;Ndufa2;Chuk;Ripk1;Sarm1;Ubb;Ube2v1;Ly96;Ubc
prerank,Estrogen-dependent Gene Expression R-HSA-9018519,-0.4071761092236682,-0.7872877432902025,0.8357664233576643,1.0,1.0,9/103,5.70%,Erbb4;Bcl2;Tle3;Kat2b;Esr1;Nrip1;Kank1;Ctsd;Runx1
prerank,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.47122629926695747,0.7867974993436572,0.7370786516853932,1.0,1.0,11/32,18.43%,Ndc1;Ranbp2;Ncbp1;Nup93;Eif4e;Nup160;Nup155;Nup214;Nup210;Nup153;Tpr
prerank,Pre-NOTCH Processing In Golgi R-HSA-1912420,0.49096175074434867,0.786195748449203,0.7222222222222222,1.0,1.0,2/18,1.91%,Notch2;B4galt1
prerank,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.4091390137986869,0.7854126034487788,0.8414096916299559,1.0,1.0,8/81,8.71%,Gtf2h2;Ercc4;Ccnh;Gtf2h5;Pias1;Parp1;Mnat1;Sumo2
prerank,HCMV Infection R-HSA-9609646,-0.40325916349948004,-0.7849279255881684,0.8308550185873605,1.0,1.0,6/104,9.34%,Tbl1x;Pcsk1;Kcnh8;Itgb1;Egfr;Dync1h1
prerank,Kinesins R-HSA-983189,-0.4567014147614047,-0.7849075230536106,0.7583892617449665,1.0,1.0,7/36,5.90%,Kif21b;Kif6;Kif5a;Kif26a;Kif16b;Kif13b;Kif9
prerank,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.4678661136164904,0.7841146991697041,0.7397959183673469,1.0,1.0,4/28,5.45%,Mapk1;Cbl;Mapk3;Src
prerank,Tie2 Signaling R-HSA-210993,-0.4774530313821293,-0.781411667439407,0.7430441898527005,1.0,1.0,2/17,1.62%,Pik3r1;Angpt1
prerank,O-linked Glycosylation Of Mucins R-HSA-913709,0.438048051047824,0.7799924300710431,0.7809734513274337,1.0,1.0,5/50,3.45%,St6galnac3;Galnt18;Galnt14;B4galt5;B3gnt2
prerank,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.4005666024440098,-0.7793640245273638,0.8518518518518519,1.0,1.0,26/111,10.73%,Fn1;Igf1;Sgpp2;Ltbp1;Cst3;Vgf;Fam20a;Apoe;App;Igfbp4;Igfbp7;Vcan;Wfs1;Scg3;Eva1a;Fam20c;Calu;Cp;Mfge8;Chgb;Adam10;Fgf23;Shisa5;Gas6;Igfbp2;Mgat4a
prerank,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,-0.4717696654163035,-0.7789816250661664,0.7816091954022989,1.0,1.0,7/21,4.76%,Pde11a;Pde1a;Pde5a;Prkg2;Pde2a;Pde10a;Irag1
prerank,cGMP Effects R-HSA-418457,-0.48764537289294757,-0.7788802591927408,0.7703583061889251,1.0,1.0,7/15,4.76%,Pde11a;Pde1a;Pde5a;Prkg2;Pde2a;Pde10a;Irag1
prerank,Phase I - Functionalization Of Compounds R-HSA-211945,-0.42659530621684244,-0.7775639058593623,0.8127208480565371,1.0,1.0,8/63,6.77%,Acss1;Arnt2;Aldh1a1;Smox;Tbxas1;Maob;Ptgs1;Cyp26b1
prerank,Host Interactions Of HIV Factors R-HSA-162909,0.38574030094731904,0.7769523521646328,0.8642241379310345,1.0,1.0,14/122,8.92%,Sgip1;Btrc;Fyn;Cul5;Ap1s2;Ndc1;Ranbp2;Xpo1;Psmd13;Nup93;Npm1;Ap1g1;Psip1;Ap1s3
prerank,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.4752253089052426,0.7759572343806974,0.7645569620253164,1.0,1.0,8/29,6.40%,Mapk1;Jun;Mef2c;Rps6ka2;Mapk10;Mapk3;Mapk14;Dusp4
prerank,ABC-family Proteins Mediated Transport R-HSA-382556,-0.40110215990033693,-0.7748875039332421,0.8632958801498127,1.0,1.0,12/97,14.58%,Abca9;Abcb9;Abca7;Cftr;Abca6;Abcc1;Abca3;Abcb5;Psmb8;Sel1l;Psme4;Abcd1
prerank,Mitophagy R-HSA-5205647,-0.4606768586472915,-0.7733210020556959,0.7671009771986971,1.0,1.0,1/27,2.45%,Mfn1
prerank,Nucleotide Excision Repair R-HSA-5696398,0.389470019781782,0.7730830141818466,0.8771929824561403,1.0,1.0,11/105,10.60%,Gtf2h2;Ercc4;Ccnh;Gtf2h5;Pias1;Parp1;Mnat1;Sumo2;Usp7;Polr2e;Ino80d
prerank,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.47016297574423993,-0.7729054946925689,0.7772277227722773,1.0,1.0,7/18,27.30%,Birc3;Ticam1;Tlr3;Chuk;Ripk1;Ubb;Ube2v1
prerank,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.46794696713625666,-0.7719423093387342,0.7749576988155669,1.0,1.0,5/21,6.55%,Dusp5;Dusp10;Dusp6;Jak2;Dusp16
prerank,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.4440774846426022,-0.7717623741083338,0.7837370242214533,1.0,1.0,1/39,2.60%,Trmt9b
prerank,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.4412808325470136,0.7699145848143817,0.7761194029850746,1.0,1.0,11/40,13.39%,Herc2;Babam2;Rad50;Tdp1;Paxip1;H2bc4;Atm;H2ax;Rnf8;Brcc3;Uimc1
prerank,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.4774140082636933,-0.7694520696479661,0.7764705882352941,1.0,1.0,5/19,7.96%,Gng4;Arhgef6;Gng12;Gnb4;Gng3
prerank,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.4129272286751823,-0.7690344212832707,0.8140794223826715,1.0,1.0,5/68,12.01%,Rbbp8;Nsd2;Wrn;Artn;Top3a
prerank,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.45898938569506464,-0.7679345082851217,0.790268456375839,1.0,1.0,4/29,22.47%,Tdrd9;Piwil1;Hsp90aa1;Mybl1
prerank,Ovarian Tumor Domain Proteases R-HSA-5689896,0.4454947944541604,0.7664703688248998,0.7980769230769231,1.0,1.0,7/37,6.43%,Otud7a;Tnip2;Rnf128;Zranb1;Ripk2;Otub2;Ube2d1
prerank,tRNA Processing In Nucleus R-HSA-6784531,-0.42809264911618206,-0.7648434127374534,0.7969052224371374,1.0,1.0,1/51,2.42%,Colec12
prerank,CD28 Co-Stimulation R-HSA-389356,-0.4469873766115363,-0.764661473094512,0.792358803986711,1.0,1.0,9/33,14.61%,Pik3r1;Vav1;Lyn;Cd86;Pik3ca;Prr5;Cd80;Cdc42;Pkn2
prerank,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.37301884710176486,-0.7635639746622226,0.9265536723163842,1.0,1.0,12/164,5.90%,Kif21b;Cux1;Man2a1;Kif6;Akr1b10;Kif5a;Golim4;Usp6nl;Kif26a;Kif16b;Kif13b;Kif9
prerank,Circadian Clock R-HSA-400253,0.4045620823978139,0.7620567510123729,0.8461538461538461,1.0,1.0,14/65,5.92%,Ncor1;Ppp1cb;Crtc3;Crtc1;Mef2c;Mef2d;Btrc;Noct;Cry2;Ncoa1;Tbl1xr1;Crebbp;Cul1;Nampt
prerank,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.44237904560668945,0.7606896186601536,0.7825112107623319,1.0,1.0,8/39,12.63%,Ndc1;Ranbp2;Ncbp1;Nup93;Wdr33;Eif4e;Nup160;Nup155
prerank,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.3723803026578775,0.7606586048024352,0.9287356321839081,1.0,1.0,11/139,3.86%,Adcy1;Htr4;Adcy2;Gng7;Adcyap1r1;Adcy9;Gng2;Ramp1;Plcg2;Fyn;Itpr1
prerank,G-protein Activation R-HSA-202040,0.4708784916072927,0.7601374997429788,0.7537688442211056,1.0,1.0,4/23,3.57%,Gng7;Gnaq;Gng2;Pdyn
prerank,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.4021937716608242,0.7599401234607527,0.8741573033707866,1.0,1.0,7/75,9.93%,Gtf2h2;Ercc4;Ccnh;Gtf2h5;Mnat1;Usp7;Polr2e
prerank,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,0.3931790680617564,0.7597254805292475,0.8814317673378076,1.0,1.0,7/93,6.90%,Eml4;Cenpp;Nek6;Dync1i2;Taok1;Ranbp2;Xpo1
prerank,Intrinsic Pathway For Apoptosis R-HSA-109606,0.4236350941974917,0.7590680969548746,0.7966101694915254,1.0,1.0,10/49,6.91%,Ppp1r13b;Akt3;Mapk1;Ppp3r1;Ywhaz;Nmt1;Mapk3;Ywhab;Ywhah;Ywhae
prerank,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.47320333420649857,-0.7589257521816154,0.7544141252006421,1.0,1.0,3/15,4.44%,Bcl2;Ywhaq;Ppp3cc
prerank,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.39317872690548517,-0.7582530774125648,0.8927272727272727,1.0,1.0,17/96,18.70%,Relb;Tnfrsf11a;Edaradd;Traf3;Birc3;Tnfrsf13b;Tnfrsf11b;Ltb;Psmb8;Psme4;Edar;Cd40;Tnfsf12;Ltbr;Tnfrsf1b;Cd40lg;Tnfsf11
prerank,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.44258737140347765,-0.7574243956747989,0.8108108108108109,1.0,1.0,10/36,24.71%,E2f1;Ccnd1;Ccnd3;Anapc11;Cdkn1c;Cdk2;Anapc5;Anapc2;E2f2;Ccne2
prerank,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.45821344364260475,0.7560946148707173,0.7850678733031674,1.0,1.0,11/31,18.43%,Ndc1;Ranbp2;Xpo1;Nup93;Nup160;Nup155;Ranbp1;Nup214;Nup210;Nup153;Tpr
prerank,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.4658429189535243,-0.7541472029897961,0.7864583333333334,1.0,1.0,3/21,13.40%,Edem1;Uggt2;Sel1l
prerank,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.46253590562742075,0.7537753011396088,0.7480916030534351,1.0,1.0,3/18,4.69%,Mapk10;Map2k4;Ripk2
prerank,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.4149054428510159,-0.7531307152517577,0.8532110091743119,1.0,1.0,16/59,13.41%,Egr1;Vgf;Dusp6;Trib1;Mapk11;Sgk1;Kcnh8;Id1;Rps6ka5;Arc;F3;Id3;Id4;Dusp3;Tph1;Fos
prerank,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.4562377323872633,-0.7525917501877029,0.8114104595879557,1.0,1.0,5/22,14.10%,Pik3r1;Cd86;Pik3ca;Prr5;Cd80
prerank,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.4283183561835378,-0.7520137664712164,0.8302521008403362,1.0,1.0,6/41,5.71%,Tbl1x;Arl4c;Abca1;Apoe;Nrip1;Kdm3a
prerank,Protein Methylation R-HSA-8876725,-0.4653596920134563,-0.7501725075456749,0.8019169329073482,1.0,1.0,1/17,3.87%,Camkmt
prerank,FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.46621723960449113,-0.7500052641393438,0.8169717138103162,1.0,1.0,2/20,9.27%,Fgf1;Fgf23
prerank,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.460098030074585,0.7496839409024646,0.7514285714285714,1.0,1.0,1/19,0.46%,Rims1
prerank,Intraflagellar Transport R-HSA-5620924,0.4386573990669262,0.7494419378478367,0.7915632754342432,1.0,1.0,16/39,16.86%,Dync2h1;Hspb11;Cluap1;Ift122;Ift57;Ttc26;Dynlt2b;Tnpo1;Ift80;Wdr19;Wdr35;Dync2li1;Ift74;Ift22;Kif17;Dynll1
prerank,Peroxisomal Protein Import R-HSA-9033241,-0.4127736440487914,-0.7482645752650027,0.8502673796791443,1.0,1.0,13/58,27.50%,Phyh;Crot;Pex7;Glyat;Ide;Pex13;Idh1;Crat;Acox3;Hmgcl;Ehhadh;Ubb;Acox1
prerank,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.4572812347259427,-0.7477998672159619,0.8080133555926544,1.0,1.0,3/23,1.12%,Erbb4;Nrg1;Pik3r1
prerank,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.4557097412069683,-0.7475868275019565,0.8036912751677853,1.0,1.0,3/24,1.12%,Erbb4;Nrg1;Pik3r1
prerank,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.4120212690691146,-0.7468460784868775,0.8472727272727273,1.0,1.0,6/52,4.67%,Homer2;Tpd52;Hip1r;Sh3gl2;Dtnbp1;Ap3s1
prerank,Downstream TCR Signaling R-HSA-202424,-0.3904925428565136,-0.7457607629272741,0.8816029143897997,1.0,1.0,3/83,4.18%,Pik3r1;Inpp5d;Prkcq
prerank,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.4433450584514011,-0.7457047963861217,0.7909238249594813,1.0,1.0,11/25,39.62%,Lrig1;Lrig3;Pold4;Rfc2;Ubb;Slc19a1;Ubc;Polk;Pole4;Rfc3;Polr1b
prerank,G2/M Transition R-HSA-69275,0.35237282603991815,0.7448688865754934,0.9645232815964523,1.0,1.0,22/176,9.40%,Fbxl7;Ppp1r12b;Ppp1cb;Dync1i2;Fbxw11;Btrc;Odf2;Sdccag8;Nme7;Ccnh;Cul1;Prkar2b;Xpo1;Ywhae;Tubgcp2;Mnat1;Psmd13;Dctn1;Fbxl18;Pcm1;Wee1;Cep70
prerank,SHC-mediated cascade:FGFR1 R-HSA-5654688,-0.46517136980843277,-0.7447460247598398,0.8105939004815409,1.0,1.0,2/18,9.27%,Fgf1;Fgf23
prerank,PI3K Events In ERBB2 Signaling R-HSA-1963642,-0.4661598040961615,-0.7442887167116646,0.8157051282051282,1.0,1.0,3/15,1.12%,Erbb4;Nrg1;Pik3r1
prerank,Cellular Response To Chemical Stress R-HSA-9711123,-0.3543251892429435,-0.7438617912144563,0.9606741573033708,1.0,1.0,21/174,14.83%,Tbl1x;Smarcd3;Mafg;Gpx8;Atp7a;Prkcd;Slc7a11;Ncf2;Cox16;Cyba;Nfe2l2;Glyat;Abcc1;Trim21;Psmb8;Txnip;Notch1;Sod3;Psme4;Nlrp3;Ncf1
prerank,Cyclin D Associated Events In G1 R-HSA-69231,-0.42118030421655506,-0.7435461216252086,0.8330494037478705,1.0,1.0,7/46,15.11%,E2f1;Jak2;Lyn;Ccnd1;Ccnd3;Cks1b;Cdkn1c
prerank,G2/M DNA Damage Checkpoint R-HSA-69473,-0.4020852812799317,-0.7425782337298736,0.8471223021582733,1.0,1.0,6/64,12.01%,Rbbp8;Ywhaq;Nsd2;Wrn;Artn;Top3a
prerank,Antigen processing-Cross Presentation R-HSA-1236975,-0.3907694343492496,-0.7425738356602969,0.8842676311030742,1.0,1.0,18/93,22.10%,Itgb5;Ctss;S100a1;Ncf2;Cyba;Mrc1;Btk;Psmb8;Tlr6;Psme4;Tapbp;Ncf1;B2m;Ndufa2;Ctsl;Psme2;Sem1;Psma1
prerank,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.3857033705245724,-0.7415961569754435,0.8886861313868614,1.0,1.0,7/84,6.50%,Lef1;Tcf7l2;Ppp2r5a;Tle3;Tle2;Ppp2r5c;Tcf7l1
prerank,RNA Polymerase I Promoter Opening R-HSA-73728,0.44853734626364217,0.7408102462595728,0.772020725388601,1.0,1.0,5/20,11.24%,Mapk3;Ubtf;H2bc4;H2ax;H2ac6
prerank,Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.46397279155960647,0.7391175735504601,0.8108108108108109,1.0,1.0,3/23,2.29%,Gng7;Gnaq;Gng2
prerank,MAP2K And MAPK Activation R-HSA-5674135,0.4244043177042891,0.7387211512293956,0.819634703196347,1.0,1.0,10/35,6.30%,Cnksr2;Mapk1;Ksr2;Map2k1;Ksr1;Mapk3;Ywhab;Src;Araf;Mark3
prerank,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.43210452123486276,-0.7383906912776302,0.8208955223880597,1.0,1.0,2/32,9.00%,Usp43;Trim25
prerank,Glycosphingolipid Metabolism R-HSA-1660662,0.4274408825700687,0.7383624999910611,0.8135593220338984,1.0,1.0,5/36,6.99%,Arsb;Arsj;Esyt3;Galc;Smpd3
prerank,Unfolded Protein Response (UPR) R-HSA-381119,0.3804480977344721,0.7378735145740251,0.8951965065502183,1.0,1.0,12/85,8.67%,Atf6;Pdia5;Extl2;Mbtps2;Ssr1;Khsrp;Cebpb;Exosc8;Ctdsp2;Dctn1;Mbtps1;Wipi1
prerank,Polo-like Kinase Mediated Events R-HSA-156711,-0.4581703651313058,-0.7377865595470754,0.806873977086743,1.0,1.0,7/16,35.11%,Lin54;Foxm1;Ep300;Ccnb1;Lin52;Cenpf;Cdc25c
prerank,Translation R-HSA-72766,0.33252670418811225,0.7376259960671098,0.9910913140311804,1.0,1.0,55/256,16.78%,Fars2;Dtd1;Farsa;Ssr1;Eif4b;Rars2;Eif4a1;Eif3a;Rpl15;Eif5b;Lars2;Eef1a1;Gspt1;Ptcd3;Eif4e;Spcs2;Rpl4;Eef2;Eif4a2;Rplp0;Pabpc1;Rpl10a;Eif5;N6amt1;Rplp1;Mrps26;Iars2;Rpl3;Mrpl13;Mrps22;Eif2b5;Tars2;Eef1d;Rpsa;Ssr3;Eef1g;Rpn2;Mrpl37;Eif3h;Mtif2;Sec61a2;Rpl8;Rpl36a;Mrps9;Rsl24d1;Mrpl58;Mrpl45;Rpl18;Rpl6;Gspt2;Mrpl1;Mrps25;Farsb;Mrps17;Mrps15
prerank,Nuclear Signaling By ERBB4 R-HSA-1251985,0.4443785858345029,0.7368504352924617,0.8009950248756219,1.0,1.0,3/31,1.66%,Nrg2;Nrg3;Ncor1
prerank,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.42808811326930685,0.7336123616447445,0.8203309692671394,1.0,1.0,10/31,6.30%,Cnksr2;Mapk1;Ksr2;Map2k1;Ksr1;Mapk3;Ywhab;Src;Araf;Mark3
prerank,ERK/MAPK Targets R-HSA-198753,0.45699607346719984,0.7321878988973489,0.8042895442359249,1.0,1.0,6/21,6.40%,Mapk1;Mef2c;Rps6ka2;Mapk3;Mapk14;Dusp4
prerank,Autophagy R-HSA-9612973,0.3573472989478278,0.7315398494528984,0.9504504504504504,1.0,1.0,14/124,9.04%,Prkag2;Dync1i2;Rragd;Vps37b;Rb1cc1;Nbr1;Rptor;Src;Uvrag;Eef1a1;Wipi1;Dync1i1;Slc38a9;Pgam5
prerank,Telomere Maintenance R-HSA-157579,-0.38552653418673327,-0.731438837940784,0.9107468123861566,1.0,1.0,12/78,24.09%,Ankrd28;Lrig1;Pif1;Wrn;H2aj;Dna2;H2bc3;Pold4;Prim2;Cdk2;Blm;Rfc2
prerank,Neddylation R-HSA-8951664,0.33603777980127014,0.7306587329584319,0.9871794871794872,1.0,1.0,34/231,9.97%,Lmo7;Fbxl7;Zbtb16;Fbxw11;Btrc;Dcaf6;Klhl3;Fbxo41;Cul9;Rbbp5;Cul5;Klhl2;Cul1;Klhl22;Ube2d1;Dcaf8;Spsb1;Fbxo11;Fbxl16;Rbbp7;Asb18;Psmd13;Fbxl18;Obsl1;Ube2d3;Dcaf5;Vhl;Fbxo31;Commd1;Commd10;Kctd6;Klhl11;Dcaf7;Cul3
prerank,Signaling By EGFR In Cancer R-HSA-1643713,-0.4429817365720316,-0.7287317545576744,0.8178752107925801,1.0,1.0,1/23,1.12%,Pik3r1
prerank,Macroautophagy R-HSA-1632852,0.36160265002193465,0.7283832198952718,0.9401330376940134,1.0,1.0,7/110,5.45%,Prkag2;Dync1i2;Rragd;Rb1cc1;Nbr1;Rptor;Src
prerank,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.3732745075119248,0.728325755535162,0.919661733615222,1.0,1.0,8/94,5.53%,Sgip1;Itsn1;Ston2;Tgfa;Sh3gl1;Cbl;Epn2;Syt1
prerank,Synthesis Of PA R-HSA-1483166,-0.42252260570126776,-0.7273194192410202,0.8377425044091711,1.0,1.0,9/37,23.72%,Gpat3;Pla2g4a;Pld2;Pla2r1;Pla2g5;Liph;Lpcat1;Lipi;Lclat1
prerank,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.43986243249357515,-0.7272065384303973,0.8190630048465266,1.0,1.0,1/20,2.42%,Colec12
prerank,RNA Polymerase II Transcription Termination R-HSA-73856,0.39998303489648124,0.7260141990689435,0.8568181818181818,1.0,1.0,19/66,13.23%,Cdc40;Thoc2;Cstf3;Srsf9;Nudt21;Srsf11;Srsf1;Papola;Ncbp1;Cpsf6;Wdr33;Fyttd1;Cstf2t;Snrpd3;Snrpb;Thoc3;Pabpn1;Srsf7;Srsf3
prerank,Peroxisomal Lipid Metabolism R-HSA-390918,-0.43609578619855816,-0.7259685796024962,0.8412438625204582,1.0,1.0,7/27,27.50%,Phyh;Crot;Abcd1;Crat;Acox3;Ehhadh;Acox1
prerank,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.4510528174507552,-0.7236317976186938,0.8308702791461412,1.0,1.0,4/20,22.04%,Cdc14a;Anapc11;Anapc5;Anapc2
prerank,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.4194662140779993,-0.7195929060014619,0.8569051580698835,1.0,1.0,4/34,2.76%,Tbl1x;Arl4c;Abca1;Apoe
prerank,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.42997573464026495,0.7194647850313647,0.83,1.0,1.0,13/34,20.53%,Atrx;Polr2e;H2bc4;H2ax;H2ac6;Polr2k;H2ac4;Tinf2;H2bc21;Terf2ip;H2az1;Polr2f;Terf2
prerank,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.39098915735774176,0.7179433207546418,0.8903508771929824,1.0,1.0,3/61,4.28%,Pcsk5;Bmp1;Mbtps2
prerank,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.4440105815039626,0.7178356895070718,0.8295739348370927,1.0,1.0,3/24,2.29%,Gng7;Akt3;Gng2
prerank,Recycling Pathway Of L1 R-HSA-437239,-0.431846253357671,-0.7172732876035354,0.8305084745762712,1.0,1.0,7/25,8.08%,L1cam;Sh3gl2;Ap2b1;Rps6ka5;Ezr;Numb;Dnm3
prerank,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.43628399023964076,-0.7165136231024735,0.8480138169257341,1.0,1.0,5/23,15.63%,Smox;Bbs9;Bbs5;Bbs2;Mchr1
prerank,TCR Signaling R-HSA-202403,0.37141225595042315,0.7161076011768283,0.9290465631929047,1.0,1.0,13/104,7.95%,Ptprj;Fbxw11;Btrc;Pik3cb;Plcg2;Arhgef7;Ripk2;Cul1;Nck1;Ube2d1;Ptpn22;Psmd13;Nfkb1
prerank,Signaling By BMP R-HSA-201451,-0.42901477436712315,-0.7158347627672305,0.8341793570219966,1.0,1.0,8/25,8.14%,Bmpr1b;Smurf1;Smad1;Smad9;Smad7;Smad6;Amhr2;Acvr2b
prerank,Interleukin-12 Signaling R-HSA-9020591,-0.4060426982990334,-0.7155449809956222,0.8633975481611208,1.0,1.0,14/39,25.44%,Rap1b;Jak2;Pitpna;Rala;Cdc42;Pkn2;Stat4;Anxa2;Msn;Psme2;Lmnb1;Sod1;Capza1;Il10
prerank,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.41001337021385265,0.7150076144919646,0.8217592592592593,1.0,1.0,7/36,7.86%,Mapk1;Smad3;Hdac1;Mapk3;Cdk8;Ybx1;Ccnt2
prerank,Cristae Formation R-HSA-8949613,0.45325922985989997,0.7147605903995414,0.7869318181818182,1.0,1.0,4/15,12.46%,Chchd3;Apoo;Mtx1;Apool
prerank,Negative Regulation Of MAPK Pathway R-HSA-5675221,0.4153455733336569,0.7146502112550328,0.8558352402745996,1.0,1.0,10/40,6.40%,Mapk1;Map2k1;Ptpn3;Ksr1;Mapk3;Ywhab;Paqr3;Araf;Mark3;Dusp4
prerank,Amino Acid Transport Across Plasma Membrane R-HSA-352230,0.4232412350798848,0.7144751719022772,0.8589108910891089,1.0,1.0,3/31,3.49%,Slc16a10;Slc6a15;Slc6a6
prerank,Mitotic G2-G2/M Phases R-HSA-453274,0.3374220672767467,0.7138987813067554,0.9866666666666667,1.0,1.0,19/178,8.23%,Fbxl7;Ppp1r12b;Ppp1cb;Dync1i2;Fbxw11;Btrc;Odf2;Sdccag8;Nme7;Ccnh;Cul1;Prkar2b;Xpo1;Ywhae;Tubgcp2;Mnat1;Psmd13;Dctn1;Fbxl18
prerank,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.3732075707221133,-0.7136302992407403,0.9106529209621993,1.0,1.0,13/83,12.74%,Rbbp8;Prkab2;Prkaa2;Mapk11;Dyrk2;Nuak1;Hipk2;Aurkb;Plk3;Wrn;Artn;Top3a;Taf1
prerank,Mitotic Prometaphase R-HSA-68877,0.3383365493137443,0.7131857664003872,0.9908883826879271,1.0,1.0,24/179,9.90%,Eml4;Cenpp;Nek6;Dync1i2;Pds5b;Odf2;Hdac8;Sdccag8;Nme7;Taok1;Ranbp2;Prkar2b;Xpo1;Ywhae;Tubgcp2;Pds5a;Dctn1;Dync1i1;Pcm1;Rcc2;Wapl;Cep70;Cep78;Ska2
prerank,M Phase R-HSA-68886,-0.3191843409742738,-0.7131857131170503,0.9926470588235294,1.0,1.0,44/348,18.77%,Prkcb;Vrk2;Tubb3;Ppp2r5a;Ncaph;Plk4;Tubb4a;Ppp2r5c;Prkca;Nedd1;Zwint;Nde1;Clasp2;Alms1;Ccp110;Aurkb;Dync1h1;Bub1;Lpin3;Pmepa1;Psmb8;Dync1li2;Sirt2;Akap9;Ndc80;Psme4;Knl1;Cep290;Anapc11;Cep164;Cenpn;Csnk1e;Rangap1;Phf8;Cep43;H2aj;Pafah1b1;Lmna;Ppp2r5e;Ska1;H2bc3;Hsp90aa1;Ndel1;Tubb4b
prerank,Activation Of BH3-only Proteins R-HSA-114452,0.4311652068942966,0.7123856609872443,0.8186528497409327,1.0,1.0,7/26,6.91%,Ppp1r13b;Akt3;Ppp3r1;Ywhaz;Ywhab;Ywhah;Ywhae
prerank,RHOF GTPase Cycle R-HSA-9035034,-0.41198249150176786,-0.7119921496343946,0.8715890850722311,1.0,1.0,6/39,5.43%,Farp1;Pik3r1;Srgap2;Akap12;Baiap2l2;Cav1
prerank,Acyl Chain Remodelling Of PI R-HSA-1482922,0.4599387678753734,0.7115437714161857,0.8052631578947368,1.0,1.0,1/16,1.58%,Pla2g4e
prerank,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.4185294035536618,-0.7102767580850249,0.8311688311688312,1.0,1.0,8/29,24.32%,Dhtkd1;Bckdhb;Agxt2;Ldhd;Pxmp2;Dlat;Gldc;Prodh2
prerank,RNA Polymerase III Chain Elongation R-HSA-73780,0.45068211259168217,0.709294666871557,0.7928388746803069,1.0,1.0,7/17,20.46%,Polr2e;Polr3gl;Polr3g;Polr3e;Polr2k;Polr3f;Polr2f
prerank,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.43314549476944053,0.7065497525598544,0.811704834605598,1.0,1.0,5/24,5.82%,Gng7;Gnaq;Gng2;Src;Mapk14
prerank,Metabolism Of Steroid Hormones R-HSA-196071,-0.4192536182186509,-0.7063256430688762,0.8467741935483871,1.0,1.0,7/29,21.47%,Hsd17b12;Stard4;Chga;Hsd11b1;Hsd17b2;Hsd17b11;Hsd11b2
prerank,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.42267694319074006,-0.706034209441476,0.8715596330275229,1.0,1.0,1/28,3.68%,Map4k2
prerank,Calnexin/calreticulin Cycle R-HSA-901042,-0.4176123701102288,-0.7039374838533636,0.839041095890411,1.0,1.0,3/26,13.40%,Edem1;Uggt2;Sel1l
prerank,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.40260998851379604,-0.7032952851464489,0.8610169491525423,1.0,1.0,2/39,9.00%,Usp43;Trim25
prerank,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.4047922880206064,-0.7012594962111358,0.8625204582651391,1.0,1.0,2/31,9.27%,Fgf1;Fgf23
prerank,DNA Double-Strand Break Repair R-HSA-5693532,-0.34698521909982755,-0.7011006408279509,0.9591439688715954,1.0,1.0,15/135,15.98%,Rbbp8;Eya4;Mapk8;Nsd2;Cnksr3;Rad51b;Wrn;Artn;Top3a;Eme1;Eya2;Lrig3;Xrcc2;Apbb1;Rrad
prerank,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.3876941135230534,-0.6986210779133614,0.902946273830156,1.0,1.0,8/54,22.14%,Smurf1;Tgfb1;Psmb8;Ep300;Psme2;Sem1;Psma1;Runx3
prerank,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.3737669093120933,0.6977749881266838,0.9006772009029346,1.0,1.0,6/62,9.93%,Gtf2h2;Ccnh;Gtf2h5;Mnat1;Usp7;Polr2e
prerank,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.32951596442821374,-0.6977534840578442,0.9962546816479401,1.0,1.0,38/219,23.02%,Vrk2;Tubb3;Ppp2r5a;Tubb4a;Ppp2r5c;Zwint;Nde1;Clasp2;Aurkb;Dync1h1;Bub1;Pmepa1;Psmb8;Dync1li2;Sirt2;Ndc80;Psme4;Knl1;Anapc11;Cenpn;Rangap1;Pafah1b1;Lmna;Ppp2r5e;Ska1;Ndel1;Tubb4b;Sec13;Incenp;Anapc5;Psme2;Anapc2;Sem1;Psma1;Tuba1a;Cdk1;Spdl1;Lmnb1
prerank,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.39228014475414247,-0.6975887954136365,0.8981001727115717,1.0,1.0,15/52,28.24%,Slc16a1;Ldhb;Idh2;Ldha;Pdk4;Ldhd;Ldlr;Adhfe1;Ldhc;Dlat;Slc16a3;Sdha;Sdhb;Slc16a8;Cs
prerank,Mitotic Anaphase R-HSA-68882,-0.32959750443534075,-0.6971836290025274,0.9944029850746269,1.0,1.0,38/218,23.02%,Vrk2;Tubb3;Ppp2r5a;Tubb4a;Ppp2r5c;Zwint;Nde1;Clasp2;Aurkb;Dync1h1;Bub1;Pmepa1;Psmb8;Dync1li2;Sirt2;Ndc80;Psme4;Knl1;Anapc11;Cenpn;Rangap1;Pafah1b1;Lmna;Ppp2r5e;Ska1;Ndel1;Tubb4b;Sec13;Incenp;Anapc5;Psme2;Anapc2;Sem1;Psma1;Tuba1a;Cdk1;Spdl1;Lmnb1
prerank,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.396310260422201,0.6969302019680937,0.8691588785046729,1.0,1.0,9/47,6.64%,Tle1;Tle4;Pygo1;Hdac1;Rbbp5;Trrap;Smarca4;Crebbp;Ctnnb1
prerank,Signaling By EGFR R-HSA-177929,-0.3941479989348483,-0.6960191425886241,0.8981481481481481,1.0,1.0,11/48,9.95%,Pik3r1;Eps15;Sh3gl2;Stam2;Adam12;Pag1;Adam10;Adam17;Egfr;Lrig1;Pik3ca
prerank,RHOH GTPase Cycle R-HSA-9013407,0.4124413538788893,0.6947857763958486,0.8329113924050633,1.0,1.0,7/34,9.11%,Slc4a7;Dbn1;Ralgapa1;Wdr11;Dbt;Pak4;Rock1
prerank,Glucagon-type Ligand Receptors R-HSA-420092,-0.4092561268079791,-0.6923639660042058,0.8573883161512027,1.0,1.0,7/29,8.11%,Gng4;Gnas;Gng12;Gnb4;C1qtnf1;Gng3;Sctr
prerank,G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.4296396463788977,-0.6923318660953659,0.875,1.0,1.0,4/17,7.96%,Gng4;Gng12;Gnb4;Gng3
prerank,Ub-specific Processing Proteases R-HSA-5689880,0.32789649266306714,0.6885659165552168,0.9841986455981941,1.0,1.0,22/171,11.24%,Tgfbr1;Usp2;Smad3;Usp15;Tnks;Rnf128;Usp47;Trrap;Usp34;Usp8;Usp32;Psmd13;Usp33;Axin2;Usp7;Usp12;H2bc4;Tank;Hif1a;Pten;Otub1;H2ac6
prerank,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.4200987936723639,-0.6865180330981737,0.8717948717948718,1.0,1.0,6/17,33.95%,Casp8;Usp14;Chuk;Ubb;Ubc;Nlrx1
prerank,Signaling By FGFR2 R-HSA-5654738,-0.3695404763663778,-0.6831473288676286,0.926391382405745,1.0,1.0,2/68,2.15%,Pik3r1;Fgf1
prerank,G2/M Checkpoints R-HSA-69481,-0.34019076510119284,-0.6810703921972104,0.9697542533081286,1.0,1.0,23/135,24.09%,Rbbp8;Ywhaq;Mcm10;Nsd2;Wrn;Artn;Top3a;Psmb8;Psme4;Rrad;Slc25a2;Dna2;H2bc3;Bard1;Cdk2;Mcm3;Psme2;Sem1;Psma1;Cdk1;Blm;Ccnb1;Rfc2
prerank,SARS-CoV-2-host Interactions R-HSA-9705683,0.3251784234399471,0.679736303152826,0.9916142557651991,1.0,1.0,15/166,6.91%,Akt3;Sec24d;Pals1;Ywhaz;Ripk2;Tjp1;Ywhab;Sec23a;Crebbp;Ywhah;Vps41;Uvrag;Ndc1;Ranbp2;Ywhae
prerank,Metabolism Of Amine-Derived Hormones R-HSA-209776,-0.41544508380283585,-0.6796681861762902,0.8605769230769231,1.0,1.0,7/18,27.06%,Chga;Tshb;Tph1;Dio2;Th;Aanat;Tph2
prerank,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.42003277108478687,-0.6795349681624858,0.8715596330275229,1.0,1.0,1/16,3.04%,Mapk11
prerank,Rab Regulation Of Trafficking R-HSA-9007101,-0.3429760689209117,-0.6789042124898078,0.9708029197080292,1.0,1.0,9/115,7.53%,Optn;Rab31;Dennd3;Rin3;Tbc1d10c;Dennd4a;Dennd5b;Chml;Dennd1c
prerank,Apoptotic Factor-Mediated Response R-HSA-111471,0.41925165677772736,0.6754319690288029,0.8524590163934426,1.0,1.0,2/19,4.74%,Mapk1;Mapk3
prerank,Activation Of HOX Genes During Differentiation R-HSA-5619507,0.3646953775971442,0.6753003462412477,0.9316037735849056,1.0,1.0,12/69,10.00%,Ncor1;Jun;Rarb;Rbbp5;Ezh2;Crebbp;Suz12;Rbbp7;Kmt2c;Paxip1;Polr2e;H2bc4
prerank,Acyl Chain Remodelling Of PS R-HSA-1482801,-0.40991416641116096,-0.6738884683364819,0.8590163934426229,1.0,1.0,8/21,14.64%,Osbpl10;Osbpl5;Pla2g4a;Pla2r1;Pla2g5;Pla1a;Mboat1;Osbpl8
prerank,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.42143831929043174,0.6727543712601337,0.8840970350404312,1.0,1.0,7/20,9.61%,Cnot2;Cnot6l;Cnot4;Btg2;Npm1;Cnot1;Cnot3
prerank,Translesion Synthesis By POLI R-HSA-5656121,0.4295717302547671,0.6715351619163188,0.8301369863013699,1.0,1.0,1/17,3.96%,Rev1
prerank,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.41160248964502005,-0.6708739112495369,0.8825503355704698,1.0,1.0,2/21,11.98%,Tcn2;Acaca
prerank,"Cell Cycle, Mitotic R-HSA-69278",-0.28989207636394876,-0.6700501425500046,1.0,1.0,1.0,28/487,9.34%,Prkcb;Vrk2;Optn;Tubb3;Ppp2r5a;Cdc14a;E2f1;Phlda1;Mcm10;Ncaph;Plk4;Cdc25b;Jak2;Tubb4a;Lyn;Ppp2r5c;Prkca;Ccnd1;Nedd1;Zwint;Ccnd3;Nde1;Clasp2;Alms1;Ccp110;Aurkb;Lrig1;Dync1h1
prerank,AURKA Activation By TPX2 R-HSA-8854518,-0.35674238057593616,-0.6677724936300262,0.9484536082474226,1.0,1.0,20/71,22.33%,Plk4;Tubb4a;Prkca;Nedd1;Nde1;Alms1;Ccp110;Dync1h1;Akap9;Cep290;Cep164;Csnk1e;Cep43;Pafah1b1;Hsp90aa1;Tubb4b;Tpx2;Cntrl;Tuba1a;Cdk1
prerank,Signal Amplification R-HSA-392518,-0.39355668950397765,-0.666901196848929,0.8921232876712328,1.0,1.0,8/32,8.22%,Gng4;Gnai1;Gng12;Gnb4;Gna15;Pla2g4a;Gng3;Gnai2
prerank,Translesion Synthesis By REV1 R-HSA-110312,0.4296280618498861,0.6667967978286927,0.8319327731092437,1.0,1.0,1/16,3.96%,Rev1
prerank,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.39004637159813416,0.6650418989714092,0.9072681704260651,1.0,1.0,8/41,11.24%,Cenpp;Rsf1;Rbbp7;Npm1;Smarca5;H2bc4;H2ax;H2ac6
prerank,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.3575098366538614,-0.6649182160790558,0.9414802065404475,1.0,1.0,19/68,22.33%,Plk4;Tubb4a;Prkca;Nedd1;Nde1;Alms1;Ccp110;Dync1h1;Akap9;Cep290;Cep164;Csnk1e;Cep43;Pafah1b1;Hsp90aa1;Tubb4b;Cntrl;Tuba1a;Cdk1
prerank,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.3866014149928076,-0.6638833693001667,0.9134948096885813,1.0,1.0,13/32,25.44%,Rap1b;Pitpna;Rala;Cdc42;Pkn2;Stat4;Anxa2;Msn;Psme2;Lmnb1;Sod1;Capza1;Il10
prerank,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.35384400165725416,-0.6631897210559041,0.9480069324090121,1.0,1.0,9/71,17.18%,Smurf1;Dlx5;Esr1;Ppargc1a;Dlx6;Psmb8;Psme4;Bmp2;Esrra
prerank,G1/S-Specific Transcription R-HSA-69205,-0.3968399461538942,-0.6627311956375004,0.9248747913188647,1.0,1.0,7/29,25.36%,E2f1;Lin54;Rrm2;Dhfr;E2f6;Cdk1;Rbl1
prerank,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.32401776007643857,-0.6627157445057661,0.9962476547842402,1.0,1.0,45/146,35.40%,Slc16a1;Ldhb;Idh2;Cox16;Ldha;Ndufaf2;Pdk4;Coq10b;Ldhd;Cox7b;Ldlr;Ndufa2;Adhfe1;Ndufa1;Ldhc;Slc25a27;Dlat;Slc16a3;Ndufa3;Ndufb8;Ucp3;Cox5a;Sdha;Ndufaf7;Sdhb;Ndufa7;Timmdc1;Slc16a8;Cs;Ndufa13;Taco1;Ndufa12;Uqcrh;Tmem186;Idh3a;Cox6b1;Rxra;Uqcr10;Ndufb11;Bsg;Cox8a;Uqcrb;Ndufb9;Cox5b;Uqcrq
prerank,CTLA4 Inhibitory Signaling R-HSA-389513,0.4128196988504635,0.661900394702439,0.86,1.0,1.0,3/21,5.45%,Akt3;Fyn;Src
prerank,Selective Autophagy R-HSA-9663891,0.3553696176256312,0.6612097200477889,0.9437939110070258,1.0,1.0,4/59,5.45%,Prkag2;Dync1i2;Nbr1;Src
prerank,Homology Directed Repair R-HSA-5693538,-0.3348493112730533,-0.6606481686594231,0.9714285714285714,1.0,1.0,16/106,21.15%,Rbbp8;Nsd2;Rad51b;Wrn;Artn;Top3a;Eme1;Lrig3;Xrcc2;Rrad;Dna2;H2bc3;Bard1;Pold4;Cdk2;Xrcc3
prerank,Cell Cycle Checkpoints R-HSA-69620,-0.30848009044300134,-0.6603951937082838,1.0,1.0,1.0,42/252,22.33%,Rbbp8;Ppp2r5a;Ywhaq;Mcm10;Nsd2;Ppp2r5c;Zwint;Nde1;Clasp2;Aurkb;Dync1h1;Bub1;Wrn;Artn;Top3a;Psmb8;Dync1li2;Ndc80;Psme4;Knl1;Anapc11;Cenpn;Rangap1;Rrad;Slc25a2;Pafah1b1;Ppp2r5e;Dna2;Ska1;H2bc3;Bard1;Ndel1;Cdk2;Mcm3;Sec13;Incenp;Anapc5;Psme2;Anapc2;Sem1;Psma1;Cdk1
prerank,Dectin-2 Family R-HSA-5621480,0.417013561021085,0.6602228455299956,0.8449612403100775,1.0,1.0,2/17,3.69%,Plcg2;Fyn
prerank,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.3360869787360814,-0.6594093104473163,0.9754253308128544,1.0,1.0,15/101,21.15%,Rbbp8;Nsd2;Rad51b;Wrn;Artn;Top3a;Eme1;Xrcc2;Rrad;Dna2;H2bc3;Bard1;Pold4;Cdk2;Xrcc3
prerank,Pyruvate Metabolism R-HSA-70268,-0.39195556294950934,-0.6589090152824846,0.8905472636815921,1.0,1.0,5/29,13.21%,Slc16a1;Ldhb;Ldha;Pdk4;Ldhd
prerank,Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.3987669799801389,-0.6546305947825292,0.88,1.0,1.0,3/15,10.33%,Ddah1;Cav1;Tacr1
prerank,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.3378408604928555,0.6525171081816074,0.974477958236659,1.0,1.0,10/86,6.91%,Ppp1r12b;Ppp1cb;Dync1i2;Fbxw11;Btrc;Odf2;Sdccag8;Cul1;Prkar2b;Ywhae
prerank,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.3380722328164332,-0.6525131522311802,0.9716446124763705,1.0,1.0,14/94,16.86%,Masp1;Traf3;Il17ra;Irak2;Trim25;Rnf135;Rigi;Ifih1;Sec24a;Il17f;Nlrp3;Irf3;B2m;Tlr7
prerank,Triglyceride Catabolism R-HSA-163560,0.4142754649068699,0.6505051065815303,0.864,1.0,1.0,4/18,8.30%,Ppp1cb;Prkacb;Gpd2;Mgll
prerank,KEAP1-NFE2L2 Pathway R-HSA-9755511,0.33254477577714625,0.6470317480273288,0.9889867841409692,1.0,1.0,5/99,5.79%,Akt3;Btrc;Crebbp;Txnrd1;Cul1
prerank,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.350250705416646,-0.6432400954447083,0.9485815602836879,1.0,1.0,16/60,16.43%,App;Traf3;Rnf125;Cyld;Trim25;Tnfaip3;Rnf135;Casp8;Nkiras1;Rigi;S100b;Ifih1;Tax1bp1;Map3k1;Irf3;Nfkbia
prerank,Generation Of Second Messenger Molecules R-HSA-202433,0.4048867128747341,0.6428496746830558,0.8592592592592593,1.0,1.0,3/21,6.25%,Plcg2;Arhgef7;Nck1
prerank,Transferrin Endocytosis And Recycling R-HSA-917977,-0.3854011369245064,-0.6424917248153836,0.9042016806722689,1.0,1.0,2/28,6.16%,Steap2;Hfe
prerank,Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,-0.40182056429846325,-0.640228082529094,0.8848,1.0,1.0,3/15,8.89%,Cckbr;Prkca;Egfr
prerank,Translesion Synthesis By POLK R-HSA-5655862,0.40618841601790384,0.6394304463504806,0.8555858310626703,1.0,1.0,1/17,3.96%,Rev1
prerank,Acyl Chain Remodelling Of PE R-HSA-1482839,-0.3850236972636644,-0.6382790221003077,0.9031719532554258,1.0,1.0,8/26,13.12%,Pla2g4c;Plaat1;Pla2g4a;Pnpla8;Pla2r1;Pla2g6;Pla2g5;Mboat1
prerank,DNA Repair R-HSA-73894,-0.28876042381574923,-0.6377076104159217,1.0,1.0,1.0,24/288,15.98%,Rbbp8;Usp43;Eya4;Fancc;Mapk8;Nsd2;Cnksr3;Rad51b;Neil3;Trim25;Lrig1;Nthl1;Wrn;Artn;Top3a;Eme1;Pias3;Eya2;Lrig3;Dtl;Mgmt;Xrcc2;Apbb1;Rrad
prerank,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.390703710966034,-0.6375694149208612,0.9185667752442996,1.0,1.0,11/21,48.56%,Lrig1;Pold4;Rfc2;Slc19a1;Pole4;Rfc3;Polr1b;Pole;Rpa3;Fen1;Pcna
prerank,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.3302242487134869,-0.6362237231521721,0.9801801801801802,1.0,1.0,27/96,23.73%,Sclt1;Cep83;Plk4;Tubb4a;Prkca;Nedd1;Nde1;Alms1;Ccp110;Dync1h1;Akap9;Cep290;Cep164;Csnk1e;Rpgrip1l;Cep43;Kif24;Pafah1b1;Hsp90aa1;Tubb4b;Cntrl;Tuba1a;Cdk1;Mark4;Septin2;Rab11a;Cep97
prerank,Mismatch Repair R-HSA-5358508,-0.40258429761512676,-0.6361875043491938,0.9121405750798722,1.0,1.0,3/15,23.68%,Lrig1;Pold4;Msh2
prerank,Interleukin-10 Signaling R-HSA-6783783,0.37005441736874983,0.6360063492791073,0.920814479638009,1.0,1.0,1/35,1.63%,Il1r1
prerank,Respiratory Electron Transport R-HSA-611105,-0.33229895984663743,-0.6340711879989424,0.9791271347248577,1.0,1.0,32/89,38.41%,Cox16;Ndufaf2;Coq10b;Cox7b;Ndufa2;Ndufa1;Ndufa3;Ndufb8;Cox5a;Sdha;Ndufaf7;Sdhb;Ndufa7;Timmdc1;Ndufa13;Taco1;Ndufa12;Uqcrh;Tmem186;Cox6b1;Uqcr10;Ndufb11;Cox8a;Uqcrb;Ndufb9;Cox5b;Uqcrq;Uqcr11;Coq10a;Ndufa8;Cox6a1;Uqcrc1
prerank,Formation Of Cornified Envelope R-HSA-6809371,-0.37418954535201604,-0.632899651693496,0.936426116838488,1.0,1.0,5/33,7.62%,Kazn;Dsc3;Pcsk6;Klk8;Rcan1
prerank,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.39638700564268997,-0.6311939198891842,0.9157212317666127,1.0,1.0,1/16,3.81%,E2f1
prerank,Degradation Of GLI2 By Proteasome R-HSA-5610783,0.35003350903775277,0.6311226447843846,0.9654377880184332,1.0,1.0,9/58,13.43%,Btrc;Csnk1a1;Cul1;Prkacb;Psmd13;Sufu;Psmd14;Psmd2;Psmc1
prerank,Triglyceride Metabolism R-HSA-8979227,0.37923910536111666,0.6307392257079364,0.9057971014492754,1.0,1.0,6/30,8.30%,Ppp1cb;Dgat2;Prkacb;Gpd2;Lpin2;Mgll
prerank,Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.3092223759237314,0.6306510185040912,1.0,1.0,1.0,11/145,7.89%,Akt3;Dyrk1a;Hdac1;Mcm6;Ccnd2;Ccnh;Src;Cul1;Orc3;Mnat1;Psmd13
prerank,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.3529323614842078,0.6293109970191418,0.9398148148148148,1.0,1.0,3/54,7.89%,Btrc;Cul1;Psmd13
prerank,Cellular Response To Hypoxia R-HSA-1234174,-0.3362144853323139,-0.6293094179891392,0.9800362976406534,1.0,1.0,10/71,22.10%,Epas1;Vegfa;Limd1;Psmb8;Psme4;Hif3a;Ep300;Psme2;Sem1;Psma1
prerank,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.36182915557134626,-0.6234333110346282,0.9271186440677966,1.0,1.0,10/38,24.71%,E2f1;Ccnd1;Ccnd3;Anapc11;Cdkn1c;Cdk2;Anapc5;Anapc2;E2f2;Ccne2
prerank,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.35707047014215354,-0.6234139753775927,0.9139414802065404,1.0,1.0,3/35,13.40%,Edem1;Uggt2;Sel1l
prerank,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.36813897722306305,0.6228223544988943,0.9219143576826196,1.0,1.0,1/26,2.25%,Usp2
prerank,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.34903591470905326,0.6221460393860758,0.9628712871287128,1.0,1.0,8/52,13.69%,Eif4b;Eif4a1;Eif3a;Eif4e;Eif4a2;Eif5;Rpsa;Eif3h
prerank,Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.3324276033324466,0.6221409455230841,0.9675174013921114,1.0,1.0,6/82,9.14%,Akt3;Ccnh;Cul1;Mnat1;Psmd13;Wee1
prerank,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.38045228314784907,0.6219317263299994,0.9,1.0,1.0,6/26,13.73%,Ndc1;Nup93;Tnpo1;Nup160;Nup155;Ahctf1
prerank,Translation Initiation Complex Formation R-HSA-72649,0.3511916941539748,0.6218518499265735,0.9627791563275434,1.0,1.0,8/52,13.69%,Eif4b;Eif4a1;Eif3a;Eif4e;Eif4a2;Pabpc1;Rpsa;Eif3h
prerank,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.3826479902434716,-0.6206288057302718,0.9105180533751962,1.0,1.0,3/19,18.56%,E2f1;Lin54;Top2a
prerank,Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.37728733487700467,-0.6204245654236781,0.9020537124802528,1.0,1.0,1/18,6.13%,Podxl2
prerank,TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.3696607885853864,-0.6188329458988399,0.927487352445194,1.0,1.0,6/25,18.70%,Edaradd;Tnfrsf13b;Tnfrsf11b;Edar;Tnfrsf1b;Tnfsf11
prerank,Apoptotic Execution Phase R-HSA-75153,0.35227161085516107,0.6159813445997717,0.9443155452436195,1.0,1.0,11/44,9.78%,Ptk2;Ocln;Sptan1;Stk26;Dsg2;Tjp1;Ctnnb1;Acin1;Rock1;Dnm1l;Add1
prerank,Cleavage Of Damaged Purine R-HSA-110331,-0.3743009722495479,-0.61579244660829,0.9158249158249159,1.0,1.0,3/24,18.54%,Neil3;H2aj;H2bc3
prerank,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.3180489590070045,-0.6131285114835819,0.9790076335877863,1.0,1.0,34/97,38.41%,Cox16;Ndufaf2;Coq10b;Cox7b;Ndufa2;Ndufa1;Slc25a27;Ndufa3;Ndufb8;Ucp3;Cox5a;Sdha;Ndufaf7;Sdhb;Ndufa7;Timmdc1;Ndufa13;Taco1;Ndufa12;Uqcrh;Tmem186;Cox6b1;Uqcr10;Ndufb11;Cox8a;Uqcrb;Ndufb9;Cox5b;Uqcrq;Uqcr11;Coq10a;Ndufa8;Cox6a1;Uqcrc1
prerank,TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.3866683254239209,-0.6119434310881995,0.9189627228525121,1.0,1.0,4/16,25.36%,Ep300;Cdk1;Ccnb1;Rbl1
prerank,Keratinization R-HSA-6805567,-0.3313036275394623,-0.6107177706752884,0.9710144927536232,1.0,1.0,8/60,12.69%,Kazn;Dsc3;Pcsk6;Klk8;Rcan1;Krt25;Krt79;Tgm5
prerank,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.3290899665972756,-0.6083578597679451,0.9678571428571429,1.0,1.0,8/63,22.10%,Epas1;Limd1;Psmb8;Psme4;Hif3a;Psme2;Sem1;Psma1
prerank,Regulated Necrosis R-HSA-5218859,-0.3438722907405993,-0.6077436383047174,0.9622980251346499,1.0,1.0,11/49,18.76%,Birc3;Irf2;Casp1;Flot1;Tnfsf10;Casp8;Casp4;Mlkl;Il1a;Flot2;Hsp90aa1
prerank,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.36356525946289897,0.6077196197292487,0.9482352941176471,1.0,1.0,8/36,7.65%,Ptk2;Ocln;Sptan1;Stk26;Dsg2;Tjp1;Ctnnb1;Acin1
prerank,Defective Pyroptosis R-HSA-9710421,0.36222053142136096,0.6071014939039143,0.9349397590361446,1.0,1.0,6/30,11.24%,Ezh2;Suz12;Rbbp7;H2bc4;H2ax;H2ac6
prerank,Centrosome Maturation R-HSA-380287,-0.3186198490431993,-0.6069302502420917,0.9842657342657343,1.0,1.0,16/77,18.77%,Plk4;Tubb4a;Prkca;Nedd1;Nde1;Alms1;Ccp110;Dync1h1;Akap9;Cep290;Cep164;Csnk1e;Cep43;Pafah1b1;Hsp90aa1;Tubb4b
prerank,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.31889111333882403,-0.6066408884402688,0.9876977152899824,1.0,1.0,16/77,18.77%,Plk4;Tubb4a;Prkca;Nedd1;Nde1;Alms1;Ccp110;Dync1h1;Akap9;Cep290;Cep164;Csnk1e;Cep43;Pafah1b1;Hsp90aa1;Tubb4b
prerank,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.3645948618312419,0.6056239312433137,0.9298245614035088,1.0,1.0,5/32,9.05%,Pdzd2;Ube2k;Ube2d1;Ube2d3;Otud5
prerank,ABC Transporter Disorders R-HSA-5619084,-0.3224387933004561,-0.6045031787154166,0.9891500904159132,1.0,1.0,7/77,14.58%,Abca1;Cftr;Abca3;Psmb8;Sel1l;Psme4;Abcd1
prerank,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.3406834203454244,-0.6043057170429501,0.9775862068965517,1.0,1.0,5/47,9.73%,Plagl1;E2f1;Plk2;E2f7;Plk3
prerank,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,0.3089977277851863,0.601992520975712,0.9955654101995566,1.0,1.0,11/102,8.94%,Cenpp;Dync1i2;Pds5b;Hdac8;Taok1;Ranbp2;Xpo1;Pds5a;Dync1i1;Rcc2;Wapl
prerank,G1/S Transition R-HSA-69206,0.30014501827225276,0.6014397231834742,1.0,1.0,1.0,10/127,9.60%,Akt3;Hdac1;Mcm6;Ccnh;Cul1;Orc3;Mnat1;Psmd13;Wee1;Orc6
prerank,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.36532091880029166,-0.5997884979576796,0.9348171701112877,1.0,1.0,3/23,9.37%,Myo6;Tmod3;Msi2
prerank,S Phase R-HSA-69242,0.2904602763127568,0.5970305354132861,0.9978632478632479,1.0,1.0,14/161,9.84%,Akt3;Pds5b;Mcm6;Ccnh;Cul1;Orc3;Ube2d1;Mnat1;Pds5a;Psmd13;Wapl;Wee1;Orc6;Cdc26
prerank,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.35548362817131274,-0.5963640942420954,0.9415807560137457,1.0,1.0,4/31,18.54%,Neil3;Nthl1;H2aj;H2bc3
prerank,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.33643572655579945,-0.596039523884868,0.9702276707530648,1.0,1.0,6/46,22.10%,Mrc1;Psmb8;Psme4;Psme2;Sem1;Psma1
prerank,Influenza Viral RNA Transcription And Replication R-HSA-168273,0.2989719927398754,0.5951249407673094,0.9954337899543378,1.0,1.0,30/128,17.63%,Gtf2f2;Ndc1;Ranbp2;Parp1;Nup93;Rpl15;Polr2e;Rpl4;Gnl3;Rplp0;Rpl10a;Rplp1;Nup160;Rpl3;Nup155;Mrpl13;Rpsa;Rpl8;Rpl36a;Rsl24d1;Gtf2f1;Nup214;Rpl18;Polr2k;Rpl6;Nup210;Rps28;Nup153;Ipo5;Rps3
prerank,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.35582009924844193,-0.5946054772399532,0.9522184300341296,1.0,1.0,4/29,18.54%,Neil3;Nthl1;H2aj;H2bc3
prerank,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.3293055701410793,-0.5941171799624856,0.9634782608695652,1.0,1.0,13/51,38.61%,Ccnd1;Psmb8;Psme4;Psme2;Sem1;Psma1;Ubb;Ubc;Psmd11;Psmd12;Psmb10;Psmc6;Gsk3b
prerank,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.3237167860304284,-0.5906212913960572,0.9840142095914742,1.0,1.0,7/60,22.10%,Cftr;Psmb8;Sel1l;Psme4;Psme2;Sem1;Psma1
prerank,SUMOylation Of Transcription Factors R-HSA-3232118,-0.3612321524102188,-0.5904064248410622,0.9297124600638977,1.0,1.0,2/17,12.63%,Mitf;Pias3
prerank,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.3107334095506671,-0.588047182466969,0.9927927927927928,1.0,1.0,17/89,18.76%,Ppp2r5a;Ppp2r5c;Zwint;Nde1;Clasp2;Aurkb;Dync1h1;Bub1;Dync1li2;Ndc80;Knl1;Cenpn;Rangap1;Pafah1b1;Ppp2r5e;Ska1;Ndel1
prerank,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.3247443640870375,0.5871173140567112,0.9818181818181818,1.0,1.0,5/58,7.89%,Btrc;Csnk1a1;Cul1;Prkacb;Psmd13
prerank,TNF Signaling R-HSA-75893,0.33088509458358895,0.584995434951876,0.9710843373493976,1.0,1.0,4/44,6.99%,Usp2;Bag4;Sppl2a;Smpd3
prerank,PRC2 Methylates Histones And DNA R-HSA-212300,0.34933107237391237,0.5849732816198755,0.9342723004694836,1.0,1.0,8/30,11.24%,Mtf2;Ezh2;Suz12;Rbbp7;Aebp2;H2bc4;H2ax;H2ac6
prerank,Iron Uptake And Transport R-HSA-917937,-0.32333852607998564,-0.5847521572387158,0.9661921708185054,1.0,1.0,3/54,7.56%,Steap2;Hfe;Cp
prerank,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.3168892446337437,-0.5845411150570285,0.9831144465290806,1.0,1.0,16/59,30.89%,Stat6;Trim21;Ticam1;Nkiras1;Dtx4;Tlr3;Irf3;Nfkbia;Ep300;Chuk;Ripk1;Ubb;Rela;Sting1;Prkdc;Ubc
prerank,Aggrephagy R-HSA-9646399,-0.346084579852352,-0.5844702621066518,0.9540229885057471,1.0,1.0,4/23,12.87%,Cftr;Ift88;Dync1h1;Dync1li2
prerank,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.3326562721646231,0.5837678553810681,0.972972972972973,1.0,1.0,3/51,7.89%,Btrc;Cul1;Psmd13
prerank,Interleukin-12 Family Signaling R-HSA-447115,0.3308989619495647,0.5806279616368031,0.9719626168224299,1.0,1.0,3/49,4.98%,Crlf1;Pdcd4;Hnrnpdl
prerank,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.3221017708446062,0.5787622580189459,0.9688249400479616,1.0,1.0,4/58,7.89%,Fbxw11;Btrc;Cul1;Psmd13
prerank,Regulation Of Apoptosis R-HSA-169911,-0.3193305555314695,-0.5764204135351413,0.9718804920913884,1.0,1.0,7/52,22.10%,Psmb8;Psme4;Oma1;Pkn2;Psme2;Sem1;Psma1
prerank,G0 And Early G1 R-HSA-1538133,0.35469723572061046,0.576118292970454,0.9544303797468354,1.0,1.0,2/27,3.99%,Dyrk1a;Hdac1
prerank,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.289546706512579,0.5719284415482235,0.9976851851851852,1.0,1.0,27/107,17.78%,Smg7;Smg1;Ncbp1;Rpl15;Upf1;Dcp1a;Gspt1;Rpl4;Upf2;Rplp0;Pabpc1;Rpl10a;Rplp1;Rpl3;Mrpl13;Rpsa;Smg6;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6;Gspt2;Eif4a3;Rps28;Rps3;Upf3a
prerank,Late Endosomal Microautophagy R-HSA-9615710,-0.34354340150635865,-0.5680319345449916,0.9696969696969697,1.0,1.0,15/29,36.33%,Cftr;Ift88;Hspa8;Arl13b;Vps37c;Ubb;Chmp7;Mvb12a;Pcnt;Vps37d;Ubc;Plin2;Rnase1;Ubap1;Vps28
prerank,Attenuation Phase R-HSA-3371568,0.34937287622506275,0.5666684037804961,0.9387186629526463,1.0,1.0,3/24,6.48%,Hspa2;Crebbp;Dnajb6
prerank,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.31271573642831807,0.5664037697736019,0.9789227166276346,1.0,1.0,4/61,7.89%,Fbxw11;Btrc;Cul1;Psmd13
prerank,Acyl Chain Remodelling Of PC R-HSA-1482788,0.3517073827261224,0.5657976995014428,0.9398496240601504,1.0,1.0,4/26,8.56%,Pla2g4e;Mboat2;Pla2g3;Plb1
prerank,DNA Damage Bypass R-HSA-73893,-0.31591889390256245,-0.5639025550764497,0.9809688581314879,1.0,1.0,2/48,9.00%,Usp43;Trim25
prerank,Regulation Of Necroptotic Cell Death R-HSA-5675482,0.3311203004172686,0.5630255949595869,0.9207161125319693,1.0,1.0,2/27,3.28%,Peli1;Sdcbp
prerank,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.31418716301404437,0.5582437312201173,0.995085995085995,1.0,1.0,8/53,13.69%,Eif4b;Eif4a1;Eif3a;Eif4e;Eif4a2;Pabpc1;Rpsa;Eif3h
prerank,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.2965011637338094,0.5568198074775689,0.9931506849315068,1.0,1.0,6/84,9.14%,Akt3;Ccnh;Cul1;Mnat1;Psmd13;Wee1
prerank,RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.32426594495579153,0.5550026397640928,0.9291139240506329,1.0,1.0,2/29,3.28%,Peli1;Sdcbp
prerank,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.3076966084717138,-0.5548932442321474,0.9912587412587412,1.0,1.0,18/55,43.33%,Psmb8;Sel1l;Psme4;Shh;Psme2;Sem1;Psma1;Ubb;Ubc;Psmd11;Vcp;Psmd12;Psmb10;Psmc6;Psmd7;Psma2;Os9;Psmb1
prerank,Translesion Synthesis By POLH R-HSA-110320,-0.33855613749011526,-0.5543278770034767,0.9570063694267515,1.0,1.0,12/19,50.31%,Rfc2;Ubb;Slc19a1;Ubc;Vcp;Rfc3;Polr1b;Polh;Rpa3;Pcna;Ufd1;Rps27a
prerank,DNA Methylation R-HSA-5334118,-0.33968383103190425,-0.5543178200363725,0.9553719008264463,1.0,1.0,4/22,18.81%,Dnmt3a;H2aj;H2bc3;Dnmt3l
prerank,Base Excision Repair R-HSA-73884,-0.30667624007768235,-0.5539567128518501,0.9911816578483245,1.0,1.0,7/59,19.68%,Neil3;Lrig1;Nthl1;Lrig3;H2aj;H2bc3;Pold4
prerank,Mitotic Spindle Checkpoint R-HSA-69618,-0.28863355971219784,-0.5537344970018541,1.0,1.0,1.0,22/106,22.04%,Ppp2r5a;Ppp2r5c;Zwint;Nde1;Clasp2;Aurkb;Dync1h1;Bub1;Dync1li2;Ndc80;Knl1;Anapc11;Cenpn;Rangap1;Pafah1b1;Ppp2r5e;Ska1;Ndel1;Sec13;Incenp;Anapc5;Anapc2
prerank,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.3185407452437069,-0.5533268951157881,0.9746621621621622,1.0,1.0,8/38,29.83%,Lrig1;Nthl1;Lrig3;Pold4;Rfc2;Tdg;Neil2;Slc19a1
prerank,Chromosome Maintenance R-HSA-73886,-0.28239730541958225,-0.5532002152695873,1.0,1.0,1.0,14/103,21.05%,Ankrd28;Hjurp;Lrig1;Pif1;Wrn;Knl1;Cenpn;H2aj;Mis18bp1;Dna2;H2bc3;Pold4;Prim2;Cdk2
prerank,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.3414212588950663,-0.5523005933247315,0.9524564183835182,1.0,1.0,1/16,5.72%,Zfp36l1
prerank,Separation Of Sister Chromatids R-HSA-2467813,0.2665082842551844,0.5518376710187645,1.0,1.0,1.0,15/166,9.90%,Cenpp;Dync1i2;Pds5b;Hdac8;Taok1;Ube2d1;Ranbp2;Xpo1;Pds5a;Psmd13;Dync1i1;Rcc2;Wapl;Cdc26;Ska2
prerank,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.3052474016064594,-0.5509921444348156,0.9912280701754386,1.0,1.0,19/58,43.33%,Psmb8;Sel1l;Psme4;Shh;Psme2;Sem1;Psma1;Ubb;Ubc;Psmd11;Dhh;Vcp;Psmd12;Psmb10;Psmc6;Psmd7;Psma2;Os9;Psmb1
prerank,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.31394393513329516,-0.5346639272160064,0.9830508474576272,1.0,1.0,5/35,12.90%,Birc3;Cyld;Tnfaip3;Casp8;Tax1bp1
prerank,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,0.3037022613244002,0.5346171293526946,0.9786223277909739,1.0,1.0,11/48,11.72%,Herc2;Baz1b;Babam2;Rad50;Kdm4a;Chek2;Smarca5;H2bc4;Atm;H2ax;Rnf8
prerank,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.33792352375235474,-0.5332841478214724,0.9623233908948194,1.0,1.0,2/16,10.71%,Pi4k2b;Pik3c2a
prerank,DNA Double Strand Break Response R-HSA-5693606,0.30222000184172404,0.5304947954019158,0.9880382775119617,1.0,1.0,11/49,11.72%,Herc2;Baz1b;Babam2;Rad50;Kdm4a;Chek2;Smarca5;H2bc4;Atm;H2ax;Rnf8
prerank,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.31381774129014905,-0.5247882858816928,0.9698996655518395,1.0,1.0,5/24,29.83%,Pold4;Prim2;Rfc2;Ctc1;Slc19a1
prerank,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.291097941222462,-0.5242894302292652,0.988013698630137,1.0,1.0,15/49,43.33%,Psmb8;Psme4;Pkn2;Psme2;Sem1;Psma1;Ubb;Ubc;Psmd11;Psmd12;Psmb10;Psmc6;Psmd7;Psma2;Psmb1
prerank,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,0.29757875174395093,0.5215211706382338,0.9854721549636803,1.0,1.0,6/40,11.24%,Rad50;Hira;H2bc4;Atm;H2ax;H2ac6
prerank,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.3259273274397996,-0.5211839411502222,0.957166392092257,1.0,1.0,2/15,16.50%,Pcgf2;Dnmt3a
prerank,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.3204633800654285,-0.5181178585343705,0.9773413897280967,1.0,1.0,6/15,42.14%,Gfpt1;Gale;Galk1;Dolk;Gne;Dpm3
prerank,Cellular Hexose Transport R-HSA-189200,-0.32350542808687516,-0.5171441958612885,0.9706336939721792,1.0,1.0,8/15,48.24%,Slc2a8;Slc5a2;Slc2a1;Slc45a3;Slc5a10;Slc2a7;Slc50a1;Slc2a10
prerank,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.30192631916526236,-0.5157537654017189,0.9901960784313726,1.0,1.0,8/33,18.72%,Pla2g4a;Dync1h1;Pla2g6;Pafah1b3;Rab6b;Dync1li2;Pafah1b1;Rab6a
prerank,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.27401968838607227,-0.5145691926689999,1.0,1.0,1.0,28/76,42.33%,Psmb8;Psme4;Anapc11;Anapc5;Psme2;Anapc2;Sem1;Psma1;Cdk1;Ccnb1;Ubb;Anapc10;Ubc;Psmd11;Mad2l1;Psmd12;Anapc4;Psmb10;Ube2s;Ccna2;Psmc6;Nek2;Anapc15;Ccna1;Pttg1;Psmd7;Anapc1;Psma2
prerank,ROS And RNS Production In Phagocytes R-HSA-1222556,0.3045728848005014,0.5141625843765021,0.9880952380952381,1.0,1.0,3/34,7.64%,Atp6v1a;Atp6v1c2;Atp6v0e2
prerank,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.26163109090504955,0.5139169239473094,1.0,1.0,1.0,21/102,15.72%,Eif4b;Eif4a1;Eif3a;Rpl15;Eif5b;Eif4e;Rpl4;Eif4a2;Rplp0;Rpl10a;Eif5;Rplp1;Rpl3;Mrpl13;Rpsa;Eif3h;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6
prerank,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.2746953677726676,-0.5137312247271917,1.0,1.0,1.0,28/75,42.33%,Psmb8;Psme4;Anapc11;Anapc5;Psme2;Anapc2;Sem1;Psma1;Cdk1;Ccnb1;Ubb;Anapc10;Ubc;Psmd11;Mad2l1;Psmd12;Anapc4;Psmb10;Ube2s;Ccna2;Psmc6;Nek2;Anapc15;Ccna1;Pttg1;Psmd7;Anapc1;Psma2
prerank,Activation Of Pre-Replicative Complex R-HSA-68962,-0.3031464661169223,-0.5123277144402372,0.9917763157894737,1.0,1.0,5/31,21.27%,Mcm10;Slc25a2;Prim2;Cdk2;Mcm3
prerank,Vpu Mediated Degradation Of CD4 R-HSA-180534,0.2908818545091877,0.5085963753327614,0.9951690821256038,1.0,1.0,2/51,7.89%,Btrc;Psmd13
prerank,XBP1(S) Activates Chaperone Genes R-HSA-381038,0.28571735305350826,0.5077514700620952,0.9932432432432432,1.0,1.0,7/45,9.78%,Pdia5;Extl2;Ssr1;Ctdsp2;Dctn1;Wipi1;Add1
prerank,IRE1alpha Activates Chaperones R-HSA-381070,0.28427664494281396,0.5073366766545645,0.9955056179775281,1.0,1.0,7/47,9.78%,Pdia5;Extl2;Ssr1;Ctdsp2;Dctn1;Wipi1;Add1
prerank,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.2828251396628327,-0.5062951517205909,0.9964476021314387,1.0,1.0,15/58,38.37%,Psmb8;Psme4;Hsp90aa1;Psme2;Sem1;Psma1;Cdk1;Ccnb1;Ubb;Ubc;Psmd11;Psmd12;Psmb10;Cdkn1a;Psmc6
prerank,Cap-dependent Translation Initiation R-HSA-72737,0.2543701608711464,0.505867148583919,1.0,1.0,1.0,23/109,15.72%,Eif4b;Eif4a1;Eif3a;Rpl15;Eif5b;Eif4e;Rpl4;Eif4a2;Rplp0;Pabpc1;Rpl10a;Eif5;Rplp1;Rpl3;Mrpl13;Eif2b5;Rpsa;Eif3h;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6
prerank,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.27353351299596557,-0.5005911397993941,0.9947643979057592,1.0,1.0,9/59,26.17%,Ccnd1;Psmb8;Cks1b;Cdk2;Psme2;Sem1;Psma1;Ccne2;Ubb
prerank,NS1 Mediated Effects On Host Pathways R-HSA-168276,0.2907968061010095,0.5000706222837099,0.9914163090128756,1.0,1.0,7/37,12.69%,Ndc1;Ranbp2;Nup93;Gnl3;Nup160;Nup155;Pabpn1
prerank,EPHA-mediated Growth Cone Collapse R-HSA-3928663,0.32024158720958956,0.4982173244863666,0.9475138121546961,1.0,1.0,6/15,11.72%,Fyn;Src;Rock1;Yes1;Rock2;Myh9
prerank,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.26470439461495976,-0.4975435256628787,0.9981949458483754,1.0,1.0,25/73,44.10%,Aurkb;Psmb8;Psme4;Anapc11;Anapc5;Psme2;Anapc2;Sem1;Psma1;Ubb;Anapc10;Ubc;Psmd11;Psmd12;Anapc4;Psmb10;Ube2s;Psmc6;Anapc15;Pttg1;Psmd7;Anapc1;Psma2;Psmb1;Fzr1
prerank,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.27321323018715377,-0.49206556580132615,0.9964664310954063,1.0,1.0,4/48,14.44%,Rnf152;Bcl10;Rnf144a;Pex13
prerank,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.28071956827232447,0.4914547450484284,1.0,1.0,1.0,6/53,13.43%,Ywhaz;Cul1;Psmd13;Psmd14;Psmd2;Psmc1
prerank,Complex I Biogenesis R-HSA-6799198,-0.27561894304414325,-0.4898927883985199,0.9963898916967509,1.0,1.0,22/50,47.49%,Ndufaf2;Ndufa2;Ndufa1;Ndufa3;Ndufb8;Ndufaf7;Ndufa7;Timmdc1;Ndufa13;Ndufa12;Tmem186;Ndufb11;Ndufb9;Ndufa8;Ndufb3;Ndufs8;Ndufs2;Nubpl;Ndufs5;Ndufab1;Ndufaf3;Ndufv1
prerank,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.26150206834342693,-0.4884636985394646,1.0,1.0,1.0,26/73,42.33%,Psmb8;Psme4;Anapc11;Anapc5;Psme2;Anapc2;Sem1;Psma1;Cdk1;Ubb;Anapc10;Ubc;Psmd11;Mad2l1;Psmd12;Anapc4;Psmb10;Ube2s;Ccna2;Psmc6;Nek2;Anapc15;Ccna1;Psmd7;Anapc1;Psma2
prerank,SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.2820792787521931,0.48752956568527556,0.9956521739130435,1.0,1.0,8/41,12.63%,Top1;Ndc1;Ranbp2;Nup93;Sumo2;Top2b;Nup160;Nup155
prerank,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.29491664792976957,-0.48427677695277865,0.9901477832512315,1.0,1.0,11/24,38.68%,Anapc11;Anapc5;Anapc2;Cdk1;Ccnb1;Ubb;Anapc10;Ubc;Anapc4;Ube2s;Anapc15
prerank,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.28452585015944837,-0.48403059575381924,0.9965576592082617,1.0,1.0,6/35,24.09%,Mcm10;Rrad;Slc25a2;Cdk2;Mcm3;Rfc2
prerank,Mitochondrial Protein Import R-HSA-1268020,0.25781001149984833,0.48365695463358926,0.9976076555023924,1.0,1.0,12/59,14.91%,Chchd3;Ccni;Timm9;Timm17a;Tafazzin;Pmpcb;Mtx1;Fxn;Timm23;Hspd1;Gfer;Tomm20
prerank,Degradation Of GLI1 By Proteasome R-HSA-5610780,0.2659274525668358,0.4801603913164092,1.0,1.0,1.0,4/58,7.89%,Btrc;Cul1;Prkacb;Psmd13
prerank,DNA Replication R-HSA-69306,-0.23652143737931566,-0.4794274282698843,1.0,1.0,1.0,19/142,22.10%,Mcm10;Lrig1;Psmb8;Psme4;Anapc11;Slc25a2;H2aj;Dna2;H2bc3;Pold4;Prim2;Gins4;Cdk2;Mcm3;Anapc5;Psme2;Anapc2;Sem1;Psma1
prerank,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.25926775873955304,-0.4791919644544041,1.0,1.0,1.0,27/72,44.10%,Psmb8;Psme4;Anapc11;Cdk2;Anapc5;Psme2;Anapc2;Sem1;Psma1;Ccne2;Ubb;Anapc10;Ubc;Psmd11;Psmd12;Anapc4;Psmb10;Ube2s;Ccna2;Psmc6;Anapc15;Ccna1;Psmd7;Anapc1;Psma2;Psmb1;Fzr1
prerank,Orc1 Removal From Chromatin R-HSA-68949,0.26214546798457816,0.47903537798931434,1.0,1.0,1.0,9/69,13.43%,Mcm6;Cul1;Orc3;Psmd13;Orc6;Psmd14;Psmd2;Mcm7;Psmc1
prerank,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.25717465263044686,-0.4782882008096834,1.0,1.0,1.0,25/72,42.33%,Psmb8;Psme4;Anapc11;Anapc5;Psme2;Anapc2;Sem1;Psma1;Cdk1;Ubb;Anapc10;Ubc;Psmd11;Mad2l1;Psmd12;Anapc4;Psmb10;Ube2s;Ccna2;Psmc6;Anapc15;Ccna1;Psmd7;Anapc1;Psma2
prerank,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.25243336809817735,0.4781303692790199,1.0,1.0,1.0,5/80,9.84%,Btrc;Cul1;Ube2d1;Psmd13;Cdc26
prerank,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.24162285466915628,0.47397637491807104,1.0,1.0,1.0,20/101,15.72%,Eif4b;Eif4a1;Eif3a;Rpl15;Eif4e;Rpl4;Eif4a2;Rplp0;Pabpc1;Rpl10a;Rplp1;Rpl3;Mrpl13;Rpsa;Eif3h;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6
prerank,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.27704969392889717,0.47113971775512914,0.9877149877149877,1.0,1.0,5/26,11.24%,Orc3;Orc6;H2bc4;H2ax;H2ac6
prerank,Degradation Of AXIN R-HSA-4641257,0.26738796683104465,0.46856216596557315,1.0,1.0,1.0,6/54,13.43%,Tnks;Psmd13;Axin2;Psmd14;Psmd2;Psmc1
prerank,DNA Strand Elongation R-HSA-69190,-0.27742216613832055,-0.46705954811898615,0.9983361064891847,1.0,1.0,7/31,24.09%,Lrig1;Dna2;Pold4;Prim2;Gins4;Mcm3;Rfc2
prerank,ER-Phagosome Pathway R-HSA-1236974,-0.2481447124777438,-0.46436288817230564,1.0,1.0,1.0,21/81,32.75%,S100a1;Btk;Psmb8;Tlr6;Psme4;Tapbp;B2m;Ndufa2;Psme2;Sem1;Psma1;Chuk;Ubb;Sec61g;Ly96;Cd36;Ubc;Fgg;Vamp3;Tirap;Psmd11
prerank,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.2866836460317517,-0.4641187073929472,0.985691573926868,1.0,1.0,4/20,24.22%,Pex13;Abcd1;Pxmp2;Pxmp4
prerank,Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.2866576659066498,-0.4606852298876741,0.9846390168970814,1.0,1.0,2/15,13.21%,Pdk4;Ldhd
prerank,Influenza Infection R-HSA-168255,0.22553861752111964,0.46055865011303815,1.0,1.0,1.0,28/146,15.87%,Gtf2f2;Ndc1;Ranbp2;Xpo1;Parp1;Nup93;Rpl15;Polr2e;Rpl4;Gnl3;Rplp0;Rpl10a;Rplp1;Nup160;Rpl3;Nup155;Pabpn1;Mrpl13;Rpsa;Rpl8;Rpl36a;Rsl24d1;Gtf2f1;Nup214;Rpl18;Polr2k;Rpl6;Clta
prerank,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.24061605604788394,-0.45990170792443114,1.0,1.0,1.0,13/87,23.88%,Cdc14a;Aurkb;Psmb8;Psme4;Anapc11;Cdk2;Anapc5;Psme2;Anapc2;Sem1;Psma1;Cdk1;Ccnb1
prerank,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.2777040135464092,-0.4545704025602383,0.9950413223140496,1.0,1.0,1/29,4.96%,Stam2
prerank,Fanconi Anemia Pathway R-HSA-6783310,-0.2630785088365333,-0.4527533977473877,0.9947275922671354,1.0,1.0,3/35,17.57%,Fancc;Eme1;Fancd2
prerank,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.2748083239019095,-0.4512134056329001,0.9932203389830508,1.0,1.0,5/24,23.88%,Cdc25b;Foxm1;Cdk2;Cdk1;Ccnb1
prerank,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.2703858802098086,-0.4502454318705415,1.0,1.0,1.0,13/25,48.79%,Lrig1;Pold4;Rfc2;Slc19a1;Pole4;Rfc3;Polr1b;Pole;Parg;Rpa3;Fen1;Pcna;Adprs
prerank,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.23985076026023833,-0.4490328667225095,1.0,1.0,1.0,15/77,26.17%,Mafg;Slc7a11;Nfe2l2;Psmb8;Notch1;Idh1;Gsta3;Ep300;Srxn1;Psme2;Sem1;Psma1;Gclm;Gclc;Ubb
prerank,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.23882869582554683,-0.4426803895516221,1.0,1.0,1.0,23/67,43.33%,Psmb8;Psme4;Anapc11;Anapc5;Psme2;Anapc2;Sem1;Psma1;Ubb;Anapc10;Ubc;Psmd11;Psmd12;Anapc4;Psmb10;Ube2s;Psmc6;Anapc15;Pttg1;Psmd7;Anapc1;Psma2;Psmb1
prerank,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.24274326445409675,-0.4402156407788456,1.0,1.0,1.0,13/54,38.37%,Psmb8;Psme4;Psme2;Sem1;Psma1;Hspa8;Ubb;Hspb1;Ubc;Psmd11;Psmd12;Psmb10;Psmc6
prerank,HSF1 Activation R-HSA-3371511,0.26561342917590014,0.4397937084586112,0.9893048128342246,1.0,1.0,5/27,13.07%,Dnajb6;Ywhae;Eef1a1;Hsp90ab1;Hdac6
prerank,Phosphorylation Of APC/C R-HSA-176412,-0.2738648708320326,-0.43925358790696256,0.9950576606260296,1.0,1.0,9/20,38.68%,Anapc11;Anapc5;Anapc2;Cdk1;Ccnb1;Anapc10;Anapc4;Ube2s;Anapc15
prerank,DNA Replication Pre-Initiation R-HSA-69002,-0.2184613544783154,-0.4287696361371331,1.0,1.0,1.0,14/114,22.10%,Mcm10;Psmb8;Anapc11;Slc25a2;H2aj;H2bc3;Prim2;Cdk2;Mcm3;Anapc5;Psme2;Anapc2;Sem1;Psma1
prerank,Switching Of Origins To A Post-Replicative State R-HSA-69052,0.22598339039401993,0.4284554924553879,1.0,1.0,1.0,11/90,13.43%,Mcm6;Cul1;Orc3;Ube2d1;Psmd13;Orc6;Cdc26;Psmd14;Psmd2;Mcm7;Psmc1
prerank,DNA Damage Recognition In GG-NER R-HSA-5696394,0.24700007453230988,0.4247149982268645,0.9974747474747475,1.0,1.0,36/36,75.33%,Parp1;Ino80d;Nfrkb;Gps1;Uba52;Ino80e;Cops7a;Cops8;Rad23b;Ino80;Cops4;Cops2;Tfpt;Mcrs1;Cops6;Ino80b;Actl6a;Ruvbl1;Ino80c;Actr5;Ddb1;Cul4b;Cops5;Yy1;Parp2;Rps27a;Cetn2;Rbx1;Rad23a;Cops3;Actr8;Ubc;Ddb2;Xpc;Ubb;Cul4a
prerank,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.25783999238777866,-0.42449027328133115,0.9966722129783694,1.0,1.0,11/26,38.68%,Anapc11;Anapc5;Anapc2;Ubb;Anapc10;Ubc;Mad2l1;Anapc4;Ube2s;Nek2;Anapc15
prerank,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.23854892352149581,-0.42306397256129674,1.0,1.0,1.0,5/50,22.10%,Psmb8;Psme4;Psme2;Sem1;Psma1
prerank,Assembly Of Pre-Replicative Complex R-HSA-68867,0.22027110244020826,0.42049087746601216,1.0,1.0,1.0,13/98,13.43%,Mcm6;Orc3;Ube2d1;Psmd13;Orc6;Cdc26;H2bc4;H2ax;H2ac6;Psmd14;Psmd2;Mcm7;Psmc1
prerank,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.22921827424443172,-0.4129923061789298,1.0,1.0,1.0,14/49,43.33%,Psmb8;Psme4;Psme2;Sem1;Psma1;Ubb;Ubc;Psmd11;Psmd12;Psmb10;Psmc6;Psmd7;Psma2;Psmb1
prerank,Recycling Of Bile Acids And Salts R-HSA-159418,0.25908426895399017,0.4125643756898291,0.9855491329479769,1.0,1.0,2/15,11.06%,Ncoa1;Stard5
prerank,G1/S DNA Damage Checkpoints R-HSA-69615,-0.22318780519393652,-0.40917377334438837,1.0,1.0,1.0,20/64,43.33%,Psmb8;Psme4;Cdk2;Psme2;Sem1;Psma1;Ccne2;Ubb;Ubc;Psmd11;Psmd12;Psmb10;Cdkn1a;Ccna2;Psmc6;Ccna1;Chek1;Psmd7;Psma2;Psmb1
prerank,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.22183414941409252,-0.4002074953615599,1.0,1.0,1.0,15/51,43.33%,Psmb8;Psme4;Psme2;Sem1;Psma1;Ubb;Ubc;Psmd11;Psmd12;Psmb10;Psmc6;Chek1;Psmd7;Psma2;Psmb1
prerank,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.21858853498935893,-0.3989958937186027,1.0,1.0,1.0,19/62,43.33%,Psmb8;Psme4;Cdk2;Psme2;Sem1;Psma1;Ccne2;Ubb;Ubc;Psmd11;Psmd12;Psmb10;Cdkn1a;Ccna2;Psmc6;Ccna1;Psmd7;Psma2;Psmb1
prerank,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.2462624290110389,-0.39121667651489744,0.9967373572593801,1.0,1.0,7/17,41.31%,Pign;Pigm;Piga;Pigz;Pigc;Pigq;Pigv
prerank,Condensation Of Prophase Chromosomes R-HSA-2299718,0.22971765469624902,0.38730414614647923,1.0,1.0,1.0,4/30,11.24%,Kmt5a;H2bc4;H2ax;H2ac6
prerank,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.21055492502898182,-0.38615154216333497,1.0,1.0,1.0,22/63,44.10%,Psmb8;Anapc11;Anapc5;Psme2;Anapc2;Sem1;Psma1;Ubb;Anapc10;Ubc;Psmd11;Psmd12;Anapc4;Psmb10;Ube2s;Psmc6;Anapc15;Psmd7;Anapc1;Psma2;Psmb1;Fzr1
prerank,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.19827955469897243,0.37932972726664743,1.0,1.0,1.0,18/87,15.86%,Ncbp1;Rpl15;Upf1;Gspt1;Rpl4;Rplp0;Pabpc1;Rpl10a;Rplp1;Rpl3;Mrpl13;Rpsa;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6;Gspt2
prerank,Packaging Of Telomere Ends R-HSA-171306,0.21817755687642837,0.36203434191624534,1.0,1.0,1.0,9/20,20.53%,H2bc4;H2ax;H2ac6;H2ac4;Tinf2;H2bc21;Terf2ip;H2az1;Terf2
prerank,Synthesis Of DNA R-HSA-69239,-0.17922396122810821,-0.3497249602669546,1.0,1.0,1.0,18/119,24.71%,Lrig1;Psmb8;Psme4;Anapc11;Slc25a2;Dna2;Pold4;Prim2;Gins4;Cdk2;Mcm3;Anapc5;Psme2;Anapc2;Sem1;Psma1;Rfc2;Ccne2
prerank,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.21591469004578467,-0.3486016868690941,1.0,1.0,1.0,8/21,38.68%,Anapc11;Anapc5;Anapc2;Anapc10;Mad2l1;Anapc4;Ube2s;Anapc15
prerank,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,0.19900233763038516,0.32947136820831363,1.0,1.0,1.0,8/25,19.97%,H2bc4;H2ax;H2ac6;Tbp;H2ac4;H2bc21;Taf1c;H2az1
prerank,Selenoamino Acid Metabolism R-HSA-2408522,-0.1673003201721053,-0.32010528479299444,1.0,1.0,1.0,32/99,43.76%,Rpl3l;Hnmt;Rps11;Mat1a;Sepsecs;Aimp2;Rpl14;Rps24;Rpl22l1;Pstk;Rpl27a;Rpl37;Papss2;Rpl39;Rps27;Rps16;Rpl22;Rpl11;Rpl32;Rps6;Mars1;Rps27l;Rpl29;Rpl37a;Rps4x;Rps7;Rpl36;Fau;Rpl23;Rpl19;Rpl23a;Rps5
prerank,Stabilization Of P53 R-HSA-69541,-0.17602106256417685,-0.3194207906248609,1.0,1.0,1.0,11/54,38.37%,Psmb8;Psme4;Psme2;Sem1;Psma1;Ubb;Ubc;Psmd11;Psmd12;Psmb10;Psmc6
prerank,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.1848775719913225,0.31845882368225414,1.0,1.0,1.0,3/30,8.74%,Ube2b;Usp1;Rad18
prerank,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.16140685401359336,0.317806241135432,1.0,1.0,1.0,18/101,15.72%,Ssr1;Rpl15;Spcs2;Rpl4;Rplp0;Rpl10a;Rplp1;Rpl3;Mrpl13;Rpsa;Ssr3;Rpn2;Sec61a2;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6
prerank,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.18019597206744642,-0.3143582058341119,1.0,1.0,1.0,15/44,45.22%,Rps11;Ddx20;Rps24;Rps27;Rps16;Gemin7;Rps6;Rps27l;Rps4x;Rps7;Snrpd2;Fau;Rps5;Gemin6;Rps25
prerank,Mitochondrial Translation Elongation R-HSA-5389840,-0.16494498161486504,-0.31010848409511405,1.0,1.0,1.0,9/82,32.16%,Mrpl52;Mrps6;Mrpl36;Mrps36;Mrpl14;Gfm1;Mrpl20;Aurkaip1;Mrpl54
prerank,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.19026321447708466,-0.30671317516125235,1.0,1.0,1.0,9/20,44.10%,Anapc11;Anapc5;Anapc2;Anapc10;Anapc4;Ube2s;Anapc15;Anapc1;Fzr1
prerank,Eukaryotic Translation Elongation R-HSA-156842,0.1596983613237587,0.3052716007169245,1.0,1.0,1.0,17/85,15.72%,Rpl15;Eef1a1;Rpl4;Eef2;Rplp0;Rpl10a;Rplp1;Rpl3;Mrpl13;Eef1d;Rpsa;Eef1g;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6
prerank,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.17226008276577096,0.3044106442826506,1.0,1.0,1.0,5/52,13.43%,Cul5;Psmd13;Psmd14;Psmd2;Psmc1
prerank,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.17148182665424055,0.3001743114827882,1.0,1.0,1.0,45/45,82.88%,Eif3a;Rpsa;Eif3h;Rps28;Rps3;Rps9;Eif3b;Eif2s1;Rps8;Eif3m;Rps21;Eif3g;Rps15a;Eif3e;Rps15;Eif1ax;Rps12;Rps10;Rps13;Eif3i;Eif3k;Rps19;Eif3l;Eif3f;Eif3c;Rps17;Rps2;Rps23;Eif2s2;Rps20;Rps29;Rps14;Rps27a;Rps25;Rps5;Eif3d;Fau;Rps7;Rps4x;Rps27l;Rps6;Rps16;Rps27;Rps24;Rps11
prerank,Mitochondrial Translation R-HSA-5368287,-0.15021476683713608,-0.2826775992663864,1.0,1.0,1.0,9/88,32.16%,Mrpl52;Mrps6;Mrpl36;Mrps36;Mrpl14;Gfm1;Mrpl20;Aurkaip1;Mrpl54
prerank,Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.17011211681007207,0.2820873190477342,1.0,1.0,1.0,23/23,83.00%,H2bc4;H2ax;H2ac6;Kdm1a;H2ac4;H2bc21;Ncoa2;H2az1;H2az2;H3c13;H2bc11;Klkb1;H2ac7;H2ac20;Kdm4c;H2bc15;H2bc14;H3c7;Pkn1;H2bc9;Areg;H2bc3;H2aj
prerank,Mitochondrial Translation Termination R-HSA-5419276,-0.14613518859542624,-0.2756629789675393,1.0,1.0,1.0,8/82,32.16%,Mrpl52;Mrps6;Mrpl36;Mrps36;Mrpl14;Mrpl20;Aurkaip1;Mrpl54
prerank,Selenocysteine Synthesis R-HSA-2408557,-0.14458995751626175,-0.27143623641306364,1.0,1.0,1.0,27/84,43.76%,Rpl3l;Rps11;Sepsecs;Rpl14;Rps24;Rpl22l1;Pstk;Rpl27a;Rpl37;Rpl39;Rps27;Rps16;Rpl22;Rpl11;Rpl32;Rps6;Rps27l;Rpl29;Rpl37a;Rps4x;Rps7;Rpl36;Fau;Rpl23;Rpl19;Rpl23a;Rps5
prerank,Peptide Chain Elongation R-HSA-156902,0.14221114767158147,0.2686871506228357,1.0,1.0,1.0,15/81,15.72%,Rpl15;Eef1a1;Rpl4;Eef2;Rplp0;Rpl10a;Rplp1;Rpl3;Mrpl13;Rpsa;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6
prerank,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.13898462663496536,-0.2658475005122571,1.0,1.0,1.0,29/92,43.76%,Rpl3l;Gdnf;Impact;Rps11;Rpl14;Rps24;Rpl22l1;Rpl27a;Cebpg;Rpl37;Rpl39;Atf4;Rps27;Rps16;Rpl22;Rpl11;Rpl32;Rps6;Rps27l;Rpl29;Rpl37a;Rps4x;Rps7;Rpl36;Fau;Rpl23;Rpl19;Rpl23a;Rps5
prerank,Viral mRNA Translation R-HSA-192823,-0.14063485965306005,-0.2651661737582013,1.0,1.0,1.0,29/85,46.56%,Rpl3l;Rps11;Rpl14;Rps24;Rpl22l1;Rpl27a;Rpl37;Rpl39;Rps27;Rps16;Rpl22;Rpl11;Rpl32;Rps6;Rps27l;Rpl29;Rpl37a;Rps4x;Rps7;Rpl36;Fau;Rpl23;Rpl19;Rpl23a;Rps5;Rps25;Rpl21;Rpl36al;Rpl27
prerank,Mitochondrial Translation Initiation R-HSA-5368286,-0.14016591164576386,-0.26236373889206466,1.0,0.9999984741187654,1.0,8/82,32.16%,Mrpl52;Mrps6;Mrpl36;Mrps36;Mrpl14;Mrpl20;Aurkaip1;Mrpl54
prerank,Eukaryotic Translation Termination R-HSA-72764,0.13262511473218908,0.25429694582517826,1.0,1.0,1.0,16/85,15.86%,Rpl15;Gspt1;Rpl4;Rplp0;Rpl10a;N6amt1;Rplp1;Rpl3;Mrpl13;Rpsa;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6;Gspt2
prerank,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.12994898960010506,0.25014114000790183,1.0,0.9999978752382389,1.0,15/92,15.72%,Eif3a;Rpl15;Rpl4;Rplp0;Rpl10a;Rplp1;Rpl3;Mrpl13;Rpsa;Eif3h;Rpl8;Rpl36a;Rsl24d1;Rpl18;Rpl6
